<SEC-DOCUMENT>0000950123-11-058510.txt : 20110613
<SEC-HEADER>0000950123-11-058510.hdr.sgml : 20110613
<ACCEPTANCE-DATETIME>20110613092555
ACCESSION NUMBER:		0000950123-11-058510
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20110608
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110613
DATE AS OF CHANGE:		20110613

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TELEFLEX INC
		CENTRAL INDEX KEY:			0000096943
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				231147939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05353
		FILM NUMBER:		11907295

	BUSINESS ADDRESS:	
		STREET 1:		155 SOUTH LIMERICK ROAD
		STREET 2:		CORPORATE OFFICES
		CITY:			LIMERICK
		STATE:			PA
		ZIP:			19468
		BUSINESS PHONE:		610 948-5100

	MAIL ADDRESS:	
		STREET 1:		155 SOUTH LIMERICK ROAD
		CITY:			LIMERICK
		STATE:			PA
		ZIP:			19468
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>y91654e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><!-- xbrl,dc --><B>Date of Report (Date of earliest event reported): June&nbsp;8, 2011</B><!-- /xbrl,dc --></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>Teleflex Incorporated</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in Charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>1-5353</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>23-1147939</B></TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer Identification No.)</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>155 South Limerick Road,</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>Limerick, Pennsylvania</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>19468</B></TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code: <B>(610)&nbsp;948-5100</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Not Applicable</B></DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000">(Former Name or Former Address, if Changed Since Last Report)</FONT></DIV></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>










<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<!--TOC-->
<!--/TOC-->






<!-- link1 "Item&nbsp;1.01 Entry into a Material Definitive Agreement" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Underwriting Agreement</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;8, 2011, Teleflex Incorporated (the &#147;Company&#148;) entered into an underwriting agreement
(the &#147;Underwriting Agreement&#148;) with the subsidiaries of the Company named as guarantors therein
(the &#147;Guarantors&#148;) and Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, Goldman, Sachs &#038; Co.,
and J.P. Morgan Securities LLC (the &#147;Underwriters&#148;), pursuant to which the Company agreed to sell
$250.0&nbsp;million aggregate principal amount of 6.875% Senior Subordinated Notes due 2019 (the
&#147;Notes&#148;). The Notes were offered and sold in a public offering registered under the Securities Act
of 1933, as amended (the &#147;Offering&#148;) pursuant to a Registration Statement on Form S-3 (Registration
No.&nbsp;333-168464). On June&nbsp;13, 2011, the Company is issuing and selling to the Underwriters $250.0
million aggregate principal amount of the Notes upon payment pursuant to the Underwriting
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Underwriting Agreement includes customary representations, warranties and covenants. Under
the terms of the Underwriting Agreement, the Company and the Guarantors have agreed to indemnify
the Underwriters against certain liabilities, and contribute to payments which the Underwriters may
be required to make in respect of any such liabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company estimates that the net proceeds from the offering of the Notes will be
approximately $245.8&nbsp;million, after deducting the Underwriters&#146; discounts and commissions and
estimated net offering expenses payable by the Company. The Company intends to use the net
proceeds to prepay $125&nbsp;million of borrowings under the Company&#146;s credit facilities and the
remainder for general corporate purposes, which may include, among other things, capital
expenditures, acquisitions and additional repayment of debt.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing description of the Underwriting Agreement is qualified in its entirety by the
copy thereof which is attached as Exhibit&nbsp;1.1 and incorporated herein by reference.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U><B>Indenture and Notes </B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;13, 2011, the Company, the Guarantors and Wells Fargo Bank, N.A., as trustee (the
&#147;Trustee&#148;) executed the Second Supplemental Indenture (the &#147;Second Supplemental Indenture&#148;) to the
Indenture, dated as of August&nbsp;2, 2010 (the &#147;Base Indenture&#148; and, as supplemented by the Second
Supplemental Indenture, the &#147;Indenture&#148;) between the Company and the Trustee, pursuant to which the
Company and Guarantors are issuing the Notes and guarantees on June&nbsp;13, 2011.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Notes will pay interest semi-annually on June 1 and December&nbsp;1, commencing on December&nbsp;1,
2011, at a rate of 6.875% per year, and mature on June&nbsp;1, 2019, unless earlier redeemed or
purchased by the Company at the holder&#146;s option upon a Change of Control or Asset Sale (each as
defined in the Indenture).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Notes will be the Company&#146;s general unsecured senior subordinated obligations and are
subordinated in right of payment to all of the Company&#146;s existing and future senior indebtedness,
including the Company&#146;s indebtedness under its credit facilities, and will be equal
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in right of payment with all of the Company&#146;s existing and future senior subordinated
indebtedness, including the Company&#146;s 3.875% Convertible Senior Subordinated Notes due 2017. The
obligations under the Notes will be fully and unconditionally guaranteed, jointly and severally, by
each of the Company&#146;s existing and future domestic subsidiaries that is a guarantor or other
obligor under the Company&#146;s credit facilities and by certain of the Company&#146;s other domestic
subsidiaries. The guarantees of the Notes will be subordinated in right of payment to all of the
existing and future senior indebtedness of such Guarantors and will be equal in right of payment
with all of the future senior subordinated indebtedness of such Guarantors. The Notes and the
guarantees will be junior to the existing and future secured indebtedness of the Company and the
Guarantors to the extent of the value of the assets securing such indebtedness and will be
structurally subordinated to all of the existing and future indebtedness and other liabilities of
the Company&#146;s non-guarantor subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Optional Redemption</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At any time on or after June&nbsp;1, 2015, the Company may redeem some or all of the Notes at the
redemption prices set forth in the Second Supplemental Indenture plus accrued and unpaid interest,
if any, to, but not including, the applicable redemption date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, at any time prior to June&nbsp;1, 2015, the Company may, on one or more occasions,
redeem some or all of the Notes at a redemption price equal to 100% of the principal amount of the
Notes redeemed plus a &#147;make-whole&#148; premium plus accrued and unpaid interest, if any, to, but not
including, the applicable redemption date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At any time prior to June&nbsp;1, 2014, the Company may also redeem up to 35% of the aggregate
principal amount of the Notes, using the proceeds of certain qualified equity offerings, at a
redemption price equal to 106.875% of the principal amount of the Notes redeemed, plus accrued and
unpaid interest, if any, to, but not including, the applicable redemption date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Change of Control</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company experiences certain change of control events, the Company must offer to
repurchase the Notes at a repurchase price equal to 101% of the principal amount of the Notes
repurchased, plus accrued and unpaid interest, if any, to, but not including, the applicable
repurchase date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Asset Sale Offer</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company sells certain assets, under certain circumstances the Company must offer to
repurchase the Notes at a repurchase price equal to 100% of the principal amount of the Notes
repurchased plus accrued and unpaid interest, if any, to, but not including, the applicable
repurchase date.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->ii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Covenants</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indenture contains covenants that, among other things, impose significant restrictions on
the Company&#146;s business. The restrictions that these covenants place on the Company and its
restricted subsidiaries include limitations on the Company&#146;s ability and the ability of its
restricted subsidiaries to:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>incur additional indebtedness or issue disqualified stock or preferred stock;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>create liens;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>pay dividends, make investments or make other restricted payments;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>sell assets;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>merge, consolidate, sell or otherwise dispose of all or substantially
all of the Company&#146;s assets;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>enter into transactions with the Company&#146;s affiliates;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>permit layering of debt; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>designate subsidiaries as unrestricted.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Events of Default</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indenture also provides for events of default which, if any of them occurs, would permit
or require the principal of and accrued interest on the Notes to become or to be declared due and
payable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing description of the Indenture is qualified in its entirety by the copies thereof
which are attached as Exhibit&nbsp;4.1 and Exhibit&nbsp;4.2 (which includes the form of 6.875% Senior
Subordinated Notes due 2019) and incorporated herein by reference.
</DIV>
<!-- link1 "Item&nbsp;2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet
Arrangement of a Registrant</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information set forth in Item&nbsp;1.01 under the caption &#147;Indenture and Notes&#148; is incorporated
by reference into this Item&nbsp;2.03.
</DIV>
<!-- link1 "Item&nbsp;9.01 Financial Statements and Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(d)&nbsp;Exhibits.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">1.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Underwriting Agreement, dated June&nbsp;8, 2011, by and among Teleflex Incorporated, the
guarantors named therein, Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, Goldman, Sachs &#038;
Co. and J.P. Morgan Securities LLC.</TD>
</TR>





</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->iii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">4.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Indenture, dated August&nbsp;2, 2010 by and between Teleflex Incorporated and Wells Fargo Bank,
N.A. (incorporated by reference to Exhibit&nbsp;4.4 to the Company&#146;s Registration Statement on Form
S-3 (File No.&nbsp;333-168464) filed on August&nbsp;2, 2010).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">4.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Second Supplemental Indenture, dated June&nbsp;13, 2011 by and among Teleflex Incorporated, the
guarantors named therein and Wells Fargo Bank, N.A.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">5.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Simpson Thacher &#038; Bartlett LLP.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">5.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Laurence G. Miller, Executive Vice President, General Counsel, Secretary and Chief
Administrative Officer of Teleflex Incorporated.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">23.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Simpson Thacher &#038; Bartlett LLP (included as part of Exhibit&nbsp;5.1).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">23.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Laurence G. Miller, Executive Vice President, General Counsel, Secretary and Chief
Administrative Officer of Teleflex Incorporated (included as part of Exhibit&nbsp;5.2).</TD>
</TR>

</TABLE>
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->iv<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- link1 "SIGNATURES" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: June&nbsp;13, 2011
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>TELEFLEX INCORPORATED</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ RICHARD A. MEIER
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Richard A. Meier&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and Chief
Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- link1 "EXHIBIT INDEX" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT INDEX
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">1.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Underwriting Agreement, dated June&nbsp;8, 2011, by and among Teleflex Incorporated, the
guarantors named therein, Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, Goldman, Sachs &#038;
Co. and J.P. Morgan Securities LLC.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">4.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Indenture, dated August&nbsp;2, 2010 by and between Teleflex Incorporated and Wells Fargo Bank,
N.A. (incorporated by reference to Exhibit&nbsp;4.4 to the Company&#146;s Registration Statement on Form
S-3 (File No.&nbsp;333-168464) filed on August&nbsp;2, 2010).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">4.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Second Supplemental Indenture, dated June&nbsp;13, 2011 by and among Teleflex Incorporated, the
guarantors named therein and Wells Fargo Bank, N.A.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">5.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Simpson Thacher &#038; Bartlett LLP.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">5.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Laurence G. Miller, Executive Vice President, General Counsel, Secretary and Chief
Administrative Officer of Teleflex Incorporated.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">23.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Simpson Thacher &#038; Bartlett LLP (included as part of Exhibit&nbsp;5.1).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="left">23.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Laurence G. Miller, Executive Vice President, General Counsel, Secretary and Chief
Administrative Officer of Teleflex Incorporated (included as part of Exhibit&nbsp;5.2).</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>y91654exv1w1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv1w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;1.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Teleflex Incorporated</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>$250,000,000 6.875% Senior Subordinated Notes Due 2019</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U><B>Underwriting Agreement</B></U>
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">June&nbsp;8, 2011
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated<BR>
Goldman, Sachs &#038; Co.<BR>
J.P. Morgan Securities LLC<BR>
c/o Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated<BR>
One Bryant Park<BR>
New York, NY 10036

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Teleflex Incorporated, a Delaware corporation (the &#147;Company&#148;), proposes, subject to the terms
and conditions stated in this Underwriting Agreement (this &#147;Agreement&#148;), to issue and sell to the
Underwriters named in Schedule&nbsp;I hereto (such Underwriters together with Goldman, Sachs &#038; Co.
acting in its capacity as Independent Underwriter (as defined below), the &#147;Underwriters&#148;) an
aggregate of $250,000,000 principal amount of its Senior Subordinated Notes due 2019 (the &#147;Notes&#148;).
The Securities (as defined below) will be issued pursuant to an indenture, dated as of August&nbsp;2,
2010 (the &#147;Base Indenture&#148;) by and between the Company and Wells Fargo Bank, N.A., as trustee (the
&#147;Trustee&#148;), as supplemented by the first supplemental indenture, dated as of August&nbsp;9, 2010, by and
between the Company and the Trustee (the &#147;First Supplemental Indenture&#148;) and the second
supplemental indenture, dated as of the Time of Delivery (as defined below), by and among the
Company, the Guarantors (as defined below) and the Trustee (the &#147;Second Supplemental Indenture&#148;
and, together with the First Supplemental Indenture and the Base Indenture, the &#147;Indenture&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and the Guarantors, in accordance with the requirements of Conduct Rule&nbsp;5121
(&#147;Rule&nbsp;5121&#148;) of the Financial Industry Regulatory Authority (&#147;FINRA&#148;) and subject to the terms and
conditions stated herein, also hereby confirm the engagement of the services of Goldman, Sachs &#038;
Co. (the &#147;Independent Underwriter&#148;), as a &#147;qualified independent underwriter&#148; within the meaning of
Section (f)(12) of Rule&nbsp;5121 in connection with the offering and sale of the Securities, and the
Independent Underwriter hereby confirms its engagement to render such services.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The payment of principal of, premium, if any, and interest of the Notes will be fully and
unconditionally guaranteed, jointly and severally by (i)&nbsp;the entities listed on the signature pages
hereof as &#147;Guarantors&#148; (collectively, the &#147;Guarantors&#148;) and (ii)&nbsp;any subsidiary of the Company
formed or acquired after the Time of Delivery that executes an additional guarantee in accordance
with the terms of the Indenture, and their respective successors and assigns, pursuant
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to their guarantees (the &#147;Guarantees&#148;). The Notes and the Guarantees attached thereto are
herein collectively referred to as the &#147;Securities.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Agreement, the Securities and the Indenture are collectively referred to herein as the &#147;Note
Documents.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">1. Each of the Company and the Guarantors, jointly and severally, represent and warrant to, and
agree with, each of the Underwriters that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;An &#147;automatic shelf registration statement&#148; as defined under Rule&nbsp;405 under the Securities
Act of 1933, as amended (the &#147;Act&#148;) on Form S-3 (File No.&nbsp;333-168464) in respect of the Securities
has been filed with the Securities and Exchange Commission (the &#147;Commission&#148;) not earlier than
three years prior to the date hereof; such registration statement, and any post-effective amendment
thereto, became effective on filing; and no stop order suspending the effectiveness of such
registration statement or any part thereof has been issued and no proceeding for that purpose has
been initiated or, to the knowledge of the Company, threatened by the Commission, and no notice of
objection of the Commission to the use of such registration statement or any post-effective
amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Act has been received by the Company (the
base prospectus filed as part of such registration statement, in the form in which it has most
recently been filed with the Commission on or prior to the date of this Agreement, is hereinafter
called the &#147;Basic Prospectus&#148;; any preliminary prospectus (including any preliminary prospectus
supplement) relating to the Securities filed with the Commission pursuant to Rule 424(b) under the
Act is hereinafter called a &#147;Preliminary Prospectus&#148;; the various parts of such registration
statement, including all exhibits thereto but excluding Form T-1 and including any prospectus
supplement relating to the Securities that is filed with the Commission and deemed by virtue of
Rule&nbsp;430B to be part of such registration statement, each as amended at the time such part of the
registration statement became effective, are hereinafter collectively called the &#147;Registration
Statement&#148;; the Basic Prospectus, as amended and supplemented immediately prior to the Applicable
Time (as defined in Section 1(c) hereof), is hereinafter called the &#147;Pricing Prospectus&#148;; the form
of the final prospectus relating to the Securities filed with the Commission pursuant to Rule
424(b) under the Act in accordance with Section 5(a) hereof is hereinafter called the &#147;Prospectus&#148;;
any reference herein to the Basic Prospectus, the Pricing Prospectus, any Preliminary Prospectus or
the Prospectus shall be deemed to refer to and include the documents incorporated by reference
therein pursuant to Item&nbsp;12 of Form S-3 under the Act, as of the date of such prospectus; any
reference to any amendment or supplement to the Basic Prospectus, any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include any post-effective amendment to the Registration
Statement, any prospectus supplement relating to the Securities filed with the Commission pursuant
to Rule 424(b) under the Act and any documents filed under the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), and incorporated therein, in each case after the date of the Basic
Prospectus, such Preliminary Prospectus, or the Prospectus, as the case may be; any reference to
any amendment to the Registration Statement shall be deemed to refer to and include any annual
report of the Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the
effective date of the Registration Statement that is incorporated by reference in the Registration
Statement; and any &#147;issuer free writing prospectus&#148; as defined in Rule&nbsp;433 under the Act relating
to the Securities is hereinafter called an &#147;Issuer Free Writing Prospectus&#148;);
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;No order preventing or suspending the use of any Preliminary Prospectus or any Issuer Free
Writing Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time
of filing thereof, conformed in all material respects to the requirements of the Act and the Trust
Indenture Act of 1939, as amended (the &#147;Trust Indenture Act&#148;) and the rules and regulations of the
Commission thereunder, and did not contain an untrue statement of a material fact or omit to state
a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading; provided, however, that this representation and warranty
shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through Merrill Lynch, Pierce,
Fenner &#038; Smith Incorporated expressly for use therein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For the purposes of this Agreement, the &#147;Applicable Time&#148; is 8:30 am (Eastern time) on the
date of this Agreement; the Pricing Prospectus as supplemented by the final term sheet in the form
attached as Schedule&nbsp;III hereto prepared and filed pursuant to Section 5(a) hereof, taken together
(collectively, the &#147;Pricing Disclosure Package&#148;) as of the Applicable Time, did not include any
untrue statement of a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; and each Issuer Free Writing Prospectus listed on Schedule&nbsp;II(a) hereto does not
conflict with the information contained in the Registration Statement, the Pricing Prospectus or
the Prospectus and each such Issuer Free Writing Prospectus, as supplemented by and taken together
with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; provided,
however, that this representation and warranty shall not apply to statements or omissions made in
an Issuer Free Writing Prospectus in reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated
expressly for use therein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The documents incorporated by reference in the Pricing Prospectus and the Prospectus, when
they became effective or were filed with the Commission, as the case may be, conformed in all
material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules
and regulations of the Commission thereunder, and none of such documents contained an untrue
statement of a material fact or omitted to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; any further documents so filed and
incorporated by reference in the Prospectus or any further amendment or supplement thereto, when
such documents become effective or are filed with the Commission, as the case may be, will conform
in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the
rules and regulations of the Commission thereunder and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading; provided, however, that this representation and warranty
shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through Merrill Lynch, Pierce,
Fenner &#038; Smith Incorporated expressly for use therein; and no such documents were filed with the
Commission since the Commission&#146;s close of business on the business day immediately prior to the
date of this Agreement and prior to the execution of this Agreement, except as set forth on
Schedule&nbsp;II(b) hereto;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Registration Statement conforms, and the Prospectus and any further amendments or
supplements to the Registration Statement and the Prospectus will conform, in all material respects
to the requirements of the Act and the Trust Indenture Act and the rules and regulations of the
Commission thereunder and do not and will not, as of the applicable effective date as to each part
of the Registration Statement and as of the applicable filing date as to the Prospectus and any
amendment or supplement thereto, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading; provided, however, that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated
expressly for use therein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Neither the Company nor any of its subsidiaries has sustained since the date of the latest
audited financial statements included or incorporated by reference in the Pricing Prospectus any
material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as set forth or contemplated in the Pricing Prospectus; and, since
the respective dates as of which information is given in the Registration Statement and the Pricing
Prospectus (exclusive of any amendment or supplement thereto), there has not been any change in the
capital stock or long term debt of the Company or any of its subsidiaries (other than changes due
to (i)&nbsp;issuances of the Company&#146;s common stock under the Company&#146;s employee benefit plans and the
Company&#146;s dividend reinvestment plan, (ii)&nbsp;any shares purchased under the Company&#146;s existing stock
repurchase program or (iii)&nbsp;any scheduled repayment of the Company&#146;s existing debt) or any material
adverse change, or any development involving a prospective material adverse change, in or affecting
the general affairs, management, financial position, stockholders&#146; equity or results of operations
of the Company and its subsidiaries, taken as a whole, otherwise than as set forth or contemplated
in the Pricing Prospectus;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Each of the Company, each of its &#147;significant subsidiaries&#148; (as such term is defined in
Rule&nbsp;1-02(w) of Regulation&nbsp;S-X under the Act and each of the Guarantors; each a &#147;Subsidiary&#148; and
together the &#147;Subsidiaries&#148;) have good and marketable title in fee simple to all real property and
good and marketable title to all personal property owned by it, in each case free and clear of all
liens, encumbrances and defects (other than pledges of shares of certain of the Company&#146;s domestic
and foreign subsidiaries created pursuant to the Company&#146;s existing senior secured credit
facilities (the &#147;Existing Credit Facilities&#148;) except such as are described in the Pricing
Prospectus or such as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and its
Subsidiaries; and any real property and buildings held under lease by the Company and its
Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions
as are not material to, and do not materially interfere with the use made and proposed to be made
of such property and buildings by, the Company and its Subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Each of the Company and the Guarantors has been duly incorporated or otherwise formed and
is validly existing as a corporation, limited liability company, partnership or other legal entity
in good standing under the laws of its jurisdiction of incorporation or formation and each of them
has the power and authority (corporate and other) to own, lease and operate its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">properties and to conduct its business as described in the Pricing Prospectus. Each of the
Company and the Guarantors has been duly qualified as a foreign corporation for the transaction of
business and is in good standing under the laws of each other jurisdiction in which it owns or
leases properties or conducts any business so as to require such qualification, or is subject to no
material liability or disability by reason of the failure to be so qualified in any such
jurisdiction, except as would not be reasonably expected to have a material adverse effect on the
business, condition (financial or otherwise), results of operations, properties or prospects of the
Company and its subsidiaries, taken as a whole (a &#147;Material Adverse Effect&#148;); and each Subsidiary
of the Company is listed on Schedule&nbsp;IV hereto, has been duly incorporated or organized and is
validly existing as a corporation or limited liability company, as the case may be, in good
standing under the laws of its jurisdiction of incorporation or formation, as the case may be; and
each of the subsidiaries of the Company, other than the Subsidiaries, has been duly incorporated or
organized and is validly existing as a corporation or limited liability company, as the case may
be, in good standing under the laws of its jurisdiction of incorporation or formation, as the case
may be, except where the failure to be in good standing would not have a Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The Company and the Guarantors have all requisite corporate power and authority to execute
and deliver this Agreement and the other Note Documents to which they are a party, and to perform
their obligations hereunder and thereunder and to consummate the transactions herein and therein
contemplated. This Agreement has been duly authorized, executed and delivered by the Company and
the Guarantors;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;The Company has an authorized capitalization as set forth in the Pricing Prospectus and
all of the issued shares of capital stock of the Company have been duly and validly authorized and
issued and are fully paid and non-assessable; and all of the issued shares of capital stock of each
subsidiary of the Company have been duly and validly authorized and issued, are fully paid and
non-assessable and (except for directors&#146; qualifying shares and except as otherwise set forth in
the Pricing Prospectus) are owned directly or indirectly by the Company, free and clear of all
liens, encumbrances, equities or claims (other than pledges of shares of certain of the Company&#146;s
domestic and foreign subsidiaries created pursuant to the Existing Credit Facilities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;The Notes have been duly authorized and, when issued and delivered by the Company pursuant
to this Agreement and authenticated in the manner provided in the Indenture and delivered against
payment of the purchase price therefor, will have been duly executed, authenticated, issued and
delivered and will constitute valid and legally binding obligations of the Company, enforceable
against the Company and entitled to the benefits provided by the Indenture, which is substantially
in the form filed as an exhibit to the Registration Statement; the Guarantees have been duly
authorized and, when the Notes have been issued and delivered by the Company pursuant to this
Agreement and authenticated in the manner provided in the Indenture and delivered against payment
of the purchase price therefor, will have been duly executed, authenticated, issued and delivered
and will constitute valid and legally binding obligations of the Guarantors, enforceable against
each of the Guarantors and entitled to the benefits provided by the Indenture; the Base Indenture
has been duly authorized, executed and delivered by the Company and duly qualified under the Trust
Indenture Act and, constitutes a valid and legally binding instrument, enforceable against the
Company in accordance with its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">terms; the Second Supplemental Indenture has been duly authorized by the Company and each of
the Guarantors and, when executed and delivered by the Company, the Guarantors and the Trustee,
will constitute a valid and legally binding instrument, enforceable against the Company and the
Guarantors in accordance with its terms, subject, in the case of each of the Securities and
the Indenture, as to enforcement, to bankruptcy, insolvency, reorganization and other laws of
general applicability relating to or affecting creditors&#146; rights and to general equity principles;
the Securities and the Indenture will conform in all material respects to the descriptions thereof
in the Pricing Disclosure Package and the Prospectus; and the Indenture will conform in all
material respects to the requirements of the Trust Indenture Act and the regulations of the
Commission applicable to an indenture that is qualified thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;The issue and sale of the Securities and the compliance by the Company and the Guarantors
with all of the provisions of the Note Documents to which each is a party and the consummation of
the transactions herein and therein contemplated will not (i)&nbsp;conflict with or result in a breach
or violation of any of the terms or provisions of, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or
any of its Subsidiaries or any of the Guarantors is a party or by which the Company or any of its
Subsidiaries or any of the Guarantors is bound or to which any of the property or assets of the
Company or any of its subsidiaries is subject, except where such breach or violation would not,
individually or in the aggregate, result in a Material Adverse Effect or have a material adverse
effect on the ability of the Company and its subsidiaries to perform their obligations in
accordance with the terms of the Note Documents, (ii)&nbsp;result in any violation of the provisions of
the Certificate of Incorporation or By-laws or similar organizational documents of the Company or
any of its Subsidiaries or any of the Guarantors, or (iii)&nbsp;result in any violations of the
provisions of any statute or any order, rule or regulation of any court or governmental agency or
body having jurisdiction over the Company or any of its Subsidiaries or any of the Guarantors or
any of their properties, except where such violation would not, individually or in the aggregate,
result in a Material Adverse Effect or have a material adverse effect on the ability of the Company
and its subsidiaries to perform their obligations in accordance with the terms of the Note
Documents; and no consent, approval, authorization, order, registration or qualification of or with
any such court or governmental agency or body is required for the issue and sale of the Securities
or the consummation by the Company or any of the Guarantors of the transactions contemplated by
this Agreement or the Indenture except (i)&nbsp;such as have been obtained under the Act and the Trust
Indenture Act and (ii)&nbsp;such consents, approvals, authorizations, registrations or qualifications as
may be required under state securities or Blue Sky laws in connection with the purchase and
distribution of the Securities by the Underwriters;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;None of the Company, any of its Subsidiaries nor any of the Guarantors is (i)&nbsp;in violation
of its Certificate of Incorporation or By-laws or similar organizational document or (ii)&nbsp;in
default in the performance or observance of any obligation, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which
it is a party or by which it or any of its properties may be bound, except, in the case of clause
(ii), for any such default or violation that would not, individually or in the aggregate, result in
a Material Adverse Effect;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;The statements set forth in the Pricing Prospectus and the Prospectus under the caption
&#147;Description of Notes&#148;, insofar as they purport to constitute a summary of the terms of the
Securities, under the caption &#147;Certain United States Federal Income and Estate Tax Consequences&#148;
and under the caption &#147;Underwriting&#148;, insofar as they purport to describe the provisions of the
laws and documents referred to therein, are accurate summaries in all material respects;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;Other than as set forth in the Pricing Prospectus, there are no legal or governmental
proceedings pending to which the Company or any of its Subsidiaries or any of the Guarantors is a
party or of which any property of the Company or any of its Subsidiaries or any of the Guarantors
is the subject which, if determined adversely to the Company or any of its Subsidiaries or any of
the Guarantors, would, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect; and, other than as set forth in the Pricing Prospectus, to the Company&#146;s
or any Guarantor&#146;s knowledge, no such proceedings are threatened by governmental authorities or
others;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)&nbsp;Neither the Company nor any Guarantor is and, after giving effect to the offering and sale
of the Securities and the application of the proceeds thereof, will not be an &#147;investment company,&#148;
as such term is defined in the Investment Company Act of 1940, as amended (the &#147;Investment Company
Act&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q)&nbsp;(A) (i)&nbsp;At the time of filing the Registration Statement, (ii)&nbsp;at the time of the most
recent amendment thereto for the purposes of complying with Section&nbsp;10(a)(3) of the Act (whether
such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or
15(d) of the Exchange Act or form of prospectus) and (iii)&nbsp;at the time the Company or any person
acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Act) made
any offer relating to the Securities in reliance on the exemption of Rule&nbsp;163 under the Act, the
Company was a &#147;well-known seasoned issuer&#148; as defined in Rule&nbsp;405 under the Act; and (B)&nbsp;at the
earliest time after the filing of the Registration Statement that the Company or another offering
participant made a bona fide offer (within the meaning of Rule&nbsp;164(h)(2) under the Act) of the
Securities, the Company was not an &#147;ineligible issuer&#148; as defined in Rule&nbsp;405 under the Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r)&nbsp;PricewaterhouseCoopers LLP, who has audited certain financial statements of the Company
and its subsidiaries, and has audited the Company&#146;s internal control over financial reporting and
management&#146;s assessment thereof are independent public accountants as required by the Act and the
rules and regulations of the Commission thereunder;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s)&nbsp;The Company maintains a system of internal control over financial reporting (as such term
is defined in Rule&nbsp;13a-15(f) under the Exchange Act) that complies with the requirements of the
Exchange Act and has been designed by the Company&#146;s principal executive officer and principal
financial officer, or under their supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. The Company&#146;s internal
control over financial reporting is effective and the Company is not aware of any material
weaknesses in its internal control over financial reporting;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t)&nbsp;Since the date of the latest audited financial statements included or incorporated by
reference in the Pricing Prospectus, there has been no change in the Company&#146;s internal control
over financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company&#146;s internal control over financial reporting;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u)&nbsp;The Company maintains disclosure controls and procedures (as such term is defined in Rule
13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act; such
disclosure controls and procedures have been designed to ensure that material information relating
to the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and
principal financial officer by others within those entities; and such disclosure controls and
procedures are effective;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;The financial statements of the Company, including the notes thereto, and any supporting
schedules included in the Pricing Prospectus and Prospectus present fairly, in all material
respects, the consolidated financial position of the Company and its consolidated subsidiaries as
of the dates indicated and the cash flows and results of operations for the periods specified by
the Company and its consolidated subsidiaries; such financial statements have been prepared in all
material respects in conformity with United States generally accepted accounting principles applied
on a consistent basis throughout the periods involved; and any supporting schedules included in the
Pricing Prospectus and the Prospectus present fairly, in all material respects, the information
required to be stated therein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w)&nbsp;Except as would not, individually or in the aggregate, result in a Material Adverse Effect
or except as disclosed in the Pricing Prospectus and the Prospectus: (i)&nbsp;neither the Company nor
any of its subsidiaries is, to the Company&#146;s or any Guarantor&#146;s knowledge, or has been, in
violation of any U.S. federal, state, local or foreign law (including common law), regulation,
rule, requirement, decision or order relating to pollution or protection of worker health, the
environment (including, without limitation, ambient air, surface water, groundwater, land surface
or subsurface strata), natural resources, or wildlife, including, without limitation, laws and
regulations relating to emissions, discharges, releases or threatened releases of pollutants,
contaminants, wastes, toxic substances, hazardous substances, petroleum and petroleum products
(collectively, &#147;Materials of Environmental Concern&#148;), or otherwise relating to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport, or handling of, or exposure
to, Materials of Environmental Concern (collectively<I>, </I>&#147;Environmental Laws"<I>), </I>which violation
includes, without limitation, noncompliance with any permits or other governmental authorizations
required for the operation of the business of the Company or its subsidiaries under applicable
Environmental Laws, nor has the Company or any of its subsidiaries received any written
communication, whether from a governmental authority, citizens group, employee or otherwise, that
alleges that the Company or any of its subsidiaries is in violation of any Environmental Law, (ii)
there is no claim or action with respect to which the Company or any of its subsidiaries has
received written notice, and no written notice by any person or entity alleging potential liability
for investigatory costs, cleanup costs, governmental response costs, natural resources damages,
property damages, personal injuries, attorneys&#146; fees or penalties arising out of, based on or
resulting from the presence, or release into the environment, of any Material of Environmental
Concern at any location owned, leased or operated by the Company or any of its subsidiaries, now or
in the past (collectively, &#147;Environmental Claims&#148;) pending or, to the knowledge of the Company and
the Guarantors, threatened in writing against
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Company or any of its subsidiaries or any person or entity whose liability for any
Environmental Claim the Company or any of its subsidiaries has retained or assumed either
contractually or by operation of law and (iii)&nbsp;to the knowledge of the Company and the Guarantors,
there are no past or present actions, activities, circumstances, conditions, events or incidents,
including, without limitation, the release, emission, discharge, presence or disposal of any
Material of Environmental Concern, that would be reasonably expected to result in a violation of
any Environmental Law or form the basis of a potential Environmental Claim against the Company or
any of its subsidiaries or any person or entity whose liability for any Environmental Claim the
Company or any of its subsidiaries has retained or assumed either contractually or by operation of
law;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;The Company and each of its Subsidiaries and each of the Guarantors own, are licensed to
use, or possess all intellectual property and proprietary rights, including, without limitation,
trademarks, trademark licenses, service marks, trade names, patents, patent licenses, copyrights,
copyright licenses, works of authorship, all applications and registrations for the foregoing,
approvals, trade secrets, domain names, technology, know-how and processes and all other similar
rights (collectively, the &#147;Intellectual Property Rights&#148;) necessary to conduct their respective
businesses, free and clear of liens. To the best knowledge of the Company and the Guarantors, (i)
no third party is violating or infringing the Intellectual Property Rights of the Company or any of
its Subsidiaries or any of the Guarantors and (ii)&nbsp;the conduct of the business of the Company and
its Subsidiaries and the Guarantors does not violate or infringe the Intellectual Property Rights
of others, except as would not reasonably be expected to result in a Material Adverse Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y)&nbsp;Except as would not result, individually or in the aggregate, in a Material Adverse Effect
or except as disclosed in the Pricing Prospectus and the Prospectus, neither the Company, nor the
Company&#146;s business operations, is in violation of any Health Care Laws. For purposes of this
Agreement, &#147;Health Care Laws&#148; means (i)&nbsp;all federal and state fraud and abuse laws, including, but
not limited to, the federal Anti-Kickback Statute (42 U.S.C. &#167;1320a-7(b)), the Stark Law (42 U.S.C.
&#167;1395nn and &#167;1395(q)), the Anti-Inducement Law (42 U.S.C. &#167; 1320a-7a(a)(5)), the civil False Claims
Act (31 U.S.C. &#167;3729 et seq.), the administrative False Claims Law (42 U.S.C. &#167; 1320a-7b(a)), the
exclusion laws (42 U.S.C. &#167; 1320a-7), the civil monetary penalty laws (42 U.S.C. &#167; 1320a-7a) and
the regulations promulgated pursuant to such statutes, (ii)&nbsp;the Health Insurance Portability and
Accountability Act of 1996 (Pub. L. No.&nbsp;104-191) and the Health Information Technology for Economic
and Clinical Health Act of 2009, and the regulations promulgated thereunder and comparable state
privacy and security laws, (iii)&nbsp;Medicare (Title XVIII of the Social Security Act) and the
regulations promulgated thereunder, (iv)&nbsp;Medicaid (Title XIX of the Social Security Act) and the
regulations promulgated thereunder, (v)&nbsp;the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167; 301
et seq.) and the regulations promulgated pursuant thereto, (vi)&nbsp;quality, safety and accreditation
standards and requirements of all applicable state laws or regulatory bodies and (vii)&nbsp;any and all
other applicable health care laws, regulations, manual provisions, policies and administrative
guidance, each of (i)&nbsp;through (vii)&nbsp;as may be amended from time to time. Except as disclosed in the
Pricing Prospectus, the Company has not received notice of any claim, action, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action from any governmental authority
alleging that any product, operation or activity is in violation of any applicable Health Care Law
or permit and has no knowledge that any such governmental authority is considering any such claim,
litigation,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">arbitration, action, suit, investigation or proceeding; and the Company has not received
notice, either verbally or in writing, that any governmental authority has taken, is taking or
intends to take action to limit, suspend, modify or revoke any permits and has no knowledge that
any such governmental authority is considering such action, except for any of the foregoing that
would not reasonably be expected to result in a Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z)&nbsp;The Company and each of its Subsidiaries and each of the Guarantors possess such permits,
licenses, franchises, certificates, orders and other approvals or authorizations issued by
governmental or regulatory authorities (&#147;Permits&#148;) as are necessary under applicable law to conduct
their businesses in the manner described in the Pricing Prospectus, except for any of the foregoing
that would not, individually or in the aggregate, result in a Material Adverse Effect or except as
disclosed in the Pricing Prospectus. The Company and its Subsidiaries and each of the Guarantors
have each fulfilled and performed all of their respective obligations with respect to the Permits,
and no event has occurred that allows, or after notice or lapse of time would allow, revocation or
termination thereof or result in any other impairment of the rights of the holder of any such
Permits, except for any of the foregoing that would not, individually or in the aggregate, result
in a Material Adverse Effect. None of the Company, any of its Subsidiaries nor any of the
Guarantors has received notice of any revocation or modification of any such Permits or has any
reason to believe that any such Permits will not be renewed in the ordinary course, except that
would not, individually or in the aggregate, result in a Material Adverse Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa)&nbsp;The Company holds, and is operating in material compliance with, such registrations,
licenses, approvals, authorizations and clearances of the United States Food and Drug
Administration (&#147;FDA&#148;) required for the conduct of its business as currently conducted
(collectively, the &#147;FDA Authorizations&#148;), except where the failure to hold or operate in material
compliance with the FDA Authorizations would not result in a Material Adverse Effect, and all such
FDA Authorizations are in full force and effect. The Company has fulfilled and performed all of
its material obligations with respect to the FDA Authorizations, and no event has occurred which
allows, or after notice or lapse of time would allow, revocation or termination thereof or results
in any other material impairment of the rights of the holder of any FDA Authorization, except where
the failure to so fulfill or perform, or the occurrence of such event, would not result in a
Material Adverse Effect. Except as disclosed in the Pricing Prospectus and the Prospectus, the
Company has operated and currently is in compliance in all material respects with applicable
statutes and implementing regulations administered or enforced by the FDA, except where the failure
to so comply would not result in a Material Adverse Effect. Except as disclosed in the Pricing
Prospectus, the Company has not received notice of any pending or threatened claim, suit,
proceeding, hearing, enforcement, audit, investigation, arbitration or other action from the FDA or
applicable foreign regulatory agency alleging that any operation or activity of the Company is in
violation of any applicable law, rule or regulation;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bb)&nbsp;Except as disclosed in the Pricing Prospectus and the Prospectus, since January&nbsp;1, 2007,
the Company has not had any product or manufacturing site (whether Company-owned or that of a
contract manufacturer for the Company&#146;s products) subject to a governmental authority (including
FDA) shutdown or import or export prohibition, nor received any FDA Form&nbsp;483 or other governmental
authority notice of inspectional observations, &#147;Warning Letters,&#148; &#147;untitled letters&#148; or requests or
requirements to make changes to the Company&#146;s products that if not
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">complied with would reasonably be expected to result in a Material Adverse Effect on the
Company, or similar correspondence or notice from the FDA or other governmental authority in
respect of the Company business and alleging or asserting noncompliance with any applicable law,
Permit or such requests or requirements of a governmental authority, and, to the knowledge of the
Company, neither the FDA nor any governmental authority is considering such action;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(cc)&nbsp;Except as would not result in a Material Adverse Effect, there are no recalls, field
notifications, field corrections, market withdrawals or replacements, safety alerts or other notice
of action relating to an alleged lack of safety, efficacy or regulatory compliance of the Company&#146;s
products, or, to the Company&#146;s knowledge, material product complaints with respect to the Company&#146;s
products, and to the Company&#146;s knowledge, there are no notices or pending or threatened action by
FDA that would be reasonably likely to result in (i)&nbsp;a material recall, field notification, field
correction, market withdrawal or replacement, safety alert or other notice of action relating to an
alleged lack of safety, efficacy, or regulatory compliance of the Company&#146;s products with respect
to the Company&#146;s products, (ii)&nbsp;a material change in labeling of any the Company&#146;s products, or
(iii)&nbsp;a termination or suspension of marketing or testing of any the Company&#146;s products;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(dd)&nbsp;The Company and each of its Subsidiaries and each of the Guarantors have filed all
necessary U.S. federal, state and foreign income and franchise tax returns or have properly
requested extensions thereof, and have paid all taxes required to be paid by any of them and, if
due and payable, any related or similar assessment, fine or penalty levied against any of them
except as may be being contested in good faith and by appropriate proceedings or have been accrued
for on the consolidated financial statements of the Company, except where the failure to file such
tax returns or pay such taxes, assessments, fines and penalties individually or in the aggregate
would not result in a Material Adverse Effect. The Company has made adequate charges, accruals and
reserves in its consolidated financial statements contained in the Pricing Prospectus in respect of
all U.S. federal, state and foreign income and franchise taxes for all periods as to which the tax
liabilities of the Company or any of its subsidiaries has not been finally determined, except to
the extent that the failure to do so would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ee)&nbsp;No labor dispute with the employees of the Company or any of its subsidiaries exists or,
to the Company&#146;s or any Guarantor&#146;s knowledge, is imminent that would result in a Material Adverse
Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ff)&nbsp;The Company and each of its Subsidiaries and each of the Guarantors are insured by
recognized and, to the Company&#146;s and the Guarantors&#146; knowledge, financially sound institutions with
policies in such amounts and with such deductibles and covering such risks as are generally deemed
reasonably adequate for the conduct of their respective businesses, including, without limitation,
policies covering real and personal property owned, leased or operated by them against theft,
damage, destruction or acts of vandalism, and all such insurance is in full force and effect. None
of the Company, any of its Subsidiaries nor any of the Guarantors has any reason to believe that it
will not be able to (i)&nbsp;renew its existing insurance coverage as and when such policies expire or
(ii)&nbsp;obtain comparable coverage from similar institutions as may be reasonably necessary or
appropriate to conduct the business of the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company and its Subsidiaries and the Guarantors as now conducted and at a cost that would not
reasonably be expected to result in a Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(gg)&nbsp;No relationship, direct or indirect, that would be required to be described pursuant to
Item&nbsp;404 of Regulation&nbsp;S-K under the Act in an annual report on Form 10-K filed by the Company
exists between or among the Company or any of its subsidiaries, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company or any of its subsidiaries, on the
other hand, that has not been described in the Pricing Prospectus and the Prospectus;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(hh)&nbsp;Each &#147;employee benefit plan&#148; (as defined under Section&nbsp;3(3) of the Employee Retirement
Income Security Act of 1974, as amended, and the regulations thereunder (collectively, &#147;ERISA&#148;))
which is subject to Title IV of ERISA (each, a &#147;Plan&#148;) and is maintained by the Company or any of
its subsidiaries, is in compliance in all material respects with ERISA to the extent subject
thereto. &#147;ERISA Affiliate&#148; means, with respect to the Company, any member of any group of
organizations described in Sections&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Internal Revenue Code of 1986,
as amended, and the regulations and published interpretations thereunder (the &#147;Code&#148;) of which the
Company is a member. Except as would not, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect: (a)&nbsp;no &#147;reportable event&#148; (as defined under Section 4043(c)
of ERISA other than those events for which the 30&nbsp;day notice period has been waived) has occurred
respect to any Plan which is maintained by the Company or any of its ERISA Affiliates, (b)&nbsp;neither
the Company nor any of its ERISA Affiliates has incurred any unsatisfied liability under (i)&nbsp;Title
IV of ERISA with respect to termination of, or withdrawal from, any Plan or (ii)&nbsp;Sections&nbsp;412, or
4972 of the Code and (c)&nbsp;each Plan established or maintained by the Company that is intended to be
qualified under Section&nbsp;401 of the Code has received a determination letter from the Internal
Revenue Service stating that it is so qualified, and to the Company&#146;s knowledge nothing has
occurred, whether by action or failure to act, which would cause the loss of such qualification;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Neither the Company nor any of its subsidiaries is a party to any contract, agreement or
understanding with any person (other than this Agreement) that would give rise to a valid claim
against any of them or the Underwriters for a brokerage commission, finder&#146;s fee or like payment in
connection with the offering and sale of the Securities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(jj)&nbsp;There is and has been no failure on the part of the Company or any of its directors or
officers, in their capacities as directors or officers, to comply with any provision of the
Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(kk)&nbsp;None of the transactions contemplated by this Agreement will violate or result in a
violation of Section&nbsp;7 of the Exchange Act, or any regulation promulgated thereunder, including,
without limitation, Regulations T, U, and X of the Board of Governors of the Federal Reserve
System;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ll)&nbsp;Neither the Company nor any of its subsidiaries, nor, to the knowledge of the Company or
any Guarantor, any director, officer, agent, employee or other representative acting on behalf of
the Company or any of its subsidiaries, has taken any action in furtherance of an offer, payment,
promise to pay, or authorization or approval of the payment or giving of money,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">property, gifts or anything else of value, directly or indirectly, to any government official
or employee to influence official action or secure an improper advantage that would constitute a
violation of the Foreign Corrupt Practices Act of 1977;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(mm)&nbsp;The operations of the Company and its subsidiaries are and have been conducted at all
times (i)&nbsp;in compliance in all material respects with applicable financial recordkeeping and
reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended;
(ii)&nbsp;in compliance with (A)&nbsp;the applicable money laundering statutes of jurisdictions where the
Company and its subsidiaries conduct business and (B)&nbsp;the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the &#147;Money Laundering Laws&#148;); and (iii)&nbsp;no action, suit or
proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Company and the Guarantors, threatened;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(nn)&nbsp;Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company or
any Guarantor, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries: (i)&nbsp;is currently subject to any U.S. sanctions administered and/or enforced by the
Office of Foreign Assets Control of the U.S. Treasury Department (&#147;OFAC&#148;) or (ii)&nbsp;appears on the
Specially Designated Nationals and Blocked Persons list maintained by OFAC or the Annex to
Executive Order 13224 issued by the President of the United States, each as amended from time to
time. The Company will not directly or indirectly use the proceeds of the offering contemplated
hereby, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint
venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. trade and economic sanctions administered by OFAC nor provide
such proceeds to any destination, entity or person prohibited from receiving them by the laws or
regulations of the United States or will otherwise fail to comply with those United States laws and
regulations;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(oo)&nbsp;The Company is subject to and in compliance with the reporting requirements of Section&nbsp;13
or 15(d) of the Exchange Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(pp)&nbsp;Prior to the date hereof, neither the Company nor any of its affiliates has taken any
action which is designed to or which has constituted or which might reasonably have been expected
to cause or result in stabilization or manipulation of the price of any security of the Company in
connection with the offering of the Securities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(qq)&nbsp;Each of the Company and the Guarantors is, and immediately after the Time of Delivery
will be, Solvent. As used herein, the term &#147;Solvent&#148; means, with respect to any person on a
particular date, that on such date (i)&nbsp;the fair market value of the assets of such person is
greater than the total amount of liabilities (including contingent liabilities) of such person,
(ii)&nbsp;the present fair salable value of the assets of such person is greater than the amount that
will be required to pay the probable liabilities of such person on its debts as they become
absolute and matured, (iii)&nbsp;such person is able to realize upon its assets and pay its debts and
other liabilities, including contingent obligations, as they mature and (iv)&nbsp;such person is not
engaged in any business or transaction, and does not propose to engage in any business transaction
for which its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">property would constitute unreasonably small capital after giving due consideration to the
prevailing practice in the industry in which such person is engaged;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(rr)&nbsp;There are no persons with registration or other similar rights to have any equity or debt
securities registered for sale under the Registration Statement or included in the offering
contemplated by this Agreement, except for such rights as have been duly waived.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Subject to the terms and conditions herein set forth, the Company agrees to issue and sell
to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to
purchase from the Company, at a purchase price of 98.75% of the principal amount thereof, the
principal amount of Securities set forth opposite the name of such Underwriter in Schedule&nbsp;I
hereto. Each of the Underwriters, severally and not jointly, also agrees to reimburse, pro rata in
accordance with the principal amount of Securities set forth opposite the name of such Underwriter
in Schedule&nbsp;I hereto, the Company for certain of the Company&#146;s expenses related to the offering and
sale of Securities in the aggregate amount of $625,000 at the Time of Delivery.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;Upon the authorization by you of the release of the Securities, the several Underwriters
propose to offer the Securities for sale upon the terms and conditions set forth in the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;(a)&nbsp;The Securities to be purchased by each Underwriter hereunder will be represented by
one or more definitive global Securities in book-entry form which will be deposited by or on behalf
of the Company with The Depository Trust Company (&#147;DTC&#148;) or its designated custodian. The Company
will deliver the Securities to Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, for the account
of each Underwriter, against payment by or on behalf of such Underwriter of the purchase price
therefor by wire transfer in Federal (same day) funds, by causing DTC to credit the Securities to
the account of Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated at DTC. The Company will cause
the certificates representing the Securities to be made available to Merrill Lynch, Pierce, Fenner
&#038; Smith Incorporated for checking at least twenty-four hours prior to the Time of Delivery at the
office of Latham &#038; Watkins LLP, 885 Third Avenue, Suite&nbsp;1000, New York, NY 10022-4834 (the &#147;Closing
Location&#148;). The time and date of such delivery and payment shall be, 9:30 a.m., New York City
time, on June&nbsp;13, 2011, or such other time and date as Merrill Lynch, Pierce, Fenner &#038; Smith
Incorporated and the Company may agree upon in writing. Such time and date for delivery of the
Securities is herein called the &#147;Time of Delivery.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The documents to be delivered at the Time of Delivery by or on behalf of the parties
hereto pursuant to Section&nbsp;8 hereof, including the cross-receipt for the Securities and any
additional documents requested by the Underwriters pursuant to Section 8(j) hereof, will be
delivered at such time and date at the Closing Location, and the Securities will be delivered at
DTC or its designated custodian, all at the Time of Delivery. A meeting will be held at the
Closing Location at 6:00 p.m., New York City time, on the New York Business Day next preceding the
Time of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to
the preceding sentence will be available for review by the parties hereto. For the purposes of
this Section&nbsp;4, &#147;New York Business Day&#148; shall mean each Monday, Tuesday, Wednesday, Thursday and
Friday which is not a day on which banking institutions in New York are generally authorized or
obligated by law or executive order to close.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;Each of the Company and the Guarantors, jointly and severally, agrees with each of the
Underwriters:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;To prepare the Prospectus in a form approved by you and to file such Prospectus pursuant
to Rule 424(b) under the Act not later than the Commission&#146;s close of business on the second
business day following the date of this Agreement; to make no further amendment or any supplement
to the Registration Statement, the Basic Prospectus or the Prospectus prior to the Time of Delivery
which shall be disapproved by you promptly after reasonable notice thereof; to advise you, promptly
after it receives notice thereof, of the time when any amendment to the Registration Statement has
been filed or becomes effective or any amendment or supplement to the Prospectus has been filed and
to furnish you with copies thereof; to prepare a final term sheet, containing solely a description
of the Securities, in a form approved by you and to file such term sheet pursuant to Rule 433(d)
under the Act within the time required by such Rule; to file promptly all other material required
to be filed by the Company with the Commission pursuant to Rule 433(d) under the Act; to file
promptly all reports and any definitive proxy or information statements required to be filed by the
Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act
subsequent to the date of the Prospectus and for so long as the delivery of a prospectus (or in
lieu thereof, the notice referred to in Rule 173(a) under the Act) is required in connection with
the offering or sale of the Securities; to advise you, promptly after it receives notice thereof,
of the issuance by the Commission of any stop order or of any order preventing or suspending the
use of any Preliminary Prospectus or other prospectus in respect of the Securities, of any notice
of objection of the Commission to the use of the Registration Statement or any post-effective
amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Act, of the suspension of the qualification
of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any
proceeding for any such purpose, or of any request by the Commission for the amending or
supplementing of the Registration Statement or the Prospectus or for additional information; and,
in the event of the issuance of any stop order or of any order preventing or suspending the use of
any Preliminary Prospectus or other prospectus or suspending any such qualification, to promptly
use its best efforts to obtain the withdrawal of such order; and in the event of any such issuance
of a notice of objection, promptly to take such steps including, without limitation, amending the
Registration Statement or filing a new registration statement, at its own expense, as may be
necessary to permit offers and sales of the Securities by the Underwriters (references herein to
the Registration Statement shall include any such amendment or new registration statement);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If required by Rule&nbsp;430B(h) under the Act, to prepare a form of prospectus in a form
approved by you and to file such form of prospectus pursuant to Rule 424(b) under the Act not later
than may be required by Rule 424(b) under the Act; and to make no further amendment or supplement
to such form of prospectus which shall be disapproved by you promptly after reasonable notice
therereof;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If by the third anniversary (the &#147;Renewal Deadline&#148;) of the initial effective date of the
Registration Statement, any of the Securities remain unsold by the Underwriters, the Company will
file, if it has not already done so and is eligible to do so, a new automatic shelf registration
statement relating to the Securities, in a form satisfactory to you. If at the Renewal Deadline
the Company is no longer eligible to file an automatic shelf registration statement, the Company
will, if it has not already done so, file a new shelf registration statement relating to the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Securities, in a form satisfactory to you and will use its best efforts to cause such
registration statement to be declared effective within 180&nbsp;days after the Renewal Deadline. The
Company will take all other action necessary or appropriate to permit the public offering and sale
of the Securities to continue as contemplated in the expired registration statement relating to the
Securities. References herein to the Registration Statement shall include such new automatic shelf
registration statement or such new shelf registration statement, as the case may be;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Promptly from time to time to take such action as you may reasonably request to qualify
the Securities for offering and sale under the securities laws of such jurisdictions as you may
reasonably request and to comply with such laws so as to permit the continuance of sales and
dealings therein in such jurisdictions for as long as may be necessary to complete the distribution
of the Securities, provided that in connection therewith neither the Company nor any Guarantor
shall be required to qualify as a foreign corporation or to file a general consent to service of
process in any jurisdiction or to subject itself to taxation in any such jurisdiction where it is
not then so subject;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Prior to 10:00&nbsp;a.m., New York City time, on the New York Business Day next succeeding the
date of this Agreement and from time to time, to furnish the Underwriters with written and
electronic copies of the Prospectus in New York City in such quantities as you may reasonably
request, and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Act) is required at any time prior to the expiration of nine months after the time
of issue of the Prospectus in connection with the offering or sale of the Securities and if at such
time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made when such Prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Act) is delivered, not misleading, or, if for any other reason it shall be
necessary during such same period to amend or supplement the Prospectus or to file under the
Exchange Act any document incorporated by reference in the Prospectus in order to comply with the
Act, the Exchange Act or the Trust Indenture Act, to notify you and upon your request to file such
document and to prepare and furnish without charge to each Underwriter and to any dealer in
securities as many written and electronic copies as you may from time to time reasonably request of
an amended Prospectus or a supplement to the Prospectus which will correct such statement or
omission or effect such compliance; and in case any Underwriter is required to deliver a prospectus
(or in lieu thereof, the notice referred to in Rule 173(a) under the Act) in connection with sales
of any of the Securities at any time nine months or more after the time of issue of the Prospectus,
upon your request but at the expense of such Underwriter, to prepare and deliver to such
Underwriter as many written and electronic copies as you may request of an amended or supplemented
Prospectus complying with Section&nbsp;10(a)(3) of the Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;To make generally available to its securityholders as soon as practicable, but in any
event not later than sixteen months after the effective date of the Registration Statement (as
defined in Rule 158(c) under the Act), an earnings statement of the Company and its subsidiaries
(which need not be audited) complying with Section 11(a) of the Act and the rules and regulations
of the Commission thereunder (including, at the option of the Company, Rule&nbsp;158);
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;During the period beginning from the date hereof and continuing to, and including, the
date that is 45&nbsp;days after the date of the Prospectus, not to offer, sell, contract to sell,
pledge, grant any option to purchase, make any short sale or otherwise dispose of, except as
provided hereunder, any securities of the Company that are substantially similar to the Securities
without the prior written consent of Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;To pay the required Commission filing fees relating to the Securities within the time
required by Rule&nbsp;456(b)(1) under the Act without regard to the proviso therein and otherwise in
accordance with Rules 456(b) and 457(r) under the Act; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To use the net proceeds received by it from the sale of the Securities pursuant to this
Agreement in the manner specified in the Pricing Prospectus and the Prospectus under the caption
&#147;Use of Proceeds&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;(i)&nbsp;The Company represents and agrees that, other than the final term sheet in the form
attached as Schedule&nbsp;III hereto prepared and filed pursuant to Section 5(a) hereof, without the
prior consent of Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, the Company has not made and
will not make any offer relating to the Securities that would constitute a &#147;free writing
prospectus&#148; as defined in Rule&nbsp;405 under the Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;each Underwriter represents and agrees that, without the prior consent of the Company and
Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated, other than one or more term sheets relating to
the Securities containing customary information and conveyed to purchasers of Securities, it has
not made and will not make any offer relating to the Securities that would constitute a free
writing prospectus that would require filing with the Commission; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;any such free writing prospectus the use of which has been consented to by the Company
and Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated (including the final term sheet in the form
attached as Schedule&nbsp;III hereto prepared and filed pursuant to Section 5(a) hereof) is listed on
Schedule&nbsp;II(a) hereto (or, in the case of the final term sheet, on Schedule&nbsp;III hereto);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company has complied and will comply with the requirements of Rule&nbsp;433 under the Act
applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or
retention where required and legending; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company agrees that if at any time following issuance of an Issuer Free Writing
Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus
would conflict with the information in the Registration Statement, the Pricing Prospectus or the
Prospectus or would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances then
prevailing, not misleading, the Company will give prompt notice thereof to Merrill Lynch, Pierce,
Fenner &#038; Smith Incorporated and, if requested by Merrill Lynch, Pierce, Fenner &#038; Smith
Incorporated, will prepare and furnish without charge to each Underwriter an
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Issuer Free Writing
Prospectus or other document which will correct such conflict, statement or
omission; provided, however, that this representation and warranty shall not apply to any
statements or omissions in an Issuer Free Writing Prospectus made in reliance upon and in
conformity with information furnished in writing to the Company by an Underwriter through Merrill
Lynch, Pierce, Fenner &#038; Smith Incorporated expressly for use therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;Each of the Company and the Guarantors, jointly and severally, covenants and agrees with
the several Underwriters that the Company and the Guarantors will pay or cause to be paid the
following: (i)&nbsp;the fees, disbursements and expenses of the Company&#146;s and the Guarantors&#146; counsel
and accountants in connection with the registration of the Securities under the Act and all other
expenses in connection with the preparation, printing, reproduction and filing of the Registration
Statement, the Basic Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus and
the Prospectus and amendments and supplements thereto and the mailing and delivering of copies
thereof to the Underwriters and dealers; (ii)&nbsp;the cost of printing or producing any Agreement among
Underwriters (including any agreement with the Independent Underwriter), this Agreement, the
Indenture, the Blue Sky Memorandum, closing documents (including any compilations thereof) and any
other documents in connection with the offering, purchase, sale and delivery of the Securities;
(iii)&nbsp;all expenses in connection with the qualification of the Securities for offering and sale
under state securities laws as provided in Section 5(d) hereof, including the reasonable fees and
disbursements of counsel for the Underwriters in connection with such qualification and in
connection with the Blue Sky survey; (iv)&nbsp;any fees charged by securities rating services for rating
the Securities; (v)&nbsp;the filing fees incident to, and the fees and disbursements of counsel for the
Underwriters in connection with, any required review by FINRA of the terms of the sale of the
Securities; (vi)&nbsp;the cost of preparing the Securities; (vii)&nbsp;the fees and expenses of the Trustee
and any agent of the Trustee and the fees and disbursements of counsel for the Trustee in
connection with the Indenture and the Securities; and (viii)&nbsp;all other reasonable costs and
expenses incident to the performance of its obligations hereunder which are not otherwise
specifically provided for in this Section. It is understood, however, that, except as provided in
this Section, and Sections&nbsp;9 and 12 hereof, the Underwriters will pay all of their own costs and
expenses, including the fees of their counsel, transfer taxes on resale of any of the Securities by
them, and any advertising expenses connected with any offers they may make.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;The obligations of the Underwriters hereunder shall be subject, in their discretion, to the
condition that all representations and warranties and other statements of the Company and the
Guarantors herein are, at and as of the Time of Delivery, true and correct, the condition that the
Company and the Guarantors shall have performed all of their obligations hereunder theretofore to
be performed, and the following additional conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Prospectus shall have been filed with the Commission pursuant to Rule 424(b) under the
Act within the applicable time period prescribed for such filing by the rules and regulations under
the Act and in accordance with Section 5(a) hereof; the final term sheet contemplated by Section
5(a) hereof, and any other material required to be filed by the Company pursuant to Rule 433(d)
under the Act, shall have been filed with the Commission within the applicable time periods
prescribed for such filings by Rule&nbsp;433; no stop order suspending the effectiveness of the
Registration Statement or any part thereof shall have been issued and no proceeding for that
purpose shall have been initiated or threatened by the Commission and no
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">notice of objection of the
Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Act shall have been received;
no stop order suspending or preventing the use of the Prospectus or any Issuer Free Writing
Prospectus shall have been initiated or threatened by the Commission; and all requests for
additional information on the part of the Commission shall have been complied with to your
reasonable satisfaction;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Latham &#038; Watkins LLP, counsel for the Underwriters, shall have furnished to you such
written opinion or opinions, dated each Time of Delivery, in form and substance reasonably
satisfactory to the Underwriters, and such counsel shall have received such papers and information
as they may reasonably request to enable them to pass upon such matters;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Simpson Thacher &#038; Bartlett LLP, counsel for the Company, shall have furnished to you their
written opinion and negative assurance statement substantially in the form attached as Annex II(a)
hereto, dated the Time of Delivery;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Laurence G. Miller, as general counsel to the Company, shall have furnished to you his
written opinion substantially in the form attached as Annex II(b) hereto, dated the Time of
Delivery;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Hyman, Phelps &#038; McNamara PC, as special healthcare regulatory counsel to the Company,
shall have furnished to you their written opinion substantially in the form attached as Annex II(c)
hereto, dated the Time of Delivery;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;On the date of the Prospectus at a time prior to the execution of this Agreement, at 9:30
a.m., New York City time, on the effective date of any post effective amendment to the Registration
Statement filed subsequent to the date of this Agreement and also at the Time of Delivery,
PricewaterhouseCoopers LLP shall have furnished to you a letter or letters, dated the respective
dates of delivery thereof, in form and substance satisfactory to you, to the effect set forth in
Annex I hereto;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;(i)&nbsp;Neither the Company nor any of its subsidiaries shall have sustained since the date of
the latest audited financial statements included or incorporated by reference in the Pricing
Prospectus any loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth or contemplated in the Pricing Prospectus, and
(ii)&nbsp;since the respective dates as of which information is given in the Pricing Prospectus there
shall not have been any change in the capital stock or long term debt of the Company or any of its
subsidiaries (other than changes due to (x)&nbsp;issuances of the Company&#146;s common stock under the
Company&#146;s employee benefit plans and the Company&#146;s dividend reinvestment plan, (y)&nbsp;any shares
purchased under the Company&#146;s existing stock repurchase program or (z)&nbsp;any scheduled repayment of
the Company&#146;s existing debt) or any change, or any development involving a prospective change, in
or affecting the general affairs, management, financial position, stockholders&#146; equity or results
of operations of the Company and its subsidiaries, otherwise than as set forth or contemplated in
the Pricing Prospectus, the effect of which, in any such case described in clause (i)&nbsp;or (ii), is
in the judgment of Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated so material and adverse as to
make it impracticable or inadvisable
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to proceed with the public offering or the delivery of the Securities on the terms and in the
manner contemplated in the Pricing Prospectus and the Prospectus;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;On or after the Applicable Time (i)&nbsp;no downgrading shall have occurred in the rating
accorded the Company&#146;s debt securities by any &#147;nationally recognized statistical rating
organization&#148;, as that term is used by the Commission in Section&nbsp;15E under the Exchange Act, and
(ii)&nbsp;no such organization shall have publicly announced that it has under surveillance or review,
with possible negative implications, its rating of any of the Company&#146;s debt securities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;On or after the Applicable Time there shall not have occurred any of the following: (i)&nbsp;a
suspension or material limitation in trading in securities generally on the Exchange; (ii)&nbsp;a
suspension or material limitation in trading in the Company&#146;s or any Guarantor&#146;s securities on the
Exchange; (iii)&nbsp;a general moratorium on commercial banking activities declared by either Federal or
New York, State authorities or a material disruption in commercial banking or securities settlement
or clearance services in the United States; (iv)&nbsp;the outbreak or escalation of hostilities
involving the United States or the declaration by the United States of a national emergency or war
or (v)&nbsp;the occurrence of any other calamity or crisis or any change in financial, political or
economic conditions in the United States or elsewhere, if the effect of any such event specified in
clause (iv)&nbsp;or (v)&nbsp;in the judgment of Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated makes it
impracticable or inadvisable to proceed with the public offering or the delivery of the Securities
on the terms and in the manner contemplated in the Prospectus; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;The Company shall have furnished or caused to be furnished to you at the Time of Delivery
certificates of officers of the Company and each Guarantor satisfactory to you as to the accuracy
of the representations and warranties of the Company and the Guarantors herein at and as of such
time, as to the performance by the Company and the Guarantors of all of their obligations hereunder
to be performed at or prior to such time, as to the matters set forth in subsections (a), (g)&nbsp;and
(h)&nbsp;of this Section (as applicable) and as to such other matters as you may reasonably request; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;(a)&nbsp;Each of the Company and the Guarantors, jointly and severally, will indemnify and hold
harmless each Underwriter, its directors, officers, employees, affiliates and agents, and each
person, if any, who controls any Underwriter within the meaning of the Act and the Exchange Act
against any losses, claims, damages or liabilities, joint or several, to which such Underwriter or
such director, officer, employee, affiliate, agent or controlling person may become subject, under
the Act or otherwise (including in settlement of any litigation, if such settlement is effected
with the written consent of the Company), insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based (i)&nbsp;upon an untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement, or any amendment
thereto, or the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading or (ii)&nbsp;upon an untrue statement
or alleged untrue statement of a material fact contained in the Basic Prospectus, any Preliminary
Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, any
Issuer Free Writing Prospectus or any &#147;issuer information&#148; filed or required to be filed pursuant
to Rule 433(d) under the Act, or upon the omission or alleged omission to state therein a material
fact necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading, and will
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">reimburse each Underwriter and each such director, officer, employee, agent and controlling
person for any legal or other expenses reasonably incurred by such Underwriter or such director,
officer, employee, agent or controlling person in connection with investigating or defending any
such action or claim as such expenses are incurred; provided, however, that none of the Company or
any Guarantors shall be liable in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in the Registration Statement, the Basic Prospectus, any
Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement
thereto, or any Issuer Free Writing Prospectus, in reliance upon and in conformity with written
information furnished to the Company by any Underwriter through Merrill Lynch, Pierce, Fenner &#038;
Smith Incorporated expressly for use therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and the Guarantors, jointly and severally, will indemnify and hold harmless
Goldman, Sachs &#038; Co., in its capacity as Independent Underwriter, against any losses, claims,
damages or liabilities, joint or several, to which the Independent Underwriter may become subject,
under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon (i)&nbsp;an untrue statement or alleged untrue statement
of a material fact contained in any Preliminary Prospectus, the Registration Statement or the
Prospectus, or any amendment or supplement thereto, (ii)&nbsp;the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein
not misleading or (iii)&nbsp;any act or omission to act or any alleged act or omission to act by
Goldman, Sachs &#038; Co. as Independent Underwriter in connection with any transaction contemplated by
this Agreement or undertaken in preparing for the purchase, sale and delivery of the Shares, except
as to this clause (iii)&nbsp;to the extent that any such loss, claim, damage or liability results from
the gross negligence or bad faith of Goldman, Sachs &#038; Co. in performing the services as Independent
Underwriter, and will reimburse the Independent Underwriter for any legal or other expenses
reasonably incurred by the Independent Underwriter in connection with investigating or defending
any such action or claim as such expenses are incurred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Underwriter, severally and not jointly, will indemnify and hold harmless the Company,
each Guarantor and each of their respective directors, each of their respective officers who signed
the Registration Statement and each person, if any, who controls the Company and each Guarantor
within the meaning of the Act or the Exchange Act, against any losses, claims, damages or
liabilities to which the Company or any Guarantor or any such director, officer or controlling
person may become subject, under the Act or otherwise (including in settlement of any litigation,
if such settlement is effected with the written consent of such Underwriter), insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based
(i)&nbsp;upon an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, or any amendment or supplement thereto, or the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading or (ii)&nbsp;upon an untrue statement or alleged untrue statement of a material
fact contained in the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the
Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, or upon
the omission or alleged omission to state therein a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, in each case
to the extent, but only to the extent, that
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such untrue statement or alleged untrue statement or omission or alleged omission was made in
the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing
Prospectus or the Prospectus or any such amendment or supplement thereto, or any Issuer Free
Writing Prospectus, in reliance upon and in conformity with written information furnished to the
Company or any Guarantor by such Underwriter through Merrill Lynch, Pierce, Fenner &#038; Smith
Incorporated expressly for use therein; and will reimburse the Company or any Guarantor, or any
such director, officer or controlling person for any legal or other expenses reasonably incurred by
the Company or any Guarantor, or any such director, officer or controlling person in connection
with investigating or defending any such action or claim as such expenses are incurred. The
Company and each Guarantor hereby acknowledges that the only information furnished to the Company
and each Guarantor by any Underwriter through Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated
expressly for use in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus,
the Pricing Prospectus or the Prospectus or any such amendment or supplement thereto, or any Issuer
Free Writing Prospectus are the statements set forth in the fifth paragraph of text (concerning the
terms of the offering) and the tenth, eleventh and thirteenth paragraphs of text (concerning short
sales, stabilizing transactions and purchases to cover positions created by short sales), in each
case under the caption &#147;Underwriting&#148; in the Preliminary Prospectus and the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Promptly after receipt by an indemnified party under subsection (a), (b)&nbsp;or (c)&nbsp;above of
notice of the commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against the indemnifying party under such subsection, notify the indemnifying
party in writing of the commencement thereof; but the omission so to notify the indemnifying party
shall not relieve it from any liability which it may have to any indemnified party (except to the
extent that such failure to notify results in any material prejudice against the indemnifying party
with respect to such action) otherwise than under such subsection. In case any such action shall
be brought against any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate therein and, to the
extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume
the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except
with the consent of the indemnified party, be counsel to the indemnifying party), and, after notice
from the indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be liable to such indemnified party under such subsection
for any legal expenses of other counsel or any other expenses, in each case subsequently incurred
by such indemnified party, in connection with the defense thereof other than reasonable costs of
investigation; provided, however, that if indemnity is sought by Goldman, Sachs &#038; Co. in its
capacity as the Independent Underwriter pursuant to Section 9(b) above, then in addition to such
separate counsel of the Underwriters, their affiliates and such control persons of the
Underwriters, the indemnifying party shall be liable for fees and expenses of not more than one
separate firm (in addition to any local counsel) for Goldman, Sachs &#038; Co. in its capacity as
Independent Underwriter, its affiliates, directors, officers and all persons, if any, who control
Goldman, Sachs &#038; Co. within the meaning of either Section&nbsp;15 of the Act or Section&nbsp;20 of the
Exchange Act; provided further, that in case any such action shall be brought against any
indemnified party and such indemnifying party notifies such indemnified party of its election so to
assume the defense thereof, any indemnified party shall have the right to retain its own counsel,
but the fees and expenses of such counsel shall be at the expense of such indemnified party unless:
(i)&nbsp;the indemnifying party and the indemnified party shall have
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">mutually agreed to the contrary; (ii)&nbsp;the indemnifying party has failed within a reasonable
time to retain counsel satisfactory to the indemnified party; (iii)&nbsp;the indemnified party shall
have reasonably concluded that there may be legal defenses available to it that are different from
or in addition to those available to the indemnifying party; or (iv)&nbsp;the named parties in any such
action (including any impleaded parties) include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be inappropriate due to actual
or potential differing interests between them (it being understood, however, that the indemnifying
party shall not, in connection with any one such action or separate but substantially similar or
related actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for the fees and expenses of more than one separate firm of attorneys (in
addition to a single firm of local counsel) for all such indemnified parties, which firm shall be
designated in writing by Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated and that all such
reasonable fees and expenses shall be reimbursed as they are incurred; provided, however, that if
indemnity is sought by Goldman, Sachs &#038; Co. in its capacity as the Independent Underwriter pursuant
to Section 9(b) above, then in addition to such separate counsel of the Underwriters, their
affiliates and such control persons of the Underwriters, the indemnifying party shall be liable for
fees and expenses of not more than one separate firm (in addition to any local counsel) for
Goldman, Sachs &#038; Co. in its capacity as Independent Underwriter, its affiliates, directors,
officers and all persons, if any, who control Goldman, Sachs &#038; Co. within the meaning of either
Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act). Upon receipt of notice from the
indemnifying party to such indemnified party of such indemnifying party&#146;s election so to assume the
defense of such action and approval by the indemnified party of counsel, the indemnifying party
will not be liable to such indemnified party under this Section&nbsp;9 for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense thereof unless the
indemnified party shall have employed separate counsel in accordance with the proviso to the next
preceding sentence, in which case the reasonable fees and expenses of counsel shall be at the
expense of the indemnifying party. No indemnifying party shall, without the written consent of the
indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment
with respect to, any pending or threatened action or claim in respect of which indemnification or
contribution may be sought hereunder (whether or not the indemnified party is an actual or
potential party to such action or claim) unless such settlement, compromise or judgment (i)
includes an unconditional release of the indemnified party from all liability arising out of such
action or claim and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability
or a failure to act, by or on behalf of any indemnified party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If the indemnification provided for in this Section&nbsp;9 is unavailable to or insufficient to
hold harmless an indemnified party under subsection (a)&nbsp;or (b)&nbsp;above in respect of any losses,
claims, damages or liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages or liabilities (or actions in respect thereof) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Guarantors on the one hand and the Underwriters or the Independent Underwriter, as applicable, on
the other from the offering of the Securities. If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law or if the indemnified party
failed to give the notice required under subsection (c)&nbsp;above, then each indemnifying party shall
contribute to such amount paid or payable by such indemnified party in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of the Company
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and the Guarantors on the one hand and the Underwriters or the Independent Underwriter, as
applicable, on the other in connection with the statements or omissions which resulted in such
losses, claims, damages or liabilities (or actions in respect thereof), as well as any other
relevant equitable considerations. The relative benefits received by the Company and the
Guarantors on the one hand and the Underwriters or the Independent Underwriter, as applicable, on
the other from the offering of the Securities shall be deemed to be in the same proportion as the
total net proceeds from the offering of the Securities (before deducting expenses) received by the
Company and the Guarantors bear to the total underwriting discounts and commissions received by the
Underwriters or the Independent Underwriter, as applicable, in each case as set forth in the table
on the cover page of the Prospectus. The relative fault shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company and the
Guarantors on the one hand or the Underwriters on the other and the parties&#146; relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company, the Guarantors, the Underwriters and the Independent Underwriter agree that it would
not be just and equitable if contribution pursuant to this subsection (d)&nbsp;were determined by pro
rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any
other method of allocation which does not take account of the equitable considerations referred to
above in this subsection (d). The amount paid or payable by an indemnified party as a result of
the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in
this subsection (d)&nbsp;shall be deemed to include any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to
contribute any amount in excess of the amount by which the total price at which the Securities
underwritten by it and distributed to the public were offered to the public exceeds the amount of
any damages which such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The
Underwriters&#146; obligations in this subsection (d)&nbsp;to contribute are several in proportion to their
respective underwriting obligations and not joint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The obligations of the Company and the Guarantors under this Section&nbsp;9 shall be in
addition to any liability which the Company and the Guarantors may otherwise have and shall extend,
upon the same terms and conditions, to each person, if any, who controls any Underwriter or the
Independent Underwriter within the meaning of the Act and each broker-dealer affiliate of any
Underwriter or the Independent Underwriter; and the obligations of the Underwriters under this
Section&nbsp;9 shall be in addition to any liability which the respective Underwriters may otherwise
have and shall extend, upon the same terms and conditions, to each officer and director of the
Company or any Guarantor (including any person who, with his or her consent, is named in the
Registration Statement as about to become a director of the Company or any Guarantor) and to each
person, if any, who controls the Company or any Guarantor within the meaning of the Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;(a)&nbsp;If any Underwriter shall default in its obligation to purchase the Securities which
it has agreed to purchase hereunder, you may in your discretion arrange for you or another party or
other parties to purchase such Securities on the terms contained herein. If within thirty
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">six hours after such default by any Underwriter you do not arrange for the purchase of such
Securities, then the Company shall be entitled to a further period of thirty six hours within which
to procure another party or other parties satisfactory to you to purchase such Securities on such
terms. In the event that, within the respective prescribed periods, you notify the Company that
you have so arranged for the purchase of such Securities, or the Company notifies you that it has
so arranged for the purchase of such Securities, you or the Company shall have the right to
postpone the Time of Delivery for a period of not more than seven days, in order to effect whatever
changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any
other documents or arrangements, and the Company agrees to file promptly any amendments or
supplements to the Registration Statement, the Pricing Prospectus or the Prospectus which in your
opinion may thereby be made necessary. The term &#147;Underwriter&#148; as used in this Agreement shall
include any person substituted under this Section with like effect as if such person had originally
been a party to this Agreement with respect to such Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by you and the Company as provided in subsection (a)&nbsp;above,
the aggregate principal amount of such Securities which remains unpurchased does not exceed one
eleventh of the aggregate principal amount of all the Securities, then the Company shall have the
right to require each non-defaulting Underwriter to purchase the principal amount of Securities
which such Underwriter agreed to purchase hereunder and, in addition, to require each
non-defaulting Underwriter to purchase its pro rata share (based on the principal amount of
Securities which such Underwriter agreed to purchase hereunder) of the Securities of such
defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing
herein shall relieve a defaulting Underwriter from liability for its default.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by you and the Company as provided in subsection (a)&nbsp;above,
the aggregate principal amount of Securities which remains unpurchased exceeds one eleventh of the
aggregate principal amount of all the Securities, or if the Company shall not exercise the right
described in subsection (b)&nbsp;above to require non-defaulting Underwriters to purchase Securities of
a defaulting Underwriter or Underwriters, then this Agreement shall thereupon terminate, without
liability on the part of any non-defaulting Underwriter or the Company, except for the expenses to
be borne by the Company, each of the Guarantors and the Underwriters as provided in Section&nbsp;7
hereof and the indemnity and contribution agreements in Section&nbsp;9 hereof; but nothing herein shall
relieve a defaulting Underwriter from liability for its default.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;The respective indemnities, agreements, representations, warranties and other statements
of the Company, each of the Guarantors and the several Underwriters, as set forth in this Agreement
or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full
force and effect, regardless of any investigation (or any statement as to the results thereof) made
by or on behalf of any Underwriter, its directors, officers, employees, affiliates, agents or any
controlling person of any Underwriter, or the Company or any Guarantor, or any officer or director
or controlling person of the Company or any Guarantor, and shall survive delivery of and payment
for the Securities.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;If this Agreement shall be terminated pursuant to Section&nbsp;10 hereof, the Company and the
Guarantors shall not then be under any liability to any Underwriter or except as provided in
Sections&nbsp;7 and 9 hereof; but, if for any other reason, the Securities are not delivered by or on
behalf of the Company as provided herein, the Company and the Guarantors will, jointly and
severally, reimburse the Underwriters, through you, for all out of pocket expenses approved in
writing by you, including fees and disbursements of counsel, reasonably incurred by the
Underwriters in making preparations for the purchase, sale and delivery of the Securities, but the
Company and the Guarantors shall not then be under further liability to any Underwriter except as
provided in Sections&nbsp;7 and 9 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;In all dealings hereunder, you shall act on behalf of each of the Underwriters, and the
parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement
on behalf of any Underwriter made or given by you.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All statements, requests, notices and agreements hereunder shall be in writing, and if to the
(i)&nbsp;Underwriters shall be delivered or sent by mail, telex or facsimile transmission to Merrill
Lynch, Pierce, Fenner &#038; Smith Incorporated at One Bryant Park, NY1-100-18-03, New York, New York
10036, Attention: High Grade Transaction Management/Legal; (ii)&nbsp;Independent Underwriter, shall be
delivered or sent by mail, telex or facsimile transmission to Goldman, Sachs &#038; Co. at 200 West
Street, New York, New York 10282-2198, Attention: Registration Department; and (iii)&nbsp;Company shall
be delivered or sent by mail, telex or facsimile transmission to the address of the Company set
forth in the Registration Statement, Attention: Secretary; provided, however, that any notice to an
Underwriter or the Independent Underwriter pursuant to Section 9(d) hereof shall be delivered or
sent by mail, telex or facsimile transmission to such Underwriter or Independent Underwriter at its
address set forth in its Underwriters&#146; Questionnaire, or telex constituting such Questionnaire,
which address will be supplied to the Company by you upon request. Any such statements, requests,
notices or agreements shall take effect upon receipt thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56
(signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record
information that identifies their respective clients, including the Company, which information may
include the name and address of their respective clients, as well as other information that will
allow the Underwriters to properly identify their respective clients.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;This Agreement shall be binding upon, and inure solely to the benefit of, the
Underwriters, the Company and each of the Guarantors and, to the extent provided in Sections&nbsp;9 and
11 hereof, the officers and directors of the Company and each of the Guarantors, each person who
controls the Company or any Guarantor, and the directors, officers, employees, affiliates, agents
or any controlling person of any Underwriter, and their respective heirs, executors,
administrators, successors and assigns, and no other person shall acquire or have any right under
or by virtue of this Agreement. No purchaser of any of the Securities from any Underwriter shall be
deemed a successor or assign by reason merely of such purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;Time shall be of the essence of this Agreement. As used herein, the term &#147;business day&#148;
shall mean any day when the Commission&#146;s office in Washington, D.C. is open for business.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Independent Underwriter hereby represents and warrants to, and agrees with, the
Company, each of the Guarantors and the Underwriters that with respect to the offering and sale of
the Securities as described in the Prospectus:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Independent Underwriter constitutes a &#147;qualified independent underwriter&#148; within the
meaning of Section (f)(12) of Rule&nbsp;5121;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Independent Underwriter has participated in the preparation of the Registration
Statement and the Prospectus and has exercised the usual standards of &#147;due diligence&#148; in respect
thereto; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Independent Underwriter has undertaken the legal responsibilities and liabilities of
an underwriter under the Act specifically including those inherent in Section&nbsp;11 thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Independent Underwriter hereby agrees with the Company, each of the Guarantors and the
Underwriters that, as part of its services hereunder, in the event of any amendment or supplement
to the Prospectus, the Independent Underwriter will render services as a &#147;qualified independent
underwriter&#148; within the meaning of Section (f)(12) of Rule&nbsp;5121 with respect to the offering and
sale of the Securities as described in the Prospectus as so amended or supplemented that are
substantially the same as those services being rendered with respect to the offering and sale of
the Securities as described in the Prospectus (including those described in subsection (b)&nbsp;above).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company and each of the Guarantors agrees to cooperate with the Underwriters to enable
the Underwriters to comply with Rule&nbsp;5121 and the Independent Underwriter to perform the services
contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company, each of the Guarantors and the Independent Underwriter agree that the
Independent Underwriter will provide its services in its capacity as Independent Underwriter
hereunder without compensation other than such compensation that the Independent Underwriter may
receive as an Underwriter hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Independent Underwriter hereby consents to the references to it as set forth under the
caption &#147;Underwriting&#148; in the Prospectus and in any amendment or supplement thereto made in
accordance with Section&nbsp;5 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;Each of the Company and the Guarantors acknowledges and agrees that (i)&nbsp;the purchase and
sale of the Securities pursuant to this Agreement is an arm&#146;s-length commercial transaction between
the Company and the Guarantors, on the one hand, and the several Underwriters, on the other, (ii)
in connection therewith and with the process leading to such transaction each Underwriter is acting
solely as a principal and not the agent or fiduciary of the Company and the Guarantors, (iii)&nbsp;no
Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company and the
Guarantors with respect to the offering contemplated hereby or the process leading thereto
(irrespective of whether such Underwriter has advised or is currently advising the Company and the
Guarantors on other matters) or any other
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">obligation to the Company and the Guarantors except the obligations expressly set forth in
this Agreement, (iv)&nbsp;the several Underwriters and their respective affiliates may be engaged in a
broad range of transactions that involve interests that differ from those of the Company and the
Guarantors and that the several Underwriters have no obligation to disclose any of such interests
by virtue of any advisory, agency or fiduciary relationship, and (v)&nbsp;the Company and the Guarantors
have consulted their own legal and financial advisors to the extent they deemed appropriate. The
Company and the Guarantors agree that they will not claim that the Underwriters, or any of them,
has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the
Company and the Guarantors, in connection with such transaction or the process leading thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;This Agreement supersedes all prior agreements and understandings (whether written or
oral) among the Company, the Guarantors and the Underwriters, or any of them, with respect to the
subject matter hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;THIS AGREEMENT AND ANY MATTERS RELATED TO THIS TRANSACTION SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF
CONFLICT OF LAWS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF THE STATE
OF NEW YORK. The Company agrees that any suit or proceeding arising in respect of this agreement
or our engagement will be tried exclusively in the U.S. District Court for the Southern District of
New York or, if that court does not have subject matter jurisdiction, in any state court located in
The City and County of New York and the Company agrees to submit to the jurisdiction of, and to
venue in, such courts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;The Company, each of the Guarantors and each of the Underwriters hereby irrevocably
waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in
any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;This Agreement may be executed by any one or more of the parties hereto in any number of
counterparts, each of which shall be deemed to be an original, but all such respective counterparts
shall together constitute one and the same instrument.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;Notwithstanding anything herein to the contrary, the Company is authorized to disclose to
any persons the U.S. federal and state income tax treatment and tax structure of the potential
transaction and all materials of any kind (including tax opinions and other tax analyses) provided
to the Company relating to that treatment and structure, without the Underwriters, imposing any
limitation of any kind. However, any information relating to the tax treatment and tax structure
shall remain confidential (and the foregoing sentence shall not apply) to the extent necessary to
enable any person to comply with securities laws. For this purpose, &#147;tax structure&#148; is limited to
any facts that may be relevant to that treatment.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the foregoing is in accordance with your understanding, please sign and return to us
counterparts hereof, and upon the acceptance hereof by you, this letter and such acceptance hereof
shall constitute a binding agreement between each of the Underwriters, the Company and the
Guarantors.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
<BR>
Teleflex Incorporated<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Richard A. Meier
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Richard A. Meier&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and<BR>
Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Airfoil Technologies International-California,
Inc., <br>as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Airfoil Technologies International-Ohio, Inc.,<BR>
as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Arrow International Investment Corp., <BR>as
Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Arrow Interventional, Inc., as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Specialized Medical Devices, LLC, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Technology Holding Company, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Technology Holding Company II, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Technology Holding Company III, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Teleflex Holding Company II, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TFX Equities Incorporated, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TFX Group LLC, as Guarantor<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TFX International Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TFX Medical Wire Products, Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TFX North America Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">VasoNova, Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">The Stepic Medical Distribution Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Teleflex Medical Incorporated<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Arrow International, Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Arrow Medical Products Ltd.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Accepted as of the date hereof:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Merrill Lynch, Pierce, Fenner &#038; Smith</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD colspan="3" valign="top" align="left"><DIV style="margin-left:45px; text-indent:-15px">Incorporated</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Neil Oberoi
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Neil Oberoi
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Goldman, Sachs &#038; Co.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">As Underwriter and Independent Underwriter</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Goldman, Sachs &#038; Co.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(Goldman, Sachs &#038; Co.)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">J.P. Morgan Securities LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Edward S. Pyne</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name: Edward S. Pyne</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>







<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE I</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="78%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Aggregate Principal Amount of</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Underwriter</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Securities to be Purchased</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merrill Lynch, Pierce, Fenner &#038; Smith
Incorporated</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">125,000,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goldman, Sachs &#038; Co.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">87,500,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">J.P. Morgan Securities LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">37,500,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left"><B>$</B></TD>
    <TD align="right"><B>250,000,000</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE II</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Issuer Free Writing Prospectuses not included in the Pricing Disclosure Package:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Additional Documents Incorporated by Reference:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE III</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Form of Final Term Sheet</B>
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Filed pursuant to Rule&nbsp;433 under the Securities Act of 1933<BR>
Issuer Free Writing Prospectus dated June&nbsp;8, 2011<BR>
Relating to Preliminary Prospectus Supplement dated June&nbsp;1, 2011<BR>
Post-Effective Amendment No.&nbsp;1 to Registration Statement No.&nbsp;333-168464</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PRICING TERM SHEET</B><BR>
Dated June&nbsp;8, 2011 to the<BR>
Preliminary Prospectus Supplement Referred to Below<BR>
<B>Teleflex Incorporated<BR>
$250,000,000<BR>
6.875% Senior Subordinated Notes due 2019</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>The information in this pricing term sheet relates only to the Senior Subordinated Notes offering
and should be read together with (i)&nbsp;the preliminary prospectus supplement dated June&nbsp;1, 2011
relating to the Senior Subordinated Notes offering, including the documents incorporated by
reference therein, and (ii)&nbsp;the accompanying prospectus dated June&nbsp;1, 2011, each filed with the
Securities and Exchange Commission (the &#147;SEC&#148;).</I>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Issuer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Teleflex Incorporated</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Securities Offered:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;6.875% Senior Subordinated Notes due 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Aggregate Principal Amount:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;$250,000,000</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Public Offering Price:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;100%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Gross Proceeds:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;$250,000,000</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Net Proceeds:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Approximately $245.8&nbsp;million, after deducting the
underwriters&#146; discounts and commissions and net
estimated offering expenses payable by the Issuer.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Maturity Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Annual Interest Rate:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;6.875%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Yield to Maturity:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;6.875%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Spread to Benchmark Treasury:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&#043;440 basis points</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Benchmark Treasury:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;3.125% UST due May&nbsp;15, 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Interest Payment Dates:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June 1 and December&nbsp;1, beginning on December&nbsp;1, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Interest Payment Record Dates:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;15 and November 15</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Equity Clawback:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prior to June&nbsp;1, 2014, up to 35% may be redeemed at
106.875% plus accrued and unpaid interest.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Optional Redemption:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">On or after the dates set forth below at the prices
set forth below plus accrued and unpaid interest:</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2015: 103.438%</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2016: 101.719%</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2017 and thereafter: 100.000%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Make-whole Call:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prior to June&nbsp;1, 2015, at a make-whole premium
based on Treasury Rate plus 50 basis points.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Change of Control:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Putable at 101% plus accrued and unpaid interest</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Joint Book-Running Managers:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Goldman, Sachs &#038; Co.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">J.P. Morgan Securities LLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Pricing Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;8, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Expected Settlement Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;13, 2011 (T&#043;3)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Offering:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SEC Registered</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">CUSIP / ISIN:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;879369AB2 / US879369AB25</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Denominations:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;$2,000 and integral multiples of $1,000 in excess
of $2,000.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Pro Forma Ratio of Earnings
to Fixed Charges:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The pro forma ratio of earnings to fixed charges
for the year ended December&nbsp;31, 2010 is 2.1x and
for the three months ended March&nbsp;27, 2011 is 2.0x.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>The Issuer has filed a registration statement (including the preliminary prospectus supplement
dated June&nbsp;1, 2011 and an accompanying prospectus dated June&nbsp;1, 2011) with the SEC, for the
offering to which this communication relates. Before you invest, you should read the relevant
preliminary prospectus supplement, the accompanying prospectus and the other documents the Issuer
has filed with the SEC for more complete information about the Issuer and the offering. You may get
these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively,
copies may be obtained from</B>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>BofA Merrill Lynch at 4 World Financial Center, New York, NY 10080, Attention: Prospectus
Department or emailing dg.prospectus&#95;requests@baml.com, Goldman, Sachs &#038; Co. at 200 West Street,
New York, NY 10282, (866)&nbsp;471-2526 or emailing prospectus-ny@ny.email.gs.com or J.P. Morgan at 383
Madison Avenue, 3rd Floor, New York, NY 10179, (800)&nbsp;245-8812.</B>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE IV</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Significant Subsidiaries</B>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Arrow International, Inc. (Pennsylvania)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Arrow International Investment Corp. (Delaware)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Holding Company (Canada)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Holdings Netherlands B.V. (Netherlands)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Medical Europe Limited (Ireland)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Medical Incorporated (California)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TFX Equities Incorporated (Delaware)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TFX International Corporation (Delaware)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TFX North America Inc. (Delaware)
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>y91654exv4w2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv4w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;4.2</B>
</DIV>




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TELEFLEX INCORPORATED</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>as Issuer</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>EACH OF THE GUARANTORS PARTY HERETO</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>as Guarantors</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>WELLS FARGO BANK, N.A.</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>as Trustee</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Second Supplemental Indenture</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Dated as of June&nbsp;13, 2011</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>to the Indenture dated as</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>of</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>August&nbsp;2, 2010</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>6.875% Senior Subordinated Notes due 2019</B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="94%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>PAGE</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 1. DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;1.01 Scope of Supplemental Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;1.02 Definitions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">2</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 2. THE NOTES
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">29</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;2.01 Title and Terms; Payments
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">29</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;2.02 Book-Entry Provisions for Global Notes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">30</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;2.03 Repurchase and Cancellation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">31</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 3. REDEMPTION AND PREPAYMENT
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">32</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;3.01 Effect of Notice of Redemption
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">32</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;3.02 Optional Redemption
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">32</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;3.03 Mandatory Redemption
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">33</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;3.04 Offer to Purchase by Application of Excess Proceeds
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">33</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 4. COVENANTS
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">35</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.01 Reports
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">35</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.02 Restricted Payments
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">36</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.03 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">40</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.04 Incurrence of Indebtedness and Issuance of Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">41</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.05 Asset Sales
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">45</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.06 Transactions with Affiliates
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">47</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.07 Liens
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">48</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.08 Offer to Repurchase Upon Change of Control
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">49</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.09 No Layering of Debt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">50</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.10 Additional Note Guarantees
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">50</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.11 Payments for Consent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">51</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.12 Designation of Restricted and Unrestricted Subsidiaries
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">51</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;4.13 Changes in Covenants when Notes Are Rated Investment Grade
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">51</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 5. SUCCESSORS
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">52</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;5.01 Merger, Consolidation or Sale of Assets
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">52</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;5.02 Successor Corporation Substituted
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">53</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;5.03 Opinion of Counsel to Be Given to Trustee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">54</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 6. DEFAULT AND REMEDIES
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">54</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.01 Events of Default
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">54</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.02 Acceleration
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">56</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.03 Other Remedies
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">56</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.04 Waiver of Past Defaults
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">56</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->i<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="94%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>PAGE</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.05 Control by Majority
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">57</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.06 Limitation on Suits
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">57</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;6.07 Collection Suit by Trustee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">57</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 7. LEGAL DEFEASANCE AND COVENANT DEFEASANCE
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">58</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.01 Option to Effect Legal Defeasance or Covenant Defeasance
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">58</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.02 Legal Defeasance and Discharge
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">58</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.03 Covenant Defeasance
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">58</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.04 Conditions to Legal or Covenant Defeasance
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">59</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">60</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.06 Repayment to Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">60</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;7.07 Reinstatement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">61</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 8. SATISFACTION AND DISCHARGE
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">61</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;8.01 Satisfaction and Discharge of the Supplemental Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">61</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;8.02 Application of Trust Money
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">62</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 9. NOTE GUARANTEES
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">62</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.01 Guarantee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">62</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.02 Subordination of Note Guarantee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">62</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.03 Limitation on Guarantor Liability
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">63</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.04 Execution and Delivery
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">64</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.05 Guarantors May Consolidate, etc., on Certain Terms
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">64</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;9.06 Releases
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">65</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 10. SUPPLEMENTAL INDENTURES
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">66</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;10.01 Supplemental Indentures Without Consent of Holders
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">66</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;10.02 Supplemental Indentures With Consent of Holders
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">66</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;10.03 Notice of Amendment or Supplement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">67</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 11. MISCELLANEOUS
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.01 Governing Law
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.02 No Security Interest Created
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.03 Trust Indenture Act
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.04 Benefits of Supplemental Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.05 Calculations
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.06 Effect of Headings and Table of Contents
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.07 Execution in Counterparts
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.08 Separability Clause
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.09 Ratification of Original Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">68</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.10 The Trustee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;11.11 No Recourse Against Others
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ARTICLE 12. SUBORDINATION
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->ii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="93%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>PAGE</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.01 Agreement to Subordinate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.02 Liquidation; Dissolution; Bankruptcy
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.03 Default on Designated Senior Debt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.04 Acceleration of Notes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.05 When Distribution Must Be Paid Over
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.06 Notice by Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.07 Subrogation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.08 Relative Rights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.09 Subordination May Not Be Impaired by Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.10 Distribution or Notice to Representative or Holders of Senior Debt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.11 Rights of Trustee and Paying Agent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.12 Authorization to Effect Subordination; Filing Proof of Claim
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.13 Reliance and Amendments
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Section&nbsp;12.14 No Waiver of Subordination Provisions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>EXHIBIT</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A Form of Note
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">A-1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B Form of Supplemental Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">B-1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECOND SUPPLEMENTAL INDENTURE (this &#147;<B><I>Supplemental Indenture</I></B>&#148;), dated as of June&nbsp;13, 2011,
among Teleflex Incorporated, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), the Guarantors listed on
Schedule&nbsp;A hereto (the &#147;<B><I>Guarantors</I></B>&#148;) and Wells Fargo Bank, N.A, (the &#147;<B><I>Trustee</I></B>&#148;) as trustee under
the Indenture dated as of August&nbsp;2, 2010, between the Company and the Trustee (as amended or
supplemented from time to time in accordance with the terms thereof, the &#147;<B><I>Original Indenture</I></B>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>RECITALS OF THE COMPANY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Company executed and delivered the Original Indenture to the Trustee to provide,
among other things, for the issuance, from time to time, of the Company&#146;s unsecured Securities, in
an unlimited aggregate principal amount, in one or more series to be established by the Company
under, and authenticated and delivered as provided in, the Original Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Section&nbsp;9.1(j) of the Original Indenture provides for the Company and the Trustee to
enter into supplemental indentures to the Original Indenture to establish the form and terms of
Securities of any series as contemplated by Section&nbsp;2.1 of the Original Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors has duly adopted resolutions authorizing the Company to
execute and deliver this Supplemental Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to the terms of the Original Indenture, the Company desires to establish a
new series of its Securities to be known as its &#147;6.875% Senior Subordinated Notes due 2019&#148; (the
&#147;<B><I>Notes</I></B>&#148;), the form and substance of such Notes and the terms, provisions and conditions thereof to
be set forth as provided in the Original Indenture and this Supplemental Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Form of Note, the certificate of authentication to be borne by each Note and the
Form of Assignment and Transfer contemplated under the terms of the Notes are to be substantially
in the forms hereinafter provided; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Company and the Guarantors have requested that the Trustee execute and deliver
this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH, for and in consideration of the
premises and the purchases of the Notes by the Holders thereof, it is mutually agreed, for the
benefit of the Company and the Guarantors and the equal and proportionate benefit of all Holders of
the Notes, as follows:
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ARTICLE 1.<BR>
DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION</B>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;1.01 <I>Scope of Supplemental Indenture</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise stated, the terms and provisions contained in the Original Indenture shall
constitute, and are hereby expressly made, a part of this Supplemental Indenture and the Company,
the Guarantors and the Trustee, by their execution and delivery of this Supplemental Indenture,
expressly agree to such terms and provisions and to be bound thereby. Notwithstanding any of the
foregoing to the contrary, the provisions of this Supplemental Indenture shall supersede any
corresponding provisions in the Original Indenture, and to the extent any provision of the Original
Indenture conflicts with the express provisions of this Supplemental Indenture, the provisions of
this Supplemental Indenture shall govern and
be controlling. The changes, modifications and supplements to the Original Indenture effected
by this Supplemental Indenture shall be applicable only with respect to, and shall only govern the
terms of, the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Notes, which may be issued from time to time, and shall not apply to any other
Securities that may be issued under the Original Indenture unless a supplemental indenture with
respect to such other Securities specifically incorporates such changes, modifications and
supplements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;1.02 <I>Definitions</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For all purposes of this Supplemental Indenture, except as otherwise expressly provided or
unless the context otherwise requires:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the terms defined in this Article&nbsp;1 shall have the meanings assigned to them in
this Article&nbsp;1 and include the plural as well as the singular;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;all words, terms and phrases defined in the Original Indenture (but not
otherwise defined herein) shall have the same meanings as in the Original Indenture;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;all other terms used herein that are defined in the Trust Indenture Act, either
directly or by reference therein, shall have the meanings assigned to them in the Trust Indenture
Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;all accounting terms not otherwise defined herein shall have the meanings
assigned to them in accordance with generally accepted accounting principles, and, except as
otherwise herein expressly provided, the term &#147;generally accepted accounting principles&#148; with
respect to any computation required or permitted hereunder shall mean such accounting principles as
are generally accepted at the date of this instrument; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;the words &#147;herein,&#148; &#147;hereof&#148; and &#147;hereunder&#148; and other words of similar import
refer to this Supplemental Indenture as a whole and not to any particular Article, Section or other
subdivision.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Acquired Debt</I></B>&#148; means, with respect to any specified Person:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Indebtedness of any other Person existing at the time such other Person is merged with or
into or became a Subsidiary of such specified Person, whether or not such Indebtedness is incurred
in connection with, or in contemplation of, such other Person merging with or into, or becoming a
Restricted Subsidiary of, such specified Person; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;Indebtedness secured by a Lien encumbering any asset acquired by such specified Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Additional Notes</I></B>&#148; has the meaning specified in Section&nbsp;2.01.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Affiliate</I></B>&#148; of any specified Person means any other Person directly or indirectly controlling
or controlled by or under direct or indirect common control with such specified Person. For
purposes of this definition, &#147;control,&#148; as used with respect to any Person, means the possession,
directly or indirectly, of the power to direct or cause the direction of the management or policies
of such Person, whether through the ownership of voting securities, by agreement or otherwise. For
purposes of this definition, the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under common control
with&#148; have correlative meanings. No Person (other than the Company or any Subsidiary of the
Company) in whom a Securitization Subsidiary makes
an Investment in connection with a Qualified Securitization Facility will be deemed to be an
Affiliate of the Company or any of its Subsidiaries solely by reason of such Investment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Affiliate Transaction</I></B>&#148; has the meaning specified in Section&nbsp;4.06(a).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Agent Members</I></B>&#148; has the meaning specified in Section&nbsp;2.02(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Applicable
Premium</I></B>&#148; means, with respect to any Note being redeemed
pursuant to Section 3.02(b) on any redemption date, the greater of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;1.0% of the principal amount of the Note; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the excess, if any, of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the present value at such redemption date of (i)&nbsp;the redemption price of the
Note at June&nbsp;1, 2015 (such redemption price being set forth in
the table appearing in Section&nbsp;3.02(d))
plus (ii)&nbsp;all required interest payments due on the Note through June&nbsp;1, 2015, (excluding accrued
but unpaid interest to the redemption date), computed using a discount rate equal to the Treasury
Rate as of such redemption date plus 50 basis points; over
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the principal amount of the Note.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Asset Sale</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the sale, lease, conveyance or other disposition of any assets or rights by the Company or
any of the Company&#146;s Restricted Subsidiaries; <I>provided </I>that the sale, lease, conveyance or other
disposition of all or substantially all of the assets of the Company and its Restricted
Subsidiaries taken as a whole will be governed by Section&nbsp;4.08 and/or Section&nbsp;5.01 and not by
Section&nbsp;4.05; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the issuance of Equity Interests by any of the Company&#146;s Restricted Subsidiaries or the
sale by the Company or any of the Company&#146;s Restricted Subsidiaries of Equity Interests in any of
the Company&#146;s Subsidiaries (other than preferred stock of Restricted Subsidiaries issued in
compliance with Section&nbsp;4.04).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the preceding, none of the following items will be deemed to be an Asset Sale:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;any single transaction or series of related transactions that involves assets having a
Fair Market Value of less than $25.0&nbsp;million;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;to the extent allowable under Section&nbsp;1031 of the Code, any exchange of like property
(excluding any boot thereon) for use in a Permitted Business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the lease, assignment or sub-lease of any real or personal property in the ordinary course
of business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an
Unrestricted Subsidiary;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;any
financing transaction with respect to property built or acquired by
the Company or any of its Restricted Subsidiary after the date of this Supplemental Indenture, including any sale and
leaseback transactions and asset securitizations permitted by the Indenture;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;the sale or discount of inventory, accounts receivable or notes receivable in the ordinary
course of business or the conversion of accounts receivable to notes receivable;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;a transfer of assets between or among the Company and its Restricted Subsidiaries;
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;an issuance of Equity Interests by a Restricted Subsidiary of the Company to the Company
or to a Restricted Subsidiary of the Company;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;the sale, lease or other transfer of products, services or accounts receivable in the
ordinary course of business and any sale or other disposition of damaged, worn-out, obsolete or no
longer used assets in the ordinary course of business (including the abandonment or other
disposition of intellectual property that is, in the reasonable judgment of the Company, no longer
economically practicable to maintain or useful in the conduct of the business of the Company and
its Restricted Subsidiaries taken as whole);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;licenses and sublicenses by the Company or any of its Restricted Subsidiaries of software
or intellectual property or other intangibles in the ordinary course of business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;any surrender or waiver of contract rights or settlement, release, recovery on or
surrender of contract, tort or other claims in the ordinary course of business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;foreclosures, condemnation or similar proceedings affecting assets of the Company or any
of its Restricted Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;the granting of Liens not prohibited by Section&nbsp;4.07;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;the sale or other disposition of cash or Cash Equivalents or Investment Grade Securities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;a Restricted Payment permitted under Section&nbsp;4.02 or a Permitted Investment;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;the entry into, settlement or early termination of any Hedging Obligations;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;the entry into, settlement or early termination of any Permitted Bond Hedge Transaction
and the entry into, settlement or early termination of any Permitted Warrant Transaction;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(18)&nbsp;transfers or sales of (i)&nbsp;accounts receivable, participations therein or related assets
or (ii)&nbsp;Securitization Assets and related assets (or a fractional undivided interest therein), in
each case in connection with a Qualified Securitization Facility; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(19)&nbsp;sales or other dispositions by the Company or any of its Restricted Subsidiaries of
assets constituting in whole or in part its Aerospace segment (as defined in its condensed
consolidated financial statements for the three months ended March&nbsp;27, 2011), or of Equity
Interests of any Restricted Subsidiary of the Company holding its Aerospace segment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Asset Sale Offer</I></B>&#148; has the meaning specified in Section&nbsp;3.04.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Bankruptcy Law</I></B>&#148; means Title 11, U.S. Code or any similar federal or state law for the relief
of debtors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Beneficial Owner</I></B>&#148; has the meaning assigned to such term in Rule&nbsp;13d-3 and Rule&nbsp;13d-5 under
the Exchange Act, except that in calculating the beneficial ownership of any particular &#147;person&#148;
(as that term is used in Section&nbsp;13(d)(3) of the Exchange Act), such &#147;person&#148; will be deemed to
have beneficial ownership of all securities that such &#147;person&#148; has the right to acquire by
conversion or exercise of other securities, whether such right is currently exercisable or is
exercisable only after the passage of time. The terms &#147;Beneficially Owns&#148; and &#147;Beneficially Owned&#148;
have a corresponding meaning.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Board of Directors</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;with respect to a corporation, the board of directors of the corporation or any committee
thereof duly authorized to act on behalf of such board;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;with respect to a partnership, the board of directors of the general partner of the
partnership;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;with respect to a limited liability company, the managing member or members or any
controlling committee of managing members thereof; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;with respect to any other Person, the board or committee of such Person serving a similar
function.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Business Day</I></B>&#148; means, with respect to any Note, any day other than a Saturday, a Sunday or a
day on which the Federal Reserve Bank of New York is authorized or required by law or executive
order to close or to be closed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Calculation
Date</i></b>&#148; has the meaning specified in the definition of
Fixed Charge Coverage Ratio.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Capital Lease Obligations</I></B>&#148; of any Person means the obligations of such Person to pay rent or
other amounts under any lease of (or other arrangement conveying the right to use) real or personal
property, or a combination thereof, which obligations are required to be classified and accounted
for as capital leases on a balance sheet of such Person under GAAP, and the amount of such
obligations shall be the capitalized amount thereof determined in accordance with GAAP.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Capital Stock</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;in the case of a corporation, corporate stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;in the case of an association or business entity, any and all shares, interests,
participations, rights or other equivalents (however designated) of corporate stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;in the case of a partnership or limited liability company, partnership interests (whether
general or limited) or membership interests; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any other interest or participation that confers on a Person the right to receive a share
of the profits and losses of, or distributions of assets of, the issuing Person,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">but excluding from
all of the foregoing any debt securities exchangeable or convertible into Capital Stock, whether or
not such debt securities include any right of participation with Capital Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Captive Insurance Subsidiary</I></B>&#148; means any captive insurance company that is a Subsidiary of the
Company or any of its Restricted Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Cash Equivalents</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;United States dollars;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) (a)&nbsp;pounds sterling or euros; (b)&nbsp;in the case of any Foreign Subsidiary that is a
Restricted Subsidiary, such local currencies held by it from time to time in the ordinary course
of business; and (c)&nbsp;the currency of any country that is a member of the Organization for Economic
Cooperation and Development;
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;securities issued or directly and fully guaranteed or insured by the United States
government or any agency or instrumentality of the United States government (<I>provided </I>that the full
faith and credit of the United States is pledged in support of those securities) having maturities
of not more than 24&nbsp;months from the date of acquisition;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;certificates of deposit and eurodollar time deposits with maturities of one year or less
from the date of acquisition, bankers&#146; acceptances with maturities not exceeding one year and
overnight bank deposits, in each case, with any lender party to a Credit Facility or with any
commercial bank having capital and surplus in excess of $500.0&nbsp;million;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;repurchase obligations with a term of not more than seven days for underlying securities
of the types described in clauses (3)&nbsp;and (4)&nbsp;above entered into with any financial institution
meeting the qualifications specified in clause (4)&nbsp;above;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;commercial paper having one of the two highest ratings obtainable from Moody&#146;s or S&#038;P and,
in each case, maturing within 12&nbsp;months after the date of acquisition;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;marketable short-term money market and similar securities having a rating of at least P-2
or A-2 from either Moody&#146;s or S&#038;P, respectively (or, if at any time neither Moody&#146;s nor S&#038;P shall
be rating such obligations, an equivalent rating from another &#147;nationally recognized statistical
rating organization&#148; within the meaning of Rule&nbsp;15c3-1(c)(2)(vi)(F) under the Exchange Act selected
by the Company as a replacement agency) and in each case maturing within 24&nbsp;months after the date
of creation or acquisition thereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;readily marketable direct obligations issued by any state, commonwealth or territory of
the United States or any political subdivision or taxing authority thereof having an Investment
Grade Rating from either Moody&#146;s or S&#038;P with maturities of 12&nbsp;months or less from the date of
acquisition; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;money market funds at least 95% of the assets of which constitute Cash Equivalents of the
kinds described in clauses (1)&nbsp;through (8)&nbsp;of this definition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Change of Control</I></B>&#148; means the occurrence of any of the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the direct or indirect sale, lease, transfer, conveyance or other disposition (other than
by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the properties or assets of the Company and its Restricted Subsidiaries taken
as a whole to any Person (including any &#147;person&#148; (as that term is used in Section&nbsp;13(d)(3) of the
Exchange Act)) other than to the Company or one of its Restricted Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the consummation of any transaction (including, without limitation, any merger or
consolidation), the result of which is that any Person (including any &#147;person&#148; (as defined above))
becomes the Beneficial Owner, directly or indirectly, of more than 50% of the Voting Stock of the
Company, measured by voting power rather than number of shares;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the Company consolidates with, or merges with or into, any Person, or any Person
consolidates with, or merges with or into, the Company, in any such event pursuant to a transaction
in which any of the outstanding Voting Stock of the Company is converted into or exchanged for
cash, securities or other property, other than any such transaction where:
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Voting Stock of the Company outstanding immediately prior to such
transaction is converted into or exchanged for the Voting Stock of such surviving or transferee
Person (or any direct or indirect parent thereof) immediately after giving effect to such
transaction; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the holders of the Voting Stock of the Company immediately prior to such
transaction own, directly or indirectly, not less than a majority of the Voting Stock of the
Company or such surviving or transferee Person (or any direct or indirect parent thereof)
immediately after giving effect to such transaction; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;the first day on which a majority of the members of the Board of Directors (excluding
vacant seats) of the Company are not Continuing Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Change of Control Offer</I></B>&#148; has the meaning assigned to that term in Section&nbsp;4.08.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Code</I></B>&#148; means the U.S. Internal Revenue Code of 1986, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company</I></B>&#148; has the meaning specified in the first paragraph of this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consolidated EBITDA</I></B>&#148; means, with respect to any specified Person for any period, the
Consolidated Net Income of such Person for such period <I>plus</I>, without duplication, in each case to
the extent taken into account in computing such Consolidated Net Income:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;provision for taxes based on income, profits or capital, including, without limitation,
state, franchise and similar taxes (such as the Pennsylvania capital tax) and foreign withholding
taxes of such Person and its Restricted Subsidiaries for such period; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Fixed Charges of such Person and its Restricted Subsidiaries for such period; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;any foreign currency translation losses (including losses related to currency
remeasurements of Indebtedness) of such Person and its Restricted Subsidiaries for such period;
<I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any extraordinary, non-recurring or unusual losses, charges or premiums including, but not
limited to, any expenses or charges related to any Equity Offering, incurrence of Indebtedness
permitted to be incurred under the Indenture, Permitted Investment, acquisition, restructuring,
integration (including, without limitation, the sale, closure or consolidation of facilities and
start-up costs related to new facilities), transition, executive recruiting, severance (including,
but not limited to, any severance payments related to management employment contracts), relocation
costs and curtailments or modifications to pension and post-retirement employee benefit plans,
recapitalization or the amendment, modification or refinancing of Indebtedness (including a
refinancing thereof) (whether or not successful) (for the avoidance of doubt, the losses, charges
and premiums identified in this clause
include, without limitation, those relating to the refinancing transactions undertaken by the
Company in August&nbsp;2010, December&nbsp;2010, February&nbsp;2011 and March&nbsp;2011, including the prepayment of
the Company&#146;s Repaid Senior Notes and the related prepayment make-whole amounts, the Transaction
Costs, any future losses, charges or premiums associated with the prepayment and the related
prepayment make-whole amounts of any other refinancings undertaken in the future and any amounts
paid or charges
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">incurred in connection with the termination of the interest rate swap entered into
by the Company on October&nbsp;1, 2007 in connection with the Credit Agreement or interest rate swaps
entered into in the future in connection with the Credit Facilities); <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;solely for the purpose of determining Consolidated EBITDA for the Fixed Charge Coverage
Ratio, any losses resulting from write-downs of purchase and lease commitments, write-downs of
excess, obsolete or unbalanced inventories; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;depreciation, amortization (including amortization of intangibles and other assets but
excluding amortization of prepaid cash expenses that were paid in a prior period), any non-cash
compensation charges and expenses and other non-cash charges and expenses (including any asset
impairment charges or asset write-downs or write-offs but excluding any such non-cash charge or
expense to the extent that it represents an accrual of or reserve for cash charges or expenses in
any future period or amortization of a prepaid cash charge or expense that was paid in a prior
period) of such Person and its Restricted Subsidiaries for such period to the extent that such
depreciation, amortization and other non-cash charges or expenses were deducted in computing such
Consolidated Net Income; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;to the extent actually reimbursed, expenses incurred to the extent covered by
indemnification provisions in any agreement in connection with any acquisition permitted under the
Indenture; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;any contingent or deferred payments (including earn-out payments, non-compete payments and
consulting payments but excluding ongoing royalty payments) made in connection with any acquisition
permitted under the Indenture; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;deferred financing fees and milestone payments in connection with any Investment or series
of related Investments permitted under the Indenture; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;costs of surety bonds in connection with financing activities; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;solely for the purpose of determining Consolidated EBITDA for the Fixed Charge Coverage
Ratio, the amount of net cost savings and operating expense reductions projected by the Company in
good faith to be realized as a result of specified actions taken or initiated (calculated on a pro
forma basis as though such cost savings and operating expense reductions had been realized on the
first day of such period), net of the amount of actual benefits realized during such period from
such actions; <I>provided </I>that such cost savings and operating expense reductions are (i)&nbsp;reasonably
identifiable and factually supportable and (ii)&nbsp;have been realized or are anticipated to be
realized within six months after the date of such actions; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;any loss from discontinued operations and any loss on disposal of discontinued
operations; <I>minus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;any foreign currency translation gains (including gains related to currency
remeasurements of Indebtedness) of such Person and its Restricted Subsidiaries for such period;
<I>minus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;non-cash gains, other than the accrual of revenue in the ordinary course of business;
<I>minus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;any unusual or non-recurring gains for such period; <I>minus</I>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;any income from discontinued operations and any gain on disposal of discontinued
operations,<br><br style="font-size: 6pt">in each case, on a consolidated basis and determined in accordance with GAAP.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consolidated Indebtedness</I></B>&#148; means, with respect to any specified Person as of any date, the
sum, without duplication, of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the total amount of Indebtedness of such Person and its Restricted Subsidiaries; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the total amount of Indebtedness of any other Person, to the extent that such Indebtedness
has been Guaranteed by, or is secured by a Lien on the assets of, the referent Person or one or
more of its Restricted Subsidiaries; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the aggregate liquidation value of all Disqualified Stock of such Person and all preferred
stock of Restricted Subsidiaries of such Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in each case, determined on a consolidated basis in accordance with GAAP (except as provided in the
definition of &#147;Indebtedness&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consolidated Leverage Ratio</I></B>&#148; means, as of any date of determination, the ratio of (1)&nbsp;the
Consolidated Indebtedness of the Company as of such date to (2)&nbsp;the Consolidated EBITDA of the
Company for the then most recently ended four full fiscal quarters for which internal financial
statements are available immediately preceding the date of determination, in each case with such
pro forma adjustments as are consistent with the pro forma adjustment provisions set forth in the
definition of &#147;Fixed Charge Coverage Ratio;&#148; <I>provided</I>, <I>however</I>, that for purposes of this
definition, whenever pro forma effect is to be given to an Investment, acquisition, disposition,
merger or consolidation, the pro forma calculations will be made in accordance with Regulation&nbsp;S-X
under the Securities Act, except that such calculations may take into account the reduction in net
costs and related adjustments that (i)&nbsp;were actually implemented within 12&nbsp;months after the date of
such Investment, acquisition, disposition, merger or consolidation and prior to the date of
determination, (ii)&nbsp;are reasonably expected to be realized within 12&nbsp;months after the date of
implementation and (iii)&nbsp;are supportable and quantifiable by the applicable underlying accounting
records.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consolidated Net Income</I></B>&#148; means, with respect to any specified Person for any period, the
aggregate of the net income (loss)&nbsp;of such Person and its Restricted Subsidiaries for such period,
on a consolidated basis (excluding the net income (loss)&nbsp;of any Unrestricted Subsidiary of such
Person), determined in accordance with GAAP and without any reduction in respect of preferred stock
dividends; <I>provided </I>that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;all extraordinary losses and expenses and all gains and losses realized in connection with
any Asset Sale (without regard to the dollar limitation in the definition thereof) or other
disposition, disposition of securities or early extinguishment of Indebtedness, together with any
related provision for taxes on any such gain, will be excluded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the net income and loss of any Person that is not a Restricted Subsidiary or that is
accounted for by the equity method of accounting will be included only to the extent of the amount
of
dividends or similar distributions paid in cash to the specified Person or a Restricted
Subsidiary of the Person;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;solely for the purpose of determining the amount available for Restricted Payments under
Section&nbsp;4.02(a)(3)(A) and Section&nbsp;4.02(b)(16), the net income of any Restricted
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiary for such
period will be excluded to the extent that the declaration or payment of dividends or similar
distributions by that Restricted Subsidiary of that net income is not at the date of determination
permitted without any prior governmental approval (that has not been obtained) or, directly or
indirectly, by operation of the terms of its charter or any agreement, instrument, judgment,
decree, order, statute, rule or governmental regulation applicable to that Restricted Subsidiary or
its stockholders;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;the cumulative effect of a change in accounting principles will be excluded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;non-cash gains and losses attributable to movement in the mark-to-market valuation of (a)
Hedging Obligations pursuant to FASB Accounting Standards Codification Topic 815 &#151;Derivatives and
Hedging, (b)&nbsp;Permitted Convertible Indebtedness and (c)&nbsp;any Permitted Convertible Indebtedness Call
Transaction, will be excluded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;any net unrealized gains or losses (after any offset) with respect to Hedging Obligations
will be excluded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;any amortization of deferred charges or debt discount resulting from the application of
FASB Accounting Standards Codification Topic 470-20&#151;Debt&#151;Debt with Conversion and Other Options
(formerly FASB Staff Position No.&nbsp;APB 14-1&#151;Accounting for Convertible Debt Instruments That May Be
Settled in Cash Upon Conversion (Including Partial Cash Settlement)) will be excluded; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;accruals and reserves that are established within twelve months after the date of this
Supplemental Indenture that are so required to be established as a result of the Transactions in
accordance with GAAP will be excluded.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>continuing</I></B>&#148; means, with respect to any Default or Event of Default, that such Default or
Event of Default has not been cured or waived.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Continuing Directors</I></B>&#148; means, as of any date of determination, any member of the Board of
Directors of the Company who:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;was a member of such Board of Directors on the date of this Supplemental Indenture; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of
such nomination or election.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Convertible Notes</I></B>&#148; means the Company&#146;s 3.875% Convertible Senior Subordinated Notes due 2017
outstanding on the date of this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Corporate Trust Office</I></B>&#148; means the address of the Trustee specified in Section&nbsp;12.2 of the
Original Indenture or such other address as to which the Trustee may give notice to the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Covenant Defeasance</I></B>&#148; has the meaning specified in Section&nbsp;7.03.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Credit Agreement</I></B>&#148; means that certain Credit Agreement, dated as of October&nbsp;1, 2007, by and
among the Company, the guarantors party thereto, the lenders party thereto, JPMorgan Chase Bank,
N.A., as Administrative Agent and Collateral Agent and Bank of America, N.A., as Syndication Agent,
including any related notes, Guarantees, collateral documents, instruments and agreements executed
in
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">connection therewith, and, in each case, as amended, restated, modified, renewed, refunded,
replaced in any manner (whether upon or after termination or otherwise) or refinanced (including by
means of sales of debt securities to institutional investors) in whole or in part from time to
time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Credit Facilities</I></B>&#148; means, one or more debt facilities (including, without limitation, the
Credit Agreement) or other financing arrangements (including, without limitation, commercial paper
facilities or indentures), in each case, providing for revolving credit loans, term loans,
receivables financing (including through the sale of receivables to such lenders or to special
purpose entities formed to borrow from such lenders against such receivables), letters of credit or
other indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments
and agreements executed in connection therewith, in each case, as amended, supplemented, restated,
modified, renewed, refunded, replaced in any manner (whether upon or after termination or
otherwise) or refinanced (including by means of sales of debt securities) in whole or in part from
time to time, including any such replacement, refunding or refinancing facility or indenture that
increases the amount permitted to be borrowed thereunder or alters the maturity thereof (provided
that such increase in borrowings is permitted under Section&nbsp;4.04 and, to the extent applicable,
Section&nbsp;4.07) or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and
whether by the same or any other agent, lender or group of lenders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Custodian</I></B>&#148; means the Trustee, as custodian with respect to the Notes (so long as the Notes
constitute Global Notes), or any successor entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Default</I></B>&#148; means any event that is, or with the passage of time or the giving of notice or both
would be, an Event of Default.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Depository</I></B>&#148; means initially The Depository Trust Company until a successor Depository shall
have become such pursuant to the applicable provisions of the Indenture, and thereafter
&#147;Depository&#148; shall mean such successor Depository.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Designated Non-cash Consideration</I></B>&#148; means the Fair Market Value of non-cash consideration
received by the Company or a Restricted Subsidiary in connection with an Asset Sale that is so
designated as Designated Non-cash Consideration pursuant to an officers&#146; certificate executed by a
financial officer of the Company, setting forth the basis of such valuation, less the amount of
cash or Cash Equivalents received in connection with a subsequent sale of such Designated Non-cash
Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Designated Senior Debt</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;any Indebtedness outstanding under the Credit Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any other Senior Debt the principal amount of which is $25.0&nbsp;million or more and that has
been designated by the Company as &#147;Designated Senior Debt.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Disqualified Stock</I></B>&#148; means any Capital Stock that, by its terms (or by the terms of any
security into which it is convertible, or for which it is exchangeable, in each case, at the option
of the holder of the Capital Stock), or upon the happening of any event, matures or is mandatorily
redeemable, pursuant to a sinking fund obligation or otherwise, or redeemable at the option of the
holder of the Capital Stock, in whole or in part, on or prior to the date that is 91&nbsp;days after the
date on which the Notes mature; <I>provided</I>, that if such Capital
Stock is issued pursuant to any plan for the
benefit of employees of the Company or its
Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute
Disqualified Stock solely because it may be required to be repurchased by the Company or its
Subsidiaries in order to satisfy applicable statutory or regulatory obligations. Notwithstanding
the preceding sentence, any Capital Stock that would constitute Disqualified Stock solely because
the holders of the Capital Stock
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">have the right to require the Company to repurchase such Capital
Stock upon the occurrence of a change of control or an asset sale will not constitute Disqualified
Stock if the terms of such Capital Stock provide that the Company may not repurchase or redeem any
such Capital Stock pursuant to such provisions unless such repurchase or redemption complies with
Section&nbsp;4.02. The amount of Disqualified Stock deemed to be outstanding at any time for purposes
of the Indenture will be the maximum amount that the Company and its Restricted Subsidiaries may
become obligated to pay upon the maturity of, or pursuant to any mandatory redemption provisions
of, such Disqualified Stock, exclusive of accrued dividends.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Domestic Subsidiary</I></B>&#148; means any Restricted Subsidiary of the Company that is, at the time of
determination, organized under the laws of the United States or any state of the United States or
the District of Columbia.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Equity Interests</I></B>&#148; means Capital Stock and all warrants, options or other rights to acquire
Capital Stock (but excluding any debt security that is convertible into, or exchangeable for,
Capital Stock).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Equity Offering</I></B>&#148; means a public or private sale either (1)&nbsp;of Equity Interests of the Company
by the Company (other than Disqualified Stock and other than to a Subsidiary of the Company) or (2)
of Equity Interests of a direct or indirect parent entity of the Company (other than to the Company
or a Subsidiary of the Company) to the extent that the net proceeds therefrom are contributed to
the Common Equity capital of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Existing Indebtedness</I></B>&#148; means all Indebtedness of the Company and its Subsidiaries (other than
Indebtedness under the Credit Agreement) in existence on the date of this Supplemental Indenture,
until such amounts are repaid.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Event of Default</I></B>&#148; has the meaning specified in Section&nbsp;6.01.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Excess Proceeds</I></B>&#148; has the meaning specified in Section&nbsp;4.05(d).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fair Market Value</I></B>&#148; means the value that would be paid by a willing buyer to an unaffiliated
willing seller in a transaction not involving distress or necessity of either party, determined in
good faith by the Board of Directors of the Company (unless otherwise
provided in this Supplemental Indenture).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fall
Away Date</I></B>&#148; has the meaning specified in Section 4.13(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>FASB</I></B>&#148; means Financial Accounting Standards Board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fixed Charge Coverage Ratio</I></B>&#148; means with respect to any specified Person for any period, the
ratio of the Consolidated EBITDA of such Person for such period to the Fixed Charges of such Person
for such period. In the event that the specified Person or any of its Restricted Subsidiaries
incurs, assumes, guarantees, repays, repurchases, redeems, defeases or otherwise discharges any
Indebtedness (other than ordinary working capital borrowings) or issues, repurchases or redeems
preferred stock subsequent to the commencement of the period for which the Fixed Charge Coverage
Ratio is being calculated and on or prior to the date on which the event for which the calculation
of the Fixed Charge Coverage Ratio is made (the
&#147;<I><b>Calculation Date</b></I>&#148;), then the Fixed Charge Coverage
Ratio will be calculated giving pro forma effect (as determined in good faith by the Company&#146;s
chief financial officer) to such incurrence,
assumption, Guarantee, repayment, repurchase, redemption, defeasance or other discharge of
Indebtedness, or such issuance, repurchase or redemption of preferred stock, and the application of
the proceeds therefrom, as if the same had occurred at the beginning of the applicable four-quarter
reference period.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, for purposes of calculating the Fixed Charge Coverage Ratio:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Investments, acquisitions, dispositions and mergers or consolidations that have been made
by the specified Person or any of its Restricted Subsidiaries, or any Person or any of its
Restricted Subsidiaries acquired by the specified Person or any of its Restricted Subsidiaries, and
including all related financing transactions and including increases in ownership of Restricted
Subsidiaries, during the four-quarter reference period or subsequent to such reference period and
on or prior to the Calculation Date, or that are to be made on the Calculation Date, will be given
pro forma effect (as determined in good faith by a responsible financial or accounting officer of
the Company) as if they had occurred on the first day of the four-quarter reference period;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Consolidated EBITDA attributable to discontinued operations, as determined in
accordance with GAAP, and operations or businesses (and ownership interests therein) disposed of
prior to the Calculation Date, will be excluded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the Fixed Charges attributable to discontinued operations, as determined in accordance
with GAAP, and operations or businesses (and ownership interests therein) disposed of prior to the
Calculation Date, will be excluded, but only to the extent that the obligations giving rise to such
Fixed Charges will not be obligations of the specified Person or any of its Restricted Subsidiaries
following the Calculation Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any Person that is a Restricted Subsidiary on the Calculation Date will be deemed to have
been a Restricted Subsidiary at all times during such four-quarter period;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;any Person that is not a Restricted Subsidiary on the Calculation Date will be deemed not
to have been a Restricted Subsidiary at any time during such four-quarter period; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;if any Indebtedness bears a floating rate of interest, the interest expense on such
Indebtedness will be calculated as if the rate in effect on the Calculation Date had been the
applicable rate for the entire period (taking into account any Hedging Obligation applicable to
such Indebtedness if such Hedging Obligation has a remaining term as of the Calculation Date in
excess of 12&nbsp;months).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this definition, whenever pro forma effect is to be given to an Investment,
acquisition, disposition and merger or consolidation, the pro forma calculations shall be (a)&nbsp;made
in good faith by a responsible financial or accounting officer of the Company (and may include, for
the avoidance of doubt, cost savings and operating expense reductions resulting from such
transaction which is being given pro forma effect that have been realized or are anticipated to be
realized within 12&nbsp;months after the date of such transaction) or (b)&nbsp;determined in accordance with
Regulation&nbsp;S-X under the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fixed Charges</I></B>&#148; means, with respect to any specified Person for any period, the sum, without
duplication, of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a)&nbsp;the consolidated interest expense of such Person and its Restricted Subsidiaries for
such period, to the extent such expense was deducted in computing Consolidated Net Income,
including, without limitation, amortization of debt issuance costs and original issue discount,
non-cash interest payments, (but excluding any non-cash interest expense attributable to the
movement in
the mark to market valuation of Hedging Obligations or other derivative instruments pursuant
to GAAP), the interest component of any deferred payment obligations, the interest component of all
payments associated with Capital Lease Obligations, commissions, discounts and other fees and
charges incurred in respect of letter of credit or bankers&#146; acceptance financings, commissions,
discounts, yield and other fees and charges (including interest) incurred in connection with any
Qualified Securitization Facility or any
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">other transaction pursuant to which the Company or any of
its Subsidiaries may sell, convey or otherwise transfer or grant a security interest in any
accounts receivable, Securitization Assets or related assets of the type specified in the
definition of &#147;Qualified Securitization Facility,&#148; and net of the effect of all payments made or
received pursuant to Hedging Obligations in respect of interest rates; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the consolidated interest expense of such Person and its Restricted Subsidiaries
that was capitalized during such period; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;any interest on Indebtedness of another Person that is guaranteed by such Person
or one of its Restricted Subsidiaries or secured by a Lien on assets of such Person or one of its
Restricted Subsidiaries, whether or not such Guarantee or Lien is called upon; <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;all dividends, whether paid or accrued and whether or not in cash, on any series
of preferred stock of such Person or any of its Restricted Subsidiaries, other than dividends on
Equity Interests payable solely in Equity Interests of the Company (other than Disqualified Stock)
or to the Company or a Restricted Subsidiary of the Company; <I>minus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) (a)&nbsp;interest income of such Person and its Restricted Subsidiaries for such period; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;any amortization of deferred charges or debt discount resulting from the
application of FASB Accounting Standards Codification Topic 470-20&#151;Debt&#151;Debt with Conversion and
Other Options (formerly FASB Staff Position No.&nbsp;APB 14-1&#151;Accounting for Convertible Debt
Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement)).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Foreign Subsidiary</I></B>&#148; means, with respect to any Person, any Restricted Subsidiary of such
Person that is not organized or existing under the laws of the United States, any state thereof or
the District of Columbia, and any Restricted Subsidiary of such Foreign Subsidiary
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Form of Assignment and Transfer</I></B>&#148; means the &#147;Form of Assignment and Transfer&#148; attached as
Attachment 1 to the Form of Note attached hereto as Exhibit&nbsp;A.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>GAAP</I></B>&#148; means generally accepted accounting principles set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public
Accountants and statements and pronouncements of the Financial Accounting Standards Board or in
such other statements by such other entity as have been approved by a significant segment of the
accounting profession, which are in effect on the date of this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Global Note</I></B>&#148; means any Note that is a Global Security.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Guarantee</I></B>&#148; of or by any Person means any obligation, contingent or otherwise, of the
guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other
obligation of any other Person (the &#147;<B><I>primary obligor</I></B>&#148;) in any manner, whether directly or
indirectly, and including any obligation of the guarantor, direct or indirect:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;to purchase or pay (or advance or supply funds for the purchase or payment of) such
Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of)
any security for the payment thereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;to purchase or lease property, securities or services for the purpose of assuring the
owner of such Indebtedness or other obligation of the payment thereof;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;to maintain working capital, equity capital or any other financial statement condition or
liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or
other obligation; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;as an account party in respect of any letter of credit or letter of guaranty issued to
support such Indebtedness or obligation;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>provided, </I>that the term &#147;Guarantee&#148; will not include endorsements for collection or deposit in the
ordinary course of business. In any computation of the Indebtedness or other liabilities of the
obligor under any Guarantee, the Indebtedness or other obligations that are the subject of such
Guarantee will be assumed to be direct obligations of such obligor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Guarantors</I></B>&#148;
means any Subsidiary of the Company that issues a Note Guarantee  by
executing this Supplemental Indenture in accordance
with the provisions of the Indenture or executes a supplemental
indenture in the form of Exhibit B hereto, and their respective successors and assigns, in each case,
until the Note Guarantee of such Person has been released in accordance with the provisions of the
Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Hedging Obligations</I></B>&#148; means, with respect to any specified Person, the obligations of such
Person under:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;interest rate swap agreements (whether from fixed to floating or from floating to fixed),
interest rate cap agreements and interest rate collar agreements;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;other agreements or arrangements designed to manage interest rates or interest rate risk;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign
exchange contract, currency swap agreement or any other agreements or arrangements designed to
protect such Person against fluctuations in, or providing for the transfer or mitigation of risks
related to, currency exchange rates or commodity prices, in each case, either generally or under
specific contingencies.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For the avoidance of doubt, any Permitted Convertible Indebtedness Call Transaction will not
constitute Hedging Obligations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Holder</I></B>&#148; means a person in whose name a Note is registered.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>incur</I></B>&#148; has the meaning specified in Section&nbsp;4.04(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Immaterial Subsidiary</I></B>&#148; means, as of any date, any Restricted Subsidiary whose total assets,
as of that date, are less than $10.0&nbsp;million; <I>provided </I>that (1)&nbsp;a Restricted Subsidiary will not be
considered to be an Immaterial Subsidiary if it, directly or indirectly, guarantees or otherwise
provides direct credit support for any other Indebtedness of the Company and (2)&nbsp;the aggregate
amount of total assets of all Immaterial Subsidiaries shall not at any time exceed 5.0% of the
consolidated assets of the Company and
its Subsidiaries, determined as of the end of the fiscal quarter most recently ended for which
financial statements are available.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Indebtedness</I></B>&#148; means, with respect to any specified Person, any indebtedness of such Person
(excluding accrued interest (other than accrued interest or interest paid in kind that has accreted
to the principal amount), accrued expenses and trade payables), whether or not contingent:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;in respect of borrowed money;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;evidenced by bonds, notes, debentures or similar instruments or letters of credit (or,
without duplication, reimbursement agreements in respect thereof);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;in respect of bankers&#146; acceptances;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;representing Capital Lease Obligations;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;representing the balance deferred and unpaid of the purchase price of any property or
services due more than six months after such property is acquired or such services are completed,
other than any earn-out obligations until such obligation becomes a liability on the balance sheet
of such Person in accordance with GAAP; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;representing any Hedging Obligations,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">if and to the extent any of the preceding items (other than undrawn letters of credit and Hedging
Obligations not required to appear as a liability upon a balance sheet of the specified Person)
would appear as a liability upon a balance sheet of the specified Person prepared in accordance
with GAAP. In addition, to the extent not otherwise included, the term &#147;Indebtedness&#148; includes all
Indebtedness of others secured by a Lien on any asset of the specified Person (whether or not such
Indebtedness is assumed by the specified Person) and, to the extent not otherwise included, the
Guarantee by the specified Person of any Indebtedness of any other Person. Indebtedness shall be
calculated without giving effect to the effects of FASB Accounting Standards Codification Topic
815&#151; Derivatives and Hedging and FASB Accounting Standards Codification Topic 470-20&#151;Debt&#151;Debt
with Conversion and Other Options (formerly FASB Staff Position No.&nbsp;APB 14-1&#151;Accounting for
Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash
Settlement)) and related interpretations to the extent such effects would otherwise increase or
decrease an amount of Indebtedness for any purpose under the Indenture as a result of accounting
for any embedded derivatives created by the terms of such Indebtedness.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amount of any Indebtedness outstanding as of any date will be:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the accreted value of the Indebtedness, in the case of any Indebtedness issued with
original issue discount;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the principal amount of the Indebtedness, in the case of any other Indebtedness; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;in respect of Indebtedness of another Person secured by a Lien on the assets of the
specified Person, the lesser of:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Fair Market Value of such assets at the date of determination; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the amount of the Indebtedness of the other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, for the avoidance of doubt, obligations of any Person under a
Permitted Bond Hedge Transaction or a Permitted Warrant Transaction shall be deemed not to
constitute Indebtedness.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
 <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Indenture</I></B>&#148; means the Original Indenture, as originally executed and as supplemented from time
to time by one or more Indentures supplemental thereto, including this Supplemental Indenture,
entered into pursuant to the applicable provisions of the Indenture, including, for all purposes of
this instrument and any such Supplemental Indenture, the provisions of the Trust Indenture Act that
are deemed to be a part of and govern the Original Indenture, this Supplemental Indenture and any
other such Supplemental Indenture, respectively.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Independent Financial Advisor</I></B>&#148; means an accounting, appraisal, investment banking firm or
consultant of nationally recognized standing that is, in the good faith judgment of the Company,
qualified to perform the task for which it has been engaged.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Initial Notes</I></B>&#148; has the meaning specified in Section&nbsp;2.01.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Interest Payment Date</I></B>&#148; means, with respect to the payment of interest on the Notes, each June
1 and December 1 of each year.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Investment Grade</I></B>&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s
and BBB- (or the equivalent) by S&#038;P, or, if either such entity ceases to rate the Notes for reasons
outside of the control of the Company, the equivalent investment grade credit rating from any other
&#147;nationally recognized statistical rating organization&#148; within the meaning of Rule
15c3-1(c)(2)(vi)(F) under the Exchange Act selected by the Company as a replacement agency.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Investment Grade Securities</I></B>&#148; means:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;securities issued or directly and fully guaranteed or insured by the United States
government or any agency or instrumentality thereof (other than Cash Equivalents);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;debt securities or debt instruments with an Investment Grade rating, but excluding any
debt securities or instruments constituting loans or advances among the Company and its
Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;investments in any fund that invests exclusively in investments of the type described in
clauses (1)&nbsp;and (2)&nbsp;which fund may also hold immaterial amounts of cash pending investment or
distribution; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;corresponding instruments in countries other than the United States customarily utilized
for high quality investments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Investments</I></B>&#148; means, with respect to any Person, all direct or indirect investments by such
Person in other Persons (including Affiliates) in the forms of loans (including Guarantees or other
obligations), advances or capital contributions (excluding commission, travel and similar advances
to officers and employees made in the ordinary course of business), purchases or other acquisitions
of Indebtedness, Equity Interests or other securities, together with all items that are or would be
classified as investments on a balance sheet prepared in accordance with GAAP. If the Company or
any Restricted Subsidiary of the Company sells or otherwise disposes of any Equity Interests of any
direct or indirect
Restricted Subsidiary of the Company such that, after giving effect to any such sale or
disposition, such Person is no longer a Restricted Subsidiary of the Company, the Company will be
deemed to have made an Investment on the date of any such sale or disposition equal to the Fair
Market Value of the Company&#146;s Investments in such Subsidiary that were not sold or disposed of in
an amount determined as provided in Section&nbsp;4.02(c). The acquisition by the Company or any
Restricted Subsidiary of the Company of a Person that holds an Investment in a third Person will be
deemed to be an Investment by
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Company or such Restricted Subsidiary in such third Person in an amount equal to the Fair
Market Value of the Investments held by the acquired Person in such third Person in an amount
determined as provided in Section&nbsp;4.02(c). Except as otherwise provided in the Indenture, the
amount of an Investment will be determined at the time the Investment is made and without giving
effect to subsequent changes in value.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Issue Date</I></B>&#148; means, with respect to the Notes, June&nbsp;13, 2011.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Legal Defeasance</I></B>&#148; has the meaning specified in Section&nbsp;7.02.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Lien</I></B>&#148; means, with respect to any asset, any mortgage, lien, pledge, charge, security interest
or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise
perfected under applicable law, including any conditional sale or other title retention agreement,
any lease in the nature thereof, any option or other agreement to sell or give a security interest
in and, except in connection with any Qualified Securitization Facility, any filing of or agreement
to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any
jurisdiction; <I>provided</I>, that in no event shall an operating lease be deemed to constitute a Lien.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Moody&#146;s</I></B>&#148; means Moody&#146;s Investors Service, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Net Proceeds</I></B>&#148; means the aggregate cash proceeds and Cash Equivalents received by the Company
or any of its Restricted Subsidiaries in respect of any Asset Sale (including, without limitation,
any cash or Cash Equivalents received upon the sale or other disposition of any Designated Non-Cash
Consideration received in any Asset Sale), net of the direct costs relating to such Asset Sale and
the sale or disposition of such Designated Non-Cash Consideration, including, without limitation,
legal, accounting and investment banking fees, and sales commissions, and any relocation expenses
incurred as a result of the Asset Sale, taxes paid or payable as a result of the Asset Sale, in
each case, after taking into account any available tax credits or deductions and any tax sharing
arrangements, amounts required to be applied to the repayment of principal, premium, if any, and
interest, if any, on Senior Debt required to be paid as a result of such transaction, and any
reserve for any liability, adjustment or indemnification obligations in respect of the sale price
of such asset or assets established in accordance with GAAP, including, but not limited to, pension
and other post-employment benefit liabilities and liabilities related to environmental matters or
against any indemnification obligations associated with such transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Nonpayment Default</I></B>&#148; has the meaning specified in Section&nbsp;12.03(a)(2).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Non-Recourse Debt</I></B>&#148; means Indebtedness as to which neither the Company nor any of its
Restricted Subsidiaries (1)&nbsp;provides credit support of any kind (including any undertaking,
agreement or instrument that would constitute Indebtedness) or (2)&nbsp;is directly or indirectly liable
as a guarantor or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Note</I></B>&#148; or &#147;<B><I>Notes</I></B>&#148; has the meaning specified in the fourth paragraph of the recitals of this
Supplemental Indenture, and shall include any Additional Notes issued pursuant to Section&nbsp;2.01.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Note Guarantee</I></B>&#148; means the Guarantee by each Guarantor of the Company&#146;s obligations under the
Indenture and the Notes, evidenced by the execution of this Supplemental
Indenture  or a supplemental indenture in the form of Exhibit B
hereto by such Guarantor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Obligations</I></B>&#148; means any principal, interest, penalties, fees, indemnifications,
reimbursements, damages and other liabilities payable under the documentation governing any
Indebtedness.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Offer Amount</I></B>&#148; has the meaning specified in Section&nbsp;3.04.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Offer Period</I></B>&#148; has the meaning specified in Section&nbsp;3.04.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Original Indenture</I></B>&#148; has the meaning specified in the first paragraph of this Supplemental
Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Outstanding</I></B>&#148; with respect to the Notes, has the meaning specified in Section&nbsp;2.9 of the
Original Indenture with respect to Securities &#147;outstanding,&#148; as modified by Section&nbsp;2.03.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Paying
Agent</I></B><B>&#148; </B>has the meaning set forth in the Original Indenture, which shall initially be
the Trustee, and shall be the person authorized by the Company to pay the principal amount of,
and premium and  interest on, any Notes on behalf of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Payment Blockage Notice</I></B><B>&#148; </B>has the meaning specified in Section&nbsp;12.03(a)(2).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Payment Default</I></B><B>&#148; </B>has the meaning specified in Section&nbsp;12.03(a)(1).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Permitted Bond Hedge Transaction</I></B><B>&#148; </B>means any call or capped call option (or substantively
equivalent derivative transaction) on the Company&#146;s common stock purchased by the Company in
connection with an issuance of any Permitted Convertible Indebtedness; provided that the purchase
price for such Permitted Bond Hedge Transaction, less the proceeds received by the Company from the
sale of any related Permitted Warrant Transaction, does not exceed the net proceeds received by the
Company from the sale of such Permitted Convertible Indebtedness issued in connection with the
Permitted Bond Hedge Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Permitted Business</I></B><B>&#148; </B>means any business that is the same as, or reasonably related, similar,
ancillary or complementary to, any of the businesses in which the Company and its Restricted
Subsidiaries are engaged on the date of this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Permitted Convertible Indebtedness</I></B><B>&#148; </B>means (1)&nbsp;Indebtedness of the Company (which may be
Guaranteed by the Guarantors) permitted to be incurred under the terms of the Indenture that is
either (a)&nbsp;convertible into common stock of the Company (and cash in lieu of fractional shares)
and/or cash (in an amount determined by reference to the price of such common stock) or (b)&nbsp;sold as
units with call options, warrants or rights to purchase (or substantially equivalent derivative
transactions) that are exercisable for common stock of the Company and/or cash (in an amount
determined by reference to the price of such common stock); and (2)&nbsp;the Convertible Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Convertible Indebtedness Call Transaction</I></B>&#148; means any Permitted Bond Hedge
Transaction and/or any Permitted Warrant Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Debt</I></B>&#148; has the meaning specified in Section&nbsp;4.04(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Investments</I></B>&#148; means:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;any Investment in the Company or in a Restricted Subsidiary of the Company;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any Investment in cash or Cash Equivalents or Investment Grade Securities with a maturity
of 24&nbsp;months or less from the date of purchase;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;any Investment by the Company or any Restricted Subsidiary of the Company in a Person, if
as a result of such Investment:</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) such Person becomes a Restricted Subsidiary of the Company; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) such Person is merged, consolidated or amalgamated with or into, or
transfers or conveys substantially all of its assets to, or is liquidated into, the Company
or a Restricted Subsidiary of the Company;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any Investment made as a result of the receipt of non-cash consideration from an Asset
Sale that was made pursuant to and in compliance with Section&nbsp;4.05;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;any acquisition of assets or Capital Stock solely in exchange for the issuance of Equity
Interests (other than Disqualified Stock) of the Company;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) (a)&nbsp;advances, loans or extensions of trade credit in the ordinary course of business by
the Company or any of its Restricted Subsidiaries, (b)&nbsp;Investments consisting of purchases and
acquisitions of inventory, supplies, material or equipment and (c)&nbsp;Investments received (i)&nbsp;in
compromise or resolution of obligations of trade creditors or customers that were incurred in the
ordinary course of business of the Company or any of its Restricted Subsidiaries, (ii)&nbsp;in exchange
for any other Investment or accounts receivable held by the Company or any Restricted Subsidiary in
connection with or pursuant to any bankruptcy, workout, plan of reorganization, recapitalization or
similar arrangement; or (ii)&nbsp;in connection with litigation, arbitration or other disputes or as a
result of foreclosure by the Company or any of its Restricted Subsidiaries with respect to any
secured Investment or other transfer or title to any secured Investment in default or otherwise
pursuant to the terms of the agreement governing such Investment or by operation of law;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;Investments represented by Hedging Obligations;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;loans or advances to, or guarantees of such loans or advances to, employees, former
employees, consultants or former consultants of the Company or any of its Restricted Subsidiaries
(or cancellation or forgiveness thereof) made in the ordinary course of business of the Company or
any Restricted Subsidiary of the Company in an aggregate principal amount not to exceed $5.0
million at any one time outstanding;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;any guarantee of Indebtedness permitted to be incurred by Section&nbsp;4.04;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;any Investment existing on, or made pursuant to binding commitments existing on, the date
of this Supplemental Indenture and any Investment consisting of an extension, modification or
renewal of any Investment existing on, or made pursuant to a binding commitment existing on, the
date of this Supplemental Indenture; <I>provided </I>that the amount of any such Investment may be
increased (a)&nbsp;as required by the terms of such Investment as in existence on the date of this
Supplemental Indenture or (b)&nbsp;as otherwise permitted under the Indenture;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;Investments acquired after the date of this Supplemental Indenture as a result of the
acquisition by the Company or any Restricted Subsidiary of the Company of another Person, including
by way of a merger, amalgamation or consolidation with or into the Company or any of its Restricted
Subsidiaries in a transaction that is not prohibited by Article&nbsp;5 after the date of this
Supplemental Indenture to the extent that such Investments were not made in contemplation of such
acquisition, merger, amalgamation or consolidation and were in existence on the date of such
acquisition, merger, amalgamation or consolidation;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;any Investments by the Company or a Subsidiary of the Company in a Securitization
Subsidiary or any Investment by a Securitization Subsidiary in any other Person that, in the</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">good faith determination of the Company, are necessary or advisable to effect any Qualified
Securitization Facility or any repurchase obligation in connection therewith;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;any Investment made within 90&nbsp;days after the date of the commitment to make the
Investment, that when such commitment was made, would have complied with the terms of the
Indenture;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;Permitted Bond Hedge Transactions which constitute Investments;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;Investments in any joint ventures or a Permitted Business in an amount outstanding not to
exceed, as of the date of such Investment, the greater of (a) $150.0&nbsp;million or (b)&nbsp;4.0% of Total
Assets (with the Fair Market Value of each Investment (other than any Investment consisting of a
guarantee) being measured at the time made and without giving effect
to subsequent changes in value);
<I>provided, however</I>, that if any Investment pursuant to this clause (15)&nbsp;is made in any Person that
is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes
a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been
made pursuant to clause (1)&nbsp;above and shall cease to have been made pursuant to this clause (15)
for so long as such Person continues to be a Restricted Subsidiary;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;Investments in a Captive Insurance Subsidiary in an amount that does not exceed the
minimum amount of capital required under the laws of the jurisdiction in which such Captive
Insurance Subsidiary is formed plus the amount of any reasonable general corporate and overhead
expenses of such Captive Insurance Subsidiary, and any Investment by a Captive Insurance Subsidiary
that is a legal investment for an insurance company under the laws of the jurisdiction in which
such Captive Insurance Subsidiary is formed and made in the ordinary course of its business and
rated in one of the four highest rating categories;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;any bonds, promissory notes or other securities (which may be either debt or equity
securities) received by the Company or any of its Subsidiaries issued as payment or settlement for
accounts receivables owing from an entity that is subject to a proceeding under any federal, state
or foreign bankruptcy, insolvency, receivership or similar law;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(18)&nbsp;the funding of any pension plan of the Company or a Restricted Subsidiary of the Company,
which plan has been approved by the Board of Directors of the Company; and</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(19)&nbsp;other Investments in any Person having an aggregate Fair Market Value (measured on the
date each such Investment was made without giving effect to subsequent changes in value, but
reduced by any dividend, distribution, interest payment, return of capital, repayment or other
amount or value received in cash by the Company or any of its Restricted Subsidiaries in respect of
such Investment; <I>provided </I>that any such amount or value which reduces the aggregate Fair Market
Value of Investments outstanding pursuant to this clause (19)&nbsp;will be excluded for purposes of
calculating the amount of Restricted Payments that may be made pursuant to Section&nbsp;4.02(a)(3)),
when taken together with all other Investments made pursuant to this clause (19)&nbsp;that are at the
time outstanding, not to exceed $150.0&nbsp;million; <I>provided, however</I>, that if any Investment pursuant
to this clause (19)&nbsp;is made in any Person that is not a Restricted Subsidiary at the date of the
making of such Investment and such Person becomes a Restricted Subsidiary after such date, such
Investment shall thereafter be deemed to have been made pursuant to clause (1)&nbsp;above and shall
cease to have been made pursuant to this clause (19)&nbsp;for so long as such Person continues to be a
Restricted Subsidiary.</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Permitted Junior Securities</I></B><B>&#148; </B>means:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Equity Interests in the Company or any Guarantor; and</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;debt securities that are subordinated to all Senior Debt and any debt securities issued in
exchange for Senior Debt to substantially the same extent as, or to a greater extent than, the
Notes and the Note Guarantees are subordinated to Senior Debt under the Indenture.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Liens</I></B>&#148; means:</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Liens on assets of the Company or any of its Restricted Subsidiaries securing Senior Debt
and/or Obligations with respect to Senior Debt;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;Liens in favor of the Company or the Guarantors;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;Liens on property, shares of stock or other assets of a Person existing at the time such
Person becomes a Restricted Subsidiary of the Company or is merged with or into or consolidated
with the Company or any Restricted Subsidiary of the Company; <I>provided </I>that such Liens were not
created or incurred in contemplation of such Person becoming a Restricted Subsidiary of the Company
or such merger or consolidation and do not extend to any assets other than those of the Person that
becomes a Restricted Subsidiary of the Company or is merged with or into or consolidated with the
Company or any Restricted Subsidiary of the Company;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;Liens on property (including Capital Stock) or other assets existing at the time of
acquisition of such property or assets by the Company or any Subsidiary of the Company; <I>provided</I>
that such Liens were in existence prior to such acquisition and not incurred in contemplation of,
such acquisition;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;Liens to secure the performance of statutory obligations, insurance, surety or appeal
bonds, workers compensation obligations, performance bonds or other obligations of a like nature
incurred in the ordinary course of business (including Liens to secure letters of credit issued to
assure payment of such obligations) and any Liens in favor of, or required by contracts with,
governmental entities;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;Liens to secure Indebtedness represented by Capital Lease Obligations, mortgage financings
or purchase money obligations permitted to be incurred pursuant to Section&nbsp;4.04(b)(4);</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;Liens existing on the date of this Supplemental Indenture;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;Liens for taxes, assessments or governmental charges or claims that are not yet overdue
for a period of 30&nbsp;days or that are being contested in good faith by appropriate proceedings
promptly instituted and diligently concluded; <I>provided </I>that any reserve or other appropriate
provision as is required in conformity with GAAP has been made therefor;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;Liens imposed by law, such as carriers&#146;, warehousemen&#146;s, landlord&#146;s and mechanics&#146; Liens,
in each case, incurred in the ordinary course of business;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;survey exceptions, easements or reservations of, or rights of others for, licenses,
rights-of-way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or
zoning or other restrictions as to the use of real property that were not incurred in connection
with Indebtedness and that do not in the aggregate materially adversely affect the value of said
properties or materially impair their use in the operation of the business of such Person;</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;Liens created for the benefit of (or to secure) the Notes (or the Note Guarantees);</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;Liens to secure any Permitted Refinancing Indebtedness permitted to be incurred under the
Indenture; <I>provided, however, </I>that:</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the new Lien is limited to all or part of the same property and assets that
secured or, under the written agreements pursuant to which the original Lien arose, could secure
the original Lien (plus improvements and accessions to, such property or proceeds or distributions
thereof); and</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the Indebtedness secured by the new Lien is not increased to any amount greater
than the sum of (x)&nbsp;the outstanding principal amount, or, if greater, committed amount, of the
Indebtedness renewed, refunded, refinanced, replaced, defeased or discharged with such Permitted
Refinancing Indebtedness and (y)&nbsp;an amount necessary to pay any fees and expenses, including
premiums, related to such renewal, refunding, refinancing, replacement, defeasance or discharge;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;Liens on insurance policies and proceeds thereof, or other deposits, to secure insurance
premium financings;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;filing of Uniform Commercial Code financing statements as a precautionary measure in
connection with operating leases;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;bankers&#146; Liens, rights of setoff, Liens arising out of judgments or awards not
constituting an Event of Default and notices of <I>lis pendens </I>and associated rights related to
litigation being contested in good faith by appropriate proceedings and for which adequate reserves
have been made;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;Liens on cash, Cash Equivalents or other property arising in connection with the
defeasance, discharge or redemption of Indebtedness;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;Liens on specific items of inventory or other goods (and the proceeds thereof) of any
Person securing such Person&#146;s obligations in respect of bankers&#146; acceptances issued or created in
the ordinary course of business for the account of such Person to facilitate the purchase, shipment
or storage of such inventory or other goods;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(18) (a)&nbsp;leases, subleases, licenses or sublicenses granted to others in the ordinary course
of business which do not materially interfere with the ordinary conduct of the business of the
Company or any of its Restricted Subsidiaries and do not secure any Indebtedness and (b)&nbsp;grants of
grants of software and other technology licenses in the ordinary course of business;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(19)&nbsp;Liens arising out of conditional sale, title retention, consignment or similar
arrangements for the sale of goods entered into in the ordinary course of business;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(20)&nbsp;Liens on assets transferred to a Securitization Subsidiary or on assets of a
Securitization Subsidiary, in either case, incurred in connection with a Qualified Securitization
Facility;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(21)&nbsp;Liens securing Indebtedness of Foreign Subsidiaries that relate solely to the Equity
Interests or assets of Foreign Subsidiaries;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(22)&nbsp;Liens in favor of customs and revenue authorities arising as a matter of law to secure
payment of customs duties in connection with the importation of goods in the ordinary course of
business;</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(23)&nbsp;Liens (a)&nbsp;of a collection bank arising under Section&nbsp;4-210 of the Uniform Commercial Code
on items in the course of collection, (b)&nbsp;attaching to commodity trading accounts or other
brokerage accounts incurred in the ordinary course of business, and (c)&nbsp;in favor of banking
institutions arising as a matter of law encumbering deposits (including the right of set-off);</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(24)&nbsp;Liens deemed to exist in connection with Investments in repurchase agreements permitted
under Section&nbsp;4.04; <I>provided </I>that such Liens do not extend to any assets other than those that are
the subject of such repurchase agreement;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(25)&nbsp;Liens that are contractual rights of set-off (a)&nbsp;relating to pooled deposit or sweep
accounts of the Company or any of its Restricted Subsidiaries to permit satisfaction of overdraft or
similar obligations incurred in the ordinary course of business of the Company and its Restricted
Subsidiaries or (b)&nbsp;relating to purchase orders and other agreements entered into with customers of
the Company or any of its Restricted Subsidiaries in the ordinary course of business;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(26)&nbsp;Liens securing Hedging Obligations so long as related Indebtedness is, and is permitted
to be under the Indenture, secured by a Lien on the same property securing such Hedging
Obligations;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(27)&nbsp;Liens on property at the time such Person or any of its Subsidiaries acquires the
property, including any acquisition by means of a merger or consolidation with or into such Person
or a Subsidiary of such Person; <I>provided</I>, <I>however</I>, that the Liens may not extend to any other
property owned by such Person or any of its Restricted Subsidiaries (other than assets and property
affixed or appurtenant thereto); and</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(28)&nbsp;Liens incurred in the ordinary course of business of the Company or any Restricted
Subsidiary of the Company with respect to obligations that do not exceed, as of any date of
incurrence, the greater of (a) $200.0&nbsp;million or (b)&nbsp;5.0% of Total Assets.</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Refinancing Indebtedness</I></B>&#148; means any Indebtedness of the Company or any of its
Restricted Subsidiaries issued in exchange for, or the net proceeds of which are used to renew,
refund, refinance, replace, defease or discharge other Indebtedness of the Company or any of its
Restricted Subsidiaries (other than intercompany Indebtedness); <I>provided </I>that:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the principal amount (or accreted value, if applicable) of such Permitted Refinancing
Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the
Indebtedness renewed, refunded, refinanced, replaced, defeased or discharged (plus all accrued
interest on the Indebtedness and the amount of all fees, expenses and premiums (including tender
premiums), incurred in connection therewith); <I>provided </I>that, for the avoidance of doubt, in the
case of Permitted Convertible Indebtedness, the applicable amount shall be the face amount of such
Permitted Convertible Indebtedness;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;such Permitted Refinancing Indebtedness has a final maturity date that is the same as or
later than the final maturity date of, and has a Weighted Average Life to Maturity that is (a)
equal to or greater than the Weighted Average Life to Maturity of, the Indebtedness being renewed,
refunded, refinanced, replaced, defeased or discharged or (b)&nbsp;more than 90&nbsp;days after the final
maturity date of the Notes;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;if the Indebtedness being renewed, refunded, refinanced, replaced, defeased or discharged
is subordinated in right of payment to the Notes, such Permitted Refinancing Indebtedness is
subordinated in right of payment to the Notes on terms at least as favorable to the Holders of
Notes as</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">those contained in the documentation governing the Indebtedness being renewed, refunded,
refinanced, replaced, defeased or discharged; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;no Restricted Subsidiary that is not a Guarantor shall be an obligor with respect to such
Permitted Refinancing Indebtedness unless such non-Guarantor Restricted Subsidiary was an obligor
with respect to the Indebtedness being renewed, refunded, refinanced, replaced, defeased or
discharged.</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Permitted Warrant Transaction</I></B>&#148; means any call option, warrant or right to purchase (or
substantively equivalent derivative transaction) on the Company&#146;s common stock sold by the Company
substantially concurrently with any purchase by the Company of a related Permitted Bond Hedge
Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Person</I></B>&#148; means any individual, corporation, partnership, joint venture, association,
joint-stock company, trust, unincorporated organization, limited liability company or government or
other entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Physical Notes</I></B>&#148; means certificated Notes that are not in global form and are registered in
the name of the Holder and issued in denominations of $2,000 principal amount and integral
multiples of $1,000 in excess thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Purchase Date</I></B>&#148; has the meaning specified in Section&nbsp;3.04.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Qualified Securitization Facility</I></B>&#148; means any Securitization Facility (a)&nbsp;constituting a
securitization financing facility that meets the following conditions: (1)&nbsp;the Board of Directors
of the Company shall have determined in good faith that such Securitization Facility (including
financing terms, covenants, termination events and other provisions) is in the aggregate
economically fair and reasonable to the Company and the applicable Securitization Subsidiary, (2)
all sales and/or contributions of Securitization Assets and related assets to the applicable
Securitization Subsidiary are made at Fair Market Value (as determined in good faith by the
Company) and (3)&nbsp;the financing terms, covenants, termination events and other provisions thereof
shall be market terms (as determined in good faith by the Company) or (b)&nbsp;constituting a
receivables financing facility.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Qualifying Equity Interests</I></B>&#148; means Equity Interests of the Company other than (1)
Disqualified Stock and (2)&nbsp;options, warrants or rights to purchase Capital Stock (i)&nbsp;sold as units
with Indebtedness constituting Permitted Convertible Indebtedness or (ii)&nbsp;issued in a Permitted
Warrant Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Register</I></B>&#148; has the meaning specified in Section&nbsp;2.4 of the Original Indenture with respect to
the register with respect to the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Regular Record Date</I></B>&#148; means, with respect to the payment of interest on the Notes, the May&nbsp;15
(whether or not a Business Day) immediately preceding an Interest Payment Date on June 1 and the
November&nbsp;15 (whether or not a Business Day) immediately preceding an Interest Payment Date on
December 1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Repaid Note Purchase Agreements</I></B>&#148; means that certain note purchase agreement, dated as of July
8, 2004, by and among the Company and the purchasers thereto and that certain note purchase
agreement, dated as of October&nbsp;1, 2007 among the Company and the purchasers thereto, with respect
to the Repaid Senior Notes as supplemented, amended, restated, extended, renewed, replaced or
otherwise modified from time to time prior to the date hereof.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Repaid Senior Notes</I></B>&#148; means, collectively, (1)&nbsp;the 6.66% Series&nbsp;2004-1 Tranche A Senior Notes
due 2011 in an aggregate principal amount of $145.0&nbsp;million, (2)&nbsp;the 7.14% Series&nbsp;2004-1 Tranche B
Senior Notes due 2014 in an aggregate principal amount of $96.5&nbsp;million, (3)&nbsp;the 7.46% Series
2004-1 Tranche C Senior Notes due 2016 in an aggregate principal amount of $90.1&nbsp;million, (4)&nbsp;the
7.62% Series&nbsp;A Senior Notes due 2012, (5)&nbsp;the 7.94% Series&nbsp;B Senior Notes due 2014 and (6)&nbsp;the
Floating Rate Series&nbsp;C Senior Notes due 2012, each issued
pursuant to the applicable Repaid Note Purchase
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Representative</I></B>&#148; means the Indenture trustee or other trustee, agent or representative for any
Senior Debt; <I>provided </I>that, if no Representative has been appointed under the instrument governing
any series of Senior Debt, any holder or group of holders of such series of Senior Debt certifying
that it holds a percentage of such series of Designated Senior Debt sufficient to cause the
acceleration thereof will be deemed a Representative.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Investment</I></B>&#148; means an Investment other than a Permitted Investment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted
Payments</I></B>&#148; has the meaning specified in Section 4.02(a).</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Subsidiary</I></B>&#148; of a Person means any Subsidiary of the referent Person that is not an
Unrestricted Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>S&#038;P</I></B>&#148; means Standard &#038; Poor&#146;s Ratings Group.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>SEC</I></B>&#148; means the United States Securities and Exchange Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securitization Assets</I></B>&#148; means the accounts receivable, royalty or other revenue streams and
other rights to payment under a Qualified Securitization Facility that is a securitization
financing facility (and not a receivables financing facility) and the proceeds thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securitization Facility</I></B>&#148; means any of one or more receivables or securitization financing
facilities as amended, supplemented, modified, extended, renewed, restated or refunded from time to
time, the Obligations of which are non-recourse (except for customary representations, warranties,
covenants and indemnities made in connection with such facilities) to
the Company or any of its
Restricted Subsidiaries (other than a Securitization Subsidiary) pursuant to which the Company or
any of its Restricted Subsidiaries sells or grants a security interest in its accounts receivable
or Securitization Assets or assets related thereto to either (a)&nbsp;a Person that is not a Restricted
Subsidiary or (b)&nbsp;a Securitization Subsidiary that in turn sells its accounts receivable to a
Person that is not a Restricted Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securitization Subsidiary</I></B>&#148; means any Subsidiary formed for the purpose of engaging in, and
that solely engages in, one or more Qualified Securitization Facilities and other activities
reasonably related thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Senior Debt</I></B>&#148; means:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;all Indebtedness of the Company or any Guarantor outstanding under Credit Facilities, all
Hedging Obligations, all Treasury Management Arrangements and all Obligations with respect to any
of the foregoing;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any other Indebtedness of the Company or any Guarantor permitted to be incurred under the
terms of the Indenture, unless the instrument under which such Indebtedness is incurred expressly
provides that it is on a parity with or subordinated in right of payment to the Notes or any Note
Guarantee; and</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;all Obligations with respect to the items listed in the preceding clauses (1)&nbsp;and (2).</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in the preceding, Senior Debt will not include:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the Notes or any Indebtedness of the Company under the Convertible Notes;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any liability for federal, state, local or other taxes owed or owing by the Company;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;any intercompany Indebtedness of the Company or any of its Subsidiaries to the Company or
any of its Affiliates;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;any Indebtedness incurred for the purchase of goods or materials or for services obtained
in the ordinary course of business (other than with the proceeds of revolving credit borrowings
permitted hereby); or</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;the portion of any Indebtedness that is incurred in violation of the Indenture; <I>provided</I>
that Indebtedness under a Credit Facility will not cease to be &#147;Senior Debt&#148; by virtue of this
clause (5)&nbsp;if it was advanced on the basis of an officers&#146; certificate to the effect that it was
permitted to be incurred under the Indenture; <I>provided further</I>, that such Indebtedness shall be
deemed not to have been incurred in violation of the Indenture for purposes of this clause if such
Indebtedness consists of Designated Senior Debt, and the holder(s) of such Indebtedness or their
agent or representative (a)&nbsp;had no actual knowledge at the time of incurrence that the incurrence
of such Indebtedness violated the Indenture and (b)&nbsp;shall have received an
Officers&#146; Certificate from the Company to the effect that the incurrence of such Indebtedness does not violate the
provisions of the Indenture.</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Significant Subsidiary</I></B>&#148; means any Restricted Subsidiary that would be a &#147;significant
subsidiary&#148; as defined in Article&nbsp;1, Rule&nbsp;1-02 of Regulation&nbsp;S-X, promulgated pursuant to the
Securities Act, as such Regulation is in effect on the date of this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stated Maturity</I></B>&#148; means, with respect to any installment of interest or principal on any
series of Indebtedness, the date on which the payment of interest or principal was scheduled to be
paid in the documentation governing such Indebtedness as of the date of this Supplemental
Indenture, and will not include any contingent obligations to repay, redeem or repurchase any such
interest or principal prior to the date originally scheduled for the payment thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to any specified Person:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;any corporation, association or other business entity of which more than 50% of the total
voting power of shares of Capital Stock entitled (without regard to the occurrence of any
contingency and after giving effect to any voting agreement or stockholders&#146; agreement that
effectively transfers voting power) to vote in the election of directors, managers or trustees of
the corporation, association or other business entity is at the time owned or controlled, directly
or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a
combination thereof); and</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any partnership or limited liability company of which (a)&nbsp;more than 50% of the capital
accounts, distribution rights, total equity and voting interests or general and limited partnership
interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or
more of the other Subsidiaries of that Person or a combination thereof, whether in the form of
membership,</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">general, special or limited partnership interests or otherwise, and (b)&nbsp;such Person or
any Subsidiary of such Person is a controlling general partner or otherwise controls such entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Successor
Company</I></B>&#148; has the meaning specified in Section&nbsp;5.02.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Supplemental Indenture</I></B>&#148; has the meaning specified in the first paragraph hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Total Assets</I></B>&#148; means the total assets of the Company and the Restricted Subsidiaries, as shown
on the most recent balance sheet of the Company for the then most recently ended fiscal quarter for
which internal financial statements are available immediately preceding the date of determination,
with such adjustments to Total Assets as are consistent with the pro forma adjustment provisions
set forth in the definition of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Transaction Costs</I></B>&#148; means the costs, fees, expenses and premiums associated with the
Transactions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Transactions</I></B>&#148; means the issuance of the Notes offered hereby, the use of proceeds therefrom
as described under the caption &#147;Use of Proceeds&#148; in the prospectus supplement relating to the
Notes, dated June&nbsp;8, 2011, and other transactions in connection therewith or incidental thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Treasury Management Arrangement</I></B>&#148; means any agreement or other arrangement governing the
provision of treasury or cash management services, including deposit accounts, overdraft, credit or
debit card, funds transfer, automated clearinghouse, zero balance accounts, returned check
concentration, controlled disbursement, lockbox, account reconciliation and reporting and trade
finance services and other cash management services.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Treasury
Rate</I></B>&#148; means, as of any redemption date with respect to
any Note being redeemed pursuant to Section 3.02(d), the yield to maturity as of such redemption
date of United States Treasury securities with a constant maturity (as compiled and published in
the most recent Federal Reserve Statistical Release H.15 (519)&nbsp;that has become publicly available
at least two Business Days prior to the redemption date (or, if such Statistical Release is no
longer published, any publicly available source of similar market data)) most nearly equal to the
period from the redemption date to June&nbsp;1, 2015; <I>provided, however</I>, that if the period from the
redemption date to June&nbsp;1, 2015, is less than one year, the weekly average yield on actually traded
United States Treasury securities adjusted to a constant maturity of one year will be used.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Trustee</I></B>&#148; has the meaning set forth in the first paragraph of this Supplemental Indenture.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Unrestricted Subsidiary</I></B>&#148; means any Subsidiary of the Company that is designated by the Board
of Directors of the Company as an Unrestricted Subsidiary pursuant to a resolution of the Board of
Directors, but only to the extent that such Subsidiary:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;has no Indebtedness other than Non-Recourse Debt;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;except as permitted by Section&nbsp;4.06, is not party to any agreement, contract, arrangement
or understanding with the Company or any Restricted Subsidiary of the Company unless the terms of
any such agreement, contract, arrangement or understanding are not materially less favorable to the
Company or such Restricted Subsidiary than those that might be obtained at the time from Persons
who are not Affiliates of the Company;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;is a Person with respect to which neither the Company nor any of its Restricted
Subsidiaries has any direct or indirect obligation (a)&nbsp;to subscribe for additional Equity Interests
or (b)&nbsp;to maintain or preserve such Person&#146;s financial condition or to cause such Person to achieve
any specified levels of operating results; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;has not guaranteed or otherwise directly or indirectly provided credit support for any
Indebtedness of the Company or any of its Restricted Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>U.S.</I></B>&#148; means the United States of America.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Voting Stock</I></B>&#148; of any specified Person as of any date means the Capital Stock of such Person
that is at the time entitled to vote in the election of the Board of Directors of such Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Weighted Average Life to Maturity</I></B>&#148; means, when applied to any Indebtedness at any date, the
number of years obtained by dividing:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the sum of the products obtained by multiplying (a)&nbsp;the amount of each then remaining
installment, sinking fund, serial maturity or other required payments of principal, including
payment at final maturity, in respect of the Indebtedness, by (b)&nbsp;the number of years (calculated
to the nearest one-twelfth) that will elapse between such date and the making of such payment; <I>by</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the then outstanding principal amount of such Indebtedness.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 2.<BR>
THE NOTES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;2.01 <I>Title and Terms; Payments</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is hereby established a series of Securities designated the &#147;6.875% Senior Subordinated
Notes due 2019&#148; initially limited in aggregate principal amount to $250,000,000, which amount shall
be as set forth in a Company Order for the authentication and delivery of Notes pursuant to Section
2.3 of the Original Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal amount of Notes then Outstanding shall be payable at the
Stated Maturity, which shall be June 1, 2019. Interest on the Notes shall accrue at a rate of 6.875% per annum, from the Issue Date or from the
most recent date on which interest has been paid or duly provided for, until the principal thereof
is paid or made available for payment. Interest shall be payable semi-annually in arrears on each
Interest Payment Date, beginning on December&nbsp;1, 2011, to the person in whose name a Note is
registered on the Register at 5:00 p.m., New York City time, on the Regular Record Date immediately
preceding the applicable Interest Payment Date. Interest will be computed on the basis of a
360-day year composed of twelve 30-day months. The Notes will not have the benefit of Article&nbsp;XIII
of the Original Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may, at its election and without notice to or the consent of the Holders of the
Notes, hereafter issue additional Notes (&#147;<B><I>Additional Notes</I></B>&#148;) under the Indenture with the same
terms and with the same CUSIP numbers as the Notes issued on the date of this Supplemental
Indenture (the &#147;<B><I>Initial Notes</I></B>&#148;) in an unlimited aggregate principal amount (subject to Section&nbsp;4.04
of this Supplemental Indenture). The Notes and such Additional Notes, if any, will be treated as a
single class for all purposes of the Indenture, including waivers,
amendments, redemptions and offers to
purchase; <I>provided </I>that, if any such Additional Notes subsequently issued are not fungible for U.S.
federal income tax purposes or securities
law purposes with any Notes previously issued, such Additional Notes shall trade separately from such
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">previously issued Notes under a separate CUSIP number but shall otherwise be treated as a
single class with all other Notes issued under the Indenture.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Form of Note shall be substantially as set forth in Exhibit&nbsp;A and the Form of Assignment
and Transfer shall be substantially as set forth in Attachment 1 to Exhibit&nbsp;A, each of which is
incorporated into and shall be deemed a part of this Supplemental Indenture, and in each case with
such appropriate insertions, omissions, substitutions and other variations as are required or
permitted by the Indenture, and may have such letters, numbers or other marks of identification and
such legends or endorsements placed thereon as may be required to comply with the rules of any
securities exchange or as may, consistently herewith, be determined to be necessary or appropriate
by the Officers of the Company executing such Notes, as evidenced by their execution of the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay the principal of and interest on any Global Note in immediately
available funds to the Depository or its nominee, as the case may be, as the registered Holder of
such Global Note. The Company, through the Paying Agent, shall make all payments of principal,
premium, if any, and interest, if any, with respect to Physical Notes by wire transfer of
immediately available funds to the accounts specified by the Holders of the Physical Notes or, if
no such account is specified, by mailing a check to each such Holder&#146;s registered address. The
Company has initially designated the Trustee as its Paying Agent and its Registrar in respect of
the Notes and its agency in New York City as a place where Notes may be presented for payment or
for registration of transfer. The Company may, however, change the Paying Agent or the Registrar
for the Notes without prior notice to the Holders thereof, and the Company or one of its
Subsidiaries may act as the Paying Agent or the Registrar for the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Holder may transfer or exchange Notes at the office of the Registrar in accordance with
Section&nbsp;2.7 of the Original Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;2.02 <I>Book-Entry Provisions for Global Notes</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Notes initially shall be issued in the form of one or more Global Notes
without interest coupons (i)&nbsp;registered in the name of Cede &#038; Co., as nominee of the Depository and
(ii)&nbsp;delivered to the Trustee as custodian for the Depository.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Members of, or participants in, the Depository (&#147;<B><I>Agent Members</I></B>&#148;) shall have no rights under
this Supplemental Indenture or the Original Indenture with respect to any Global Note held on their
behalf by the Depository, or the Trustee as its custodian, or under the Global Note, and Cede &#038;
Co., or such other person designated by the Depository as its nominee, may be treated by the
Company, the Trustee and any agent of the Company or the Trustee as the absolute owner of the
Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall
prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to
any written certification, proxy or other authorization furnished by the Depository or impair, as
between the Depository and its Agent Members, the operation of customary practices governing the
exercise of the rights of any Holder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Transfers of Global Notes shall be limited to transfers in whole, but not in
part, to the Depository, its successors or their respective nominees. Notwithstanding anything to
the contrary in Section&nbsp;2.7 of the Original Indenture, interests of beneficial owners in a Global
Note may be transferred or exchanged, in whole or in part, for Physical Notes, only if:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the Depository (a)&nbsp;notifies the Company that it is unwilling or unable to continue as
depositary for the Global Notes or (b)&nbsp;has ceased to be a clearing agency registered under the
Exchange Act and, in either case, the Company fails to appoint a successor depositary within 90
days of such event;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Company, at its option, notifies the Trustee in writing that it elects to cause the
issuance of the Physical Notes; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;there has occurred and is continuing a Default or Event of Default with respect to the
Notes and the Depository requests such certification of the Global Note,
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in each case in accordance with the rules and procedures of the Depository. Other than as set
forth in this Section&nbsp;2.02(b), the Notes shall remain in global form as Global Notes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In connection with any transfer or exchange of a portion of the beneficial
interest in the Global Note to beneficial owners pursuant to Section&nbsp;2.7 of the Original Indenture,
as modified by this Section&nbsp;2.02, the Registrar shall (if one or more Physical Notes are to be
issued) reflect on its books and records the date and a decrease in the principal amount of the
Global Note in an amount equal to the principal amount of the beneficial interest in the Global
Note to be transferred, and the Company shall execute, and the Trustee shall authenticate and
deliver, one or more Physical Notes of like tenor and amount in accordance with Section&nbsp;2.7 of the
Original Indenture, as modified by this Section&nbsp;2.02.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In connection with the transfer of the entire Global Note to beneficial owners
pursuant to Section&nbsp;2.7 of the Original Indenture, as modified by this Section&nbsp;2.02, the Global
Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall
execute, and the Trustee shall authenticate and deliver, to each beneficial owner identified by the
Depository in exchange for its beneficial interest in the Global Note, an equal aggregate principal
amount of Physical Notes of authorized denominations and the same tenor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Holder of Global Notes may grant proxies and otherwise authorize any person,
including Agent Members and persons that may hold interests through Agent Members, to take any
action that a Holder is entitled to take under this Supplemental Indenture, Original Indenture or
the Notes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;2.02 <I>Repurchase and Cancellation</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent permitted by law, the Company may at any time and from time to time repurchase
Notes in open market purchases or by tender at any price or in negotiated transactions without
giving prior notice to Holders. The Company shall surrender any Notes repurchased by the Company
to the Trustee for cancellation in accordance with Section&nbsp;2.12 of the Original Indenture and any
such Notes repurchased by the Company shall be deemed to be no longer Outstanding. Any Notes
surrendered for cancellation by the Company shall not be reissued or resold.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 3.<BR>
REDEMPTION AND PREPAYMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;3.01 <I>Effect of Notice of Redemption.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding Section&nbsp;3.4 of the Original Indenture, any notice of redemption may, at the
Company&#146;s discretion, be subject to one or more conditions precedent, including, but not limited
to, completion of a sale of common stock or other corporate transaction. Once notice of redemption
is mailed in accordance with the Indenture, Notes called for redemption become irrevocably due and
payable on the redemption date at the redemption price, subject only to the satisfaction or waiver
of any conditions precedent.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;3.02 <I>Optional Redemption.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;At any time prior to June&nbsp;1, 2014, the Company may on any one or more occasions
redeem up to 35% of the aggregate principal amount of Notes issued under this Supplemental
Indenture (including any Additional Notes), upon not less than 30 nor more than 60&nbsp;days&#146; notice, at
a redemption price equal to 106.875% of the principal amount of the Notes redeemed, plus accrued
and unpaid interest, if any, to, but not including, the date of redemption (subject to the rights
of Holders of Notes on the relevant record date to receive interest on the relevant interest
payment date), with the net cash proceeds of an Equity Offering by the Company; <I>provided </I>that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;at least 65% of the aggregate principal amount of Notes originally issued under this
Supplemental Indenture (excluding Notes held by the Company and its Subsidiaries) remains
outstanding immediately after the occurrence of such redemption; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the redemption occurs within 120&nbsp;days of the date of the closing of such Equity Offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;At any time prior to June&nbsp;1, 2015, the Company may on any one or more occasions
redeem all or a part of the Notes, upon not less than 30 nor more than 60&nbsp;days&#146; notice, at a
redemption price equal to 100% of the principal amount of the Notes redeemed, plus the Applicable
Premium as of, and accrued and unpaid interest, if any, to, but not including, the date of
redemption, subject to the rights of Holders of Notes on the relevant record date to receive
interest due on the relevant interest payment date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except pursuant to Sections&nbsp;3.02(a) and (b), the Notes will not be redeemable at
the Company&#146;s option prior to June&nbsp;1, 2015.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;On or after June&nbsp;1, 2015, the Company may on any one or more occasions redeem
all or a part of the Notes, upon not less than 30 nor more than 60&nbsp;days&#146; notice, at the redemption
prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid
interest, if any, on the Notes redeemed, to, but not including, the applicable date of redemption,
if redeemed during the twelve-month period beginning on June 1 of the years indicated below,
subject to the rights of Holders of Notes on the relevant record date
to receive interest due on the
relevant interest payment date:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">

<TD nowrap align="left"><div style="border-bottom: 1px solid #000000; width: 15%"><B>Year</B></div></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><div style="border-bottom: 1px solid #000000; width: 15%"><B>Percentage</B></div></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2015</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">103.438</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2016</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">101.719</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2017 and thereafter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">100.000</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless the Company defaults in the payment of the redemption price, interest will cease to
accrue on the Notes or portions thereof called for redemption on the applicable redemption date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If less than all of the Notes are to be redeemed at any time, the Trustee will
select Notes for redemption on a <I>pro rata </I>basis or, in the case of Global Notes, based on a method
that most nearly approximates a <I>pro rata </I>selection as the Trustee deems fair and appropriate)
unless otherwise required by law or applicable stock exchange or depositary requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;No Notes of $2,000 or less shall be redeemed in part.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Any redemption pursuant to this Section&nbsp;3.02 shall be made pursuant to the
provisions of Sections&nbsp;3.01 and 3.02 hereof and Sections&nbsp;3.1, 3.3, 3.5 and 3.6 of the Original
Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;3.03 <I>Mandatory Redemption.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is not required to make mandatory redemption or sinking fund payments with respect
to the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;3.04 <I>Offer to Purchase by Application of Excess Proceeds.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that, pursuant to Section&nbsp;4.05 hereof, the Company is required to commence an
offer to all Holders to purchase Notes (an &#147;<B><I>Asset Sale Offer</I></B>&#148;), it will follow the procedures
specified below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Asset Sale Offer shall be made to all Holders and all holders of other Indebtedness that
is <I>pari passu </I>with the Notes containing provisions similar to those set forth in the Indenture with
respect to offers to purchase, prepay or redeem with the proceeds of sales of assets. The Asset
Sale Offer will remain open for a period of at least 20 Business Days following its commencement
and not more than 30 Business Days, except to the extent that a longer period is required by
applicable law (the &#147;<B><I>Offer Period</I></B>&#148;). No later than three Business Days after the termination of
the Offer Period (the &#147;<B><I>Purchase Date</I></B>&#148;), the Company will apply all Excess Proceeds (the <I>&#147;</I><B><I>Offer
Amount</I></B><I>&#148;</I>) to the purchase of Notes and such other <I>pari passu </I>Indebtedness (on a <I>pro rata </I>basis based
on the principal amount of Notes and such other <I>pari passu </I>Indebtedness surrendered, if applicable)
or, if less than the Offer Amount has been tendered, all Notes and other Indebtedness tendered in
response to the Asset Sale Offer. Payment for any Notes so purchased will be made in the same
manner as interest payments are made.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Purchase Date is on or after an interest record date and on or before the related
interest payment date, any accrued and unpaid interest, if any, will be paid to the Person in whose
name a Note is registered at 5:00 p.m., New York City time, on such record date, and no additional interest
will be payable to Holders who tender Notes pursuant to the Asset Sale Offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the commencement of an Asset Sale Offer, the Company will send, by first class mail, a
notice to the Trustee and each of the Holders, with a copy to the Trustee. The notice will contain
all instructions and materials necessary to enable such Holders to tender Notes pursuant to the
Asset Sale Offer. The notice, which will govern the terms of the Asset Sale Offer, will state:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) that the Asset Sale Offer is being made pursuant to this Section&nbsp;3.04 and Section
4.05 hereof and the length of time the Asset Sale Offer will remain open;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the Offer Amount, the purchase price and the Purchase Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) that any Note not tendered or accepted for payment will continue to accrue
interest;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) that, unless the Company defaults in making such payment, any Note accepted for
payment pursuant to the Asset Sale Offer will cease to accrue interest after the Purchase
Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) that Holders electing to have a Note purchased pursuant to an Asset Sale Offer may
elect to have Notes purchased in denominations of $2,000 or an integral multiple of $1,000
in excess thereof;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) that Holders electing to have Notes purchased pursuant to any Asset Sale Offer will
be required to surrender the Note, with the form entitled &#147;Option of Holder to Elect
Purchase&#148; attached to the Notes completed, or transfer by book-entry transfer, to the
Company, a Depository, if appointed by the Company, or a Paying Agent at the address
specified in the notice at least three days before the Purchase Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) that Holders will be entitled to withdraw their election if the Company, the
Depository or the Paying Agent, as the case may be, receives, not later than the expiration
of the Offer Period, a telegram, telex, facsimile transmission or letter setting forth the
name of the Holder, the principal amount of the Note the Holder delivered for purchase and a
statement that such Holder is withdrawing his election to have such Note purchased;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) that, if the aggregate principal amount of Notes and other <I>pari passu </I>Indebtedness
surrendered by holders thereof exceeds the Offer Amount, the Company will select the Notes
and other <I>pari passu </I>Indebtedness to be purchased on a <I>pro rata </I>basis based on the principal
amount of Notes and such other <I>pari passu </I>Indebtedness surrendered (with such adjustments as
may be deemed appropriate by the Company so that only Notes in denominations of $2,000, or
an integral multiple of $1,000 in excess thereof, will be purchased); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) that Holders whose Notes were purchased only in part will be issued new Notes equal
in principal amount to the unpurchased portion of the Notes surrendered (or transferred by
book-entry transfer).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On or before the Purchase Date, the Company will, to the extent lawful, accept for payment, on
a <I>pro rata </I>basis to the extent necessary, the Offer Amount of Notes or portions thereof tendered
pursuant to the Asset Sale Offer, or if less than the Offer Amount has been tendered, all Notes
tendered, and will deliver or cause to be delivered to the Trustee the Notes properly accepted
together with an Officers&#146; Certificate stating that such Notes or portions thereof were accepted
for payment by the Company in accordance with the terms of this Section&nbsp;3.04. The Company, the
Depository or the Paying Agent, as the case may be, will promptly (but in any case not later than
five days after the Purchase Date) mail or deliver to each tendering Holder an amount equal to the
purchase price of the Notes tendered by such Holder and accepted by the Company for purchase, and
the Company will promptly issue a new Note, and the Trustee, upon written request from the Company,
will authenticate and mail or deliver (or cause to be transferred by book entry) such new Note to
such Holder, in a principal amount equal to any unpurchased portion of the Note surrendered. Any
Note not so accepted shall be promptly mailed or delivered by the Company to the Holder thereof.
The Company will publicly announce the results of the Asset Sale Offer on the Purchase Date.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 4.<BR>
COVENANTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.01 <I>Reports.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions in Section&nbsp;4.4 of the Original Indenture shall not apply with respect to the
Notes, and this Section&nbsp;4.01 supersedes the entirety thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Whether or not required by the rules and regulations of the SEC, so long as any
Notes are outstanding, the Company will furnish to the Holders of Notes or cause the Trustee to
furnish to the Holders of Notes (giving effect to any grace period provided by Rule&nbsp;12b-25 under
the Exchange Act), within the time periods specified in the SEC&#146;s rules and regulations:
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;all quarterly and annual reports that would be required to be filed with the SEC on Forms
10-Q and 10-K if the Company were required to file reports, including a &#147;Management&#146;s Discussion
and Analysis of Financial Condition and Results of Operations&#148; and, with respect to the annual
information only, a report thereon by the Company&#146;s certified independent accountants; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;all current reports that would be required to be filed with the SEC on Form 8-K if the
Company were required to file such reports.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All such reports will be prepared in all material respects in accordance with all of the rules and
regulations applicable to such reports. In addition, the Company will file a copy of each of the
reports referred to in clauses (1)&nbsp;and (2)&nbsp;above with the SEC for public availability within the
time periods) giving effect to any grace period provided by Rule&nbsp;12b-25 under the Exchange Act)
specified in the rules and regulations applicable to such reports (unless the SEC will not accept
such a filing) and will post the reports on its website within those time periods. The Company will
at all times comply with TIA &#167;314(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;For purposes of this Section&nbsp;4.01, reports filed by the Company with the SEC via
the EDGAR system will be deemed to be furnished to the Holders as of the time such reports are
filed with EDGAR. If, at any time, the Company is no longer subject to the periodic reporting
requirements of the Exchange Act for any reason, the Company will nevertheless continue filing the
reports specified in Section&nbsp;4.01(a) with the SEC within the time periods specified above unless
the SEC will not accept such a filing. The Company will not take any action for the purpose of
causing the SEC not to accept any such filings. If, notwithstanding the foregoing, the SEC will
not accept the Company&#146;s filings for any reason, the Company will post the reports referred to in
Section&nbsp;4.01(a) on its website within the time periods that would apply if the Company were
required to file those reports with the SEC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If the Company has designated any of its Subsidiaries as Unrestricted
Subsidiaries and such Unrestricted Subsidiaries, either individually or collectively, would
otherwise have been a Significant Subsidiary, then the quarterly and annual financial information
required by Section&nbsp;4.01(a) will include a reasonably detailed presentation in Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations of the financial condition
and results of operations of the Company and its Restricted Subsidiaries separate from the
financial condition and results of operations of the Unrestricted Subsidiaries of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If any direct or indirect parent company of the Company becomes a Guarantor, the
Company may satisfy its obligations in this Section&nbsp;4.01 with respect to financial information
relating to the Company by furnishing financial information relating to such other parent
Guarantor; <I>provided </I>that the same is accompanied by consolidating information that explains in
reasonable detail the differences between the information relating to such parent Guarantor, on the
one hand, and the information relating to the Company and its Subsidiaries on a standalone basis,
on the other hand.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company and the Guarantors agree that, for so long as any Notes remain
outstanding, if at any time they are not required to file with the SEC the reports required by this
Section&nbsp;4.01, they will furnish to the Holders of Notes and prospective investors, upon their
request, the information required to be delivered pursuant to Rule&nbsp;144A(d)(4) under the Securities
Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.02 <I>Restricted Payments</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to,
directly or indirectly:
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w)&nbsp;declare or pay any dividend or make any other payment or distribution on account of the
Company&#146;s or any of its Restricted Subsidiaries&#146; Equity Interests (including, without limitation,
any payment in connection with any merger or consolidation involving the Company or any of its
Restricted Subsidiaries) other than:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;dividends or distributions payable in Equity Interests (other than Disqualified
Stock) of the Company; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;dividends or distributions (including, for the purposes of this clause (w)(B),
loans, capital contributions, premium reductions, reductions of capital and returns of capital)
payable to the Company or a Restricted Subsidiary of the Company (including, for the avoidance of
doubt, dividends or distributions issued by a Restricted Subsidiary of the Company);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;purchase, redeem or otherwise acquire or retire for value (including, without limitation,
in connection with any merger or consolidation involving the Company) any Equity Interests of the
Company or any direct or indirect parent of the Company;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y)&nbsp;make any payment on or with respect to, or purchase, redeem, defease or otherwise acquire
or retire for value any Indebtedness of the Company or any Guarantor that is contractually
subordinated to the Notes or to any Note Guarantee (excluding any intercompany Indebtedness between
or among the Company and any of its Restricted Subsidiaries), except a payment of interest,
payments in satisfaction of a sinking fund obligation or principal at the Stated Maturity thereof;
or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z)&nbsp;make any Restricted Investment
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(all such payments and other actions set forth in these clauses (w)&nbsp;through (z)&nbsp;above being
collectively referred to as &#147;<I><b>Restricted Payments</b></I>&#148;),
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">unless, at the time of and after giving effect to such Restricted Payment:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;no Default or Event of Default has occurred and is continuing or would occur as a
consequence of such Restricted Payment;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Company would, at the time of such Restricted Payment and after giving pro forma
effect thereto as if such Restricted Payment had been made at the beginning of the applicable
four-quarter period, have been permitted to incur at least $1.00 of additional Indebtedness
pursuant to the Fixed Charge Coverage Ratio test set forth in Section&nbsp;4.04(a); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;such Restricted Payment, together with the aggregate amount of all other Restricted
Payments made by the Company and its Restricted Subsidiaries since the date of this Supplemental
Indenture (excluding Restricted Payments permitted by clauses (2), (3), (4), (5), (6), (7), (8),
(9), (10), (11), (13), (14), (15)&nbsp;and (16)&nbsp;of Section&nbsp;4.02(b)), is less than the sum, without
duplication, of:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;50% of the Consolidated Net Income of the Company for the period (taken as one
accounting period) from March&nbsp;27, 2011 to the end of the Company&#146;s most recently ended fiscal
quarter for which internal financial statements are available at the time of such Restricted
Payment (or, if such Consolidated Net Income for such period is a deficit, less 100% of such
deficit); <I>plus</I>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;100% of the aggregate net cash proceeds and the Fair Market Value of marketable
securities received by the Company as a contribution to its Common Equity capital or from the issue
or sale of Qualifying Equity Interests of the Company since the date of this Supplemental Indenture
or from the issue or sale of convertible or exchangeable Disqualified Stock of the Company or
convertible or exchangeable debt securities of the Company (whether issued or sold before or after
the date of this Supplemental Indenture), in each case that have been converted into or exchanged
for Qualifying Equity Interests of the Company after the date of this Supplemental Indenture
(other than Qualifying Equity Interests and convertible or exchangeable Disqualified Stock or debt
securities sold to a Subsidiary of the Company); <I>plus</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;100% of the aggregate net cash proceeds and the Fair Market Value of marketable
securities or other property received by the Company after the date of this Supplemental Indenture
by means of: (i)&nbsp;the sale or other disposition (other than to
the Company or one of its Restricted
Subsidiaries) of Restricted Investments made by the Company or its Restricted Subsidiaries and
repurchases and redemptions of such Restricted Investments from the Company or its Restricted
Subsidiaries and repayments of loans or advances, and releases of guarantees, which constituted
Restricted Investments by the Company or its Restricted Subsidiaries, in each case after the date
of this Supplemental Indenture, (ii)&nbsp;the sale (other than to the
Company or one of its Restricted
Subsidiaries) of the Capital Stock of an Unrestricted Subsidiary or (iii)&nbsp;a distribution or dividend
from an Unrestricted Subsidiary of the Company, in each case to the extent that such amounts were not otherwise
included in the Consolidated Net Income of the Company for such period; <I>plus</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)&nbsp;to the extent that any Unrestricted Subsidiary of the Company designated as such
after the date of this Supplemental Indenture is redesignated as a Restricted Subsidiary after the
date of this Supplemental Indenture, the lesser of (i)&nbsp;the Fair Market Value of the Company&#146;s
Restricted Investment in such Subsidiary as of the date of such redesignation or (ii)&nbsp;the aggregate
amount of the Company&#146;s Restricted Investments in such Subsidiary to the extent such Restricted
Investments reduced the amount available under this clause (D)&nbsp;and were not previously repaid or
otherwise reduced.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The preceding provisions will not prohibit:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the payment of any dividend or the consummation of any irrevocable redemption of any
securities within 60&nbsp;days after the date of declaration of the dividend or giving of the redemption
notice, as the case may be, if at the date of declaration or notice, the dividend or redemption
payment would have complied with the provisions of the Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the making of any Restricted Payment in exchange for, or out of or with the net cash
proceeds of the substantially concurrent sale (other than to a Subsidiary of the Company) of,
Equity Interests of the Company (other than Disqualified Stock) or from the substantially
concurrent contribution of Common Equity capital to the Company; <I>provided </I>that the amount of any
such net cash proceeds that are utilized for any such Restricted Payment will not be considered to
be net proceeds of Qualifying Equity Interests for purposes Section&nbsp;4.02(a)(3)(B);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the payment of any dividend or similar distribution by a Restricted Subsidiary of the
Company to the holders of its Equity Interests on a <I>pro rata </I>basis;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;the making of any principal payment or the repurchase, redemption, defeasance or other
acquisition or retirement for value of Indebtedness of the Company or any Guarantor that is
contractually subordinated to the Notes or to any Note Guarantee with the net cash proceeds from a
substantially concurrent incurrence of Permitted Refinancing Indebtedness;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;the repurchase, redemption or other acquisition or retirement for value of any Equity
Interests of the Company or any Restricted Subsidiary of the Company held by any current or former
officer, director, employee or consultant of the Company or any of its Restricted Subsidiaries
pursuant to any equity subscription agreement, stock option agreement, shareholders&#146; agreement or
similar agreement or any management equity plan or stock option plan or any other management or
employee benefit plan or agreement; <I>provided </I>that the aggregate price paid for all such
repurchased, redeemed, acquired or retired Equity Interests may not exceed $25.0&nbsp;million in any
twelve-month period (with unused amounts in any twelve-month period being carried over to
succeeding twelve-month periods); <I>provided further </I>that such amount in any twelve-month period may
be increased by an amount not to exceed:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the cash proceeds from the sale of Equity Interests of the Company to
members of management, directors or consultants of the Company, any of its Restricted
Subsidiaries or any of its direct or indirect parent companies that occurred after the date
of this Supplemental Indenture, to the extent the cash proceeds from the sale of such Equity
Interests have not otherwise been applied to the payment of Restricted Payments by virtue of
Section&nbsp;4.02(a)(3) or Section&nbsp;4.02(b)(2); <I>plus</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the cash proceeds of key man life insurance policies received by the
Company or its Restricted Subsidiaries after the date of this Supplemental Indenture; <I>less</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the amount of any Restricted Payments made in previous twelve-month
periods pursuant to clauses (a)&nbsp;and (b)&nbsp;of this clause (5);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;the repurchase of Equity Interests deemed to occur upon the exercise of stock options to
the extent such Equity Interests represent a portion of the exercise price of those stock options;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;payments or distributions to dissenting stockholders required by applicable law, pursuant
to or in connection with a consolidation, merger or transfer of assets of the Company or its
Restricted Subsidiaries that complies with the provisions of Section&nbsp;5.01;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;the declaration and payment of regularly scheduled or accrued dividends to holders of any
class or series of Disqualified Stock of the Company or any preferred stock of any Restricted
Subsidiary of the Company issued on or after the date of this Supplemental Indenture in accordance
with the Fixed Charge Coverage Ratio test described in
Section&nbsp;4.04(a);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;payments of cash, dividends, distributions, advances or other Restricted Payments by the
Company or any of its Restricted Subsidiaries to allow the payment of cash in lieu of the issuance
of fractional shares upon (i)&nbsp;the exercise of options or warrants or (ii)&nbsp;the conversion or
exchange of Capital Stock or Permitted Convertible Indebtedness of any such Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;the making of cash payments in connection with any conversion of Permitted Convertible
Indebtedness in an aggregate principal amount since the date of this Supplemental Indenture not to
exceed the sum of (a)&nbsp;the principal amount of such Permitted Convertible Indebtedness <I>plus </I>(b)&nbsp;any
payments received by the Company or any of its Restricted Subsidiaries pursuant to the exercise,
settlement or termination of any related Permitted Bond Hedge Transaction;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;any payments in connection with a Permitted Bond Hedge Transaction, and the settlement of
any related Permitted Warrant Transaction (a)&nbsp;by delivery of shares of the Company&#146;s common stock
upon net share settlement thereof or (b)&nbsp;by (i)&nbsp;set-off against the related Permitted Bond Hedge
Transaction, (ii)&nbsp;payment of an early termination amount thereof in shares of the Company&#146;s
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">common stock upon any early termination thereof and (iii)&nbsp;payment of an amount thereof in
cash upon exercise, settlement or an early termination thereof in an aggregate amount not to exceed
the aggregate amount of any payments received by the Company or any of its Restricted Subsidiaries
pursuant to the exercise, settlement or termination of any related Permitted Bond Hedge
Transaction, less any cash payments made with respect to any related Permitted Convertible
Indebtedness pursuant to Section&nbsp;4.02(b)(10);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;the declaration or payment of cash dividends on the Company&#146;s common stock in an amount
not to exceed $0.35 per share in any fiscal quarter (as adjusted so that the aggregate amount
payable pursuant to this clause (12)&nbsp;is not increased or decreased solely as a result of any
stock-split, stock dividend or similar reclassification);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;the purchase, redemption, cancellation or other retirement for a nominal value per right
of any rights granted to holders of the Company&#146;s common stock pursuant to a shareholder rights plan;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;payments in connection with intercompany obligations under cash pooling arrangements;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;the repurchase or redemption of any Indebtedness which is subordinated in right of
payment to the Notes or any Note Guarantee (i)&nbsp;at a purchase price not greater than 101% of the
principal amount of such Indebtedness in the event of a &#147;Change of Control&#148; in accordance with
provisions similar to those described under Section&nbsp;4.08 or (ii)&nbsp;at a purchase price not greater
than 100% of the principal amount thereof in accordance with the provisions similar to those
described under Section&nbsp;4.05; <I>provided </I>that, prior to or simultaneously with such purchase or
redemption, the Company has made an offer to purchase the Notes as provided in the above-referenced
provisions with respect to the Notes and has completed the repurchase or redemption of the Notes
validly tendered for payment in connection with such offer to purchase and the provisions described
under Section&nbsp;4.05 and Section&nbsp;4.08, as applicable; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;so long as no Default or Event of Default has occurred and is continuing, other
Restricted Payments; <I>provided</I>, that, if, immediately after giving effect to such Restricted Payment
as if it had occurred at the beginning of the Company&#146;s most recently ended four full fiscal
quarters for which internal financial statements are available at the time of such Restricted
Payment, the Company&#146;s Consolidated Leverage Ratio would have been equal to or greater than 3.00 to
1.00, the aggregate amount of such Restricted Payments pursuant to this clause (16)&nbsp;made since the
date of this Supplemental Indenture at a time when such Consolidated Leverage Ratio was equal to or
greater than 3.00 to 1.00 does not exceed $275.0&nbsp;million.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The amount of all Restricted Payments (other than cash) will be the Fair Market
Value on the date of the Restricted Payment of the asset(s) or securities proposed to be
transferred or issued by the Company or such Restricted Subsidiary, as the case may be, pursuant to
the Restricted Payment. The Fair Market Value of any assets or securities that are required to be
valued by this covenant will be determined by the Board of Directors of the Company whose
determination will be conclusive and will be evidenced by an Officers&#146; Certificate delivered to the
Trustee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.03 <I>Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries.</I>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to,
directly or indirectly, create or permit to exist or become effective any consensual encumbrance or
restriction on the ability of any Restricted Subsidiary to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;pay dividends or make any other distributions on its Capital Stock to the Company or any
of its Restricted Subsidiaries, or with respect to any other interest or participation in, or
measured by, its profits, or pay any indebtedness owed to the Company or any of its Restricted
Subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;make loans or advances to the Company or any of its Restricted Subsidiaries; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;sell, lease or transfer any of its properties or assets to the Company or any of its
Restricted Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;However, the preceding restrictions will not apply to encumbrances or
restrictions existing under or by reason of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;contractual encumbrances or restrictions in effect on the date of this Supplemental
Indenture, including pursuant to agreements governing Existing Indebtedness and Credit Facilities
as in effect on the date of this Supplemental Indenture and any amendments, restatements,
modifications, renewals, supplements, refundings, replacements or refinancings of those agreements;
<I>provided </I>that the amendments, restatements, modifications, renewals, supplements, refundings,
replacements or refinancings are not materially more restrictive, taken as a whole, with respect to
such dividend and other payment restrictions than those contained in those agreements on the date
of this Supplemental Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Indenture, the Notes and the Note Guarantees;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;agreements governing other Indebtedness permitted to be incurred under Section&nbsp;4.04 and
any amendments, restatements, modifications, renewals, supplements, refundings, replacements or
refinancings of those agreements; <I>provided </I>that the restrictions therein are not materially more
restrictive, taken as a whole, than those contained in the Indenture, the Notes and the Note
Guarantees;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;applicable law, rule, regulation or order;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;any agreement or other instrument of a Person acquired by the Company or any of its
Restricted Subsidiaries as in effect at the time of such acquisition (except to the extent created
in contemplation of such acquisition), which encumbrance or restriction is not applicable to any
Person, or the properties or assets of any Person, other than the Person, or the property or assets
of the Person, so acquired;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;customary non-assignment provisions in contracts and licenses entered into in the ordinary
course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;purchase money obligations for property acquired in the ordinary course of business and
Capital Lease Obligations that impose restrictions on the property purchased or leased of the
nature described in Section&nbsp;4.03(a)(3);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;any agreement for the sale or other disposition of a Restricted Subsidiary that restricts
distributions by that Restricted Subsidiary pending its sale or other disposition;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;Permitted Refinancing Indebtedness; <I>provided </I>that the restrictions contained in the
agreements governing such Permitted Refinancing Indebtedness are not materially more restrictive,
taken as a whole, than those contained in the agreements governing the Indebtedness being
refinanced;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;Liens permitted to be incurred under Section&nbsp;4.07 that limit the right of the debtor to
dispose of the assets subject to such Liens;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;provisions limiting the disposition or distribution of assets or property in joint
venture agreements, asset sale agreements, sale-leaseback agreements, stock sale agreements and
other similar agreements (including agreements entered into in connection with a Restricted
Investment) entered into in the ordinary course of business, which limitation is applicable only to
the assets that are the subject of such agreements;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;restrictions on cash or other deposits or net worth imposed by customers under contracts
entered into in the ordinary course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;Indebtedness, Disqualified Stock or preferred stock of Foreign Subsidiaries permitted to
be incurred pursuant to the provisions of the covenant described under Section&nbsp;4.04;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;any encumbrance or restriction in connection with an acquisition of property, so long as
such encumbrance or restriction relates solely to the property so acquired and was not created in
connection with or in anticipation of such acquisition;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;restrictions on the sale or transfer of assets imposed under any agreement to sell such
assets or granting an option to purchase such assets; <I>provided </I>that such sale or transfer complies
with the other provisions of the Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;Indebtedness or other contractual requirements or restrictions created in connection with
any Qualified Securitization Facility that, in a good faith determination of the Company, are
necessary or advisable to effect such Qualified Securitization Facility; <I>provided </I>that such
restrictions apply only to such Securitization Subsidiary; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;any encumbrances or restrictions imposed by any amendments, modifications, restatements,
renewals, increases, supplements, refundings, replacements or refinancings of the contracts,
instruments or obligations referred to in clauses (1)&nbsp;through (16)&nbsp;above; provided that the
encumbrances or restrictions in such amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings are not materially more restrictive, in the
good faith judgment of the Board of Directors of the Company, taken as a whole, than the
encumbrances or restrictions prior to such amendment, modification, restatement, renewal, increase,
supplement, refunding, replacement or refinancing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.04 <I>Incurrence of Indebtedness and Issuance of Preferred Stock</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to,
directly or indirectly, create, incur, issue, assume, guarantee or otherwise become directly or
indirectly liable, contingently or otherwise, with respect to (collectively, &#147;<B><I>incur</I></B>&#148;) any
Indebtedness (including Acquired Debt), and the Company will not issue any Disqualified Stock and
will not permit any of its Restricted Subsidiaries to issue any shares of preferred stock;
<I>provided, however</I>, that the Company may incur Indebtedness (including Acquired Debt) or issue
Disqualified Stock, and the Company&#146;s Restricted Subsidiaries may incur Indebtedness (including
Acquired Debt) or issue preferred stock, if the Fixed Charge Coverage Ratio for the Company&#146;s most
recently ended four full fiscal quarters for which internal
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">financial statements are available immediately preceding the date on which such additional
Indebtedness is incurred or such Disqualified Stock or such preferred stock is issued, as the case
may be, would have been at least 2.0 to 1.0, determined on a pro forma basis (including a pro forma
application of the net proceeds therefrom), as if the additional Indebtedness had been incurred or
the Disqualified Stock or the preferred stock had been issued, as the case may be, at the beginning
of such four-quarter period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.04(a) will not prohibit the incurrence of any of the following items
of Indebtedness (collectively, &#147;<B><I>Permitted Debt</I></B>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the incurrence by the Company and any of its Restricted Subsidiaries of additional
Indebtedness and letters of credit under Credit Facilities in an aggregate principal amount at any
one time outstanding under this clause (1) (with letters of credit being deemed to have a principal
amount equal to the face amount thereof) not to exceed $1,250.0&nbsp;million;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the incurrence by the Company and its Restricted Subsidiaries of the Existing
Indebtedness;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the incurrence by the Company and the Guarantors of Indebtedness represented by the Notes
and the related Note Guarantees to be issued on the date of this Supplemental Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness
represented by Capital Lease Obligations, mortgage financings or purchase money obligations, in
each case, incurred for the purpose of financing all or any part of the purchase price or cost of
design, construction, installation or improvement of property, plant or equipment used in the
business of the Company or any of its Restricted Subsidiaries, in an aggregate principal amount,
including all Permitted Refinancing Indebtedness incurred to renew, refund, refinance, replace,
defease or discharge any Indebtedness incurred pursuant to this clause (4), not to exceed, as of
any date of incurrence, the greater of (a) $100.0&nbsp;million or (b)&nbsp;2.5% of Total Assets;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Permitted
Refinancing Indebtedness in exchange for, or the net proceeds of which are used to renew, refund,
refinance, replace, defease or discharge any Indebtedness (other than intercompany Indebtedness)
that was permitted by the Indenture to be incurred under Section&nbsp;4.04(a) or clauses (2), (3), (4),
(5), (14), (15), (19)&nbsp;or (21)&nbsp;of this Section&nbsp;4.04(b);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of intercompany
Indebtedness between or among the Company and any of its Restricted Subsidiaries; <I>provided,
however</I>, that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any subsequent issuance or transfer of Equity Interests that results in
any such Indebtedness being held by a Person other than the Company or a Restricted
Subsidiary of the Company; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any sale or other transfer of any such Indebtedness to a Person that is
not either the Company or a Restricted Subsidiary of the Company,
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">will be deemed, in each case, to constitute an incurrence of such Indebtedness by the
Company or such Restricted Subsidiary, as the case may be, that was not permitted by this
clause (6);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;the issuance by any of the Company&#146;s Restricted Subsidiaries to the Company or to any of
its Restricted Subsidiaries of shares of preferred stock; <I>provided, however, </I>that:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any subsequent issuance or transfer of Equity Interests that results in
any such preferred stock being held by a Person other than the Company or a Restricted
Subsidiary of the Company; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any sale or other transfer of any such preferred stock to a Person that is
not either the Company or a Restricted Subsidiary of the Company,
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">will be deemed, in each case, to constitute an issuance of such preferred stock by such
Restricted Subsidiary that was not permitted by this clause (7);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Hedging Obligations
in the ordinary course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;the guarantee by the Company or any of the Guarantors of Indebtedness of the Company or a
Restricted Subsidiary of the Company to the extent that the guaranteed Indebtedness was permitted
to be incurred by another provision of this covenant; <I>provided </I>that if the Indebtedness being
guaranteed is subordinated to or <I>pari passu </I>with the Notes, then the Guarantee must be subordinated
or <I>pari passu</I>, as applicable, to the same extent as the Indebtedness guaranteed;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness in
respect of workers&#146; compensation claims, self-insurance obligations, bankers&#146; acceptances,
performance and surety bonds in the ordinary course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;reimbursement obligations in respect of standby or documentary letters of credit or
bankers&#146; acceptances in the ordinary course of business in an aggregate principal amount at any
time outstanding not to exceed $30.0&nbsp;million;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness
arising from the honoring by a bank or other financial institution of a check, draft or similar
instrument inadvertently drawn against insufficient funds, so long as such Indebtedness is covered
within five Business Days;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;the incurrence by a Securitization Subsidiary of Indebtedness in connection with a
Qualified Securitization Facility that is without recourse to the Company or to any other
Subsidiary of the Company or their assets (other than such Securitization Subsidiary and its assets
and, as to the Company or any Subsidiary of the Company, other than pursuant to representations,
warranties, covenants and indemnities customary for such transactions) and is not guaranteed by any
such Person in an aggregate principal amount not to exceed, as of any date of incurrence, the
greater of (a)&nbsp;85% of the gross book value of the accounts receivable of the Company and its
Restricted Subsidiaries determined based on the most recently available month-end consolidated
balance sheet information for the Company or (b) $250.0&nbsp;million;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of (a)&nbsp;Indebtedness
of a Person incurred and outstanding on or prior to the date on which such Person was acquired by
the Company or any of its Restricted Subsidiaries or merged into the Company or a Restricted
Subsidiary in accordance with the terms of the Indenture or (b)&nbsp;Indebtedness of the Company or any
of its Restricted Subsidiaries incurred to acquire any Person who will become a Restricted
Subsidiary or be merged into the Company or any of its Restricted Subsidiaries in accordance with
the terms of the Indenture; <I>provided</I>, <I>however</I>, that, in either case, on the date of such
incurrence, (i)&nbsp;the Company would have been able to incur $1.00 of additional Indebtedness pursuant
to Section&nbsp;4.04(a) after giving effect to the incurrence of such Indebtedness pursuant to this
clause (14)&nbsp;or (ii)&nbsp;the Fixed
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Charge Coverage Ratio for the Company would be greater than such Fixed Charge Coverage Ratio
immediately prior to such incurrence of Indebtedness;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(15)&nbsp;the incurrence by the Company of Indebtedness, to the extent the net proceeds thereof are
(a)&nbsp;used to purchase Notes in connection with a Change of Control Offer or pursuant to Section&nbsp;3.02
or (b)&nbsp;promptly deposited to defease the Notes as described under Article&nbsp;7 or Article&nbsp;8;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness
incurred in the ordinary course of business in connection with cash pooling arrangements, cash
management and other Indebtedness incurred in the ordinary course of business in respect of netting
services, overdraft protections and similar arrangements in each case in connection with cash
management and deposit accounts;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness
arising from agreements of the Company or a Restricted Subsidiary of
the Company providing for indemnification,
adjustment of purchase price, earn-out or other similar obligations, in each case, incurred or
assumed in connection with the disposition of any business, assets or a Restricted Subsidiary,
other than guarantees of Indebtedness incurred by any Person acquiring all or any portion of such
business, assets or Restricted Subsidiary for the purpose of financing such acquisition; <I>provided</I>
that the maximum assumable liability in respect of all such Indebtedness shall at no time exceed
the gross proceeds actually received by the Company and its Restricted Subsidiaries in connection
with such disposition;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(18)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness in
connection with the repurchase, redemption or other acquisition or retirement of Equity Interests
held by any current or former officer, director or employee of the Company or any of its Restricted
Subsidiaries; <I>provided </I>that such repurchase, redemption or other acquisition or retirement is
permitted by Section&nbsp;4.02; and <I>provided</I>, <I>further </I>that such Indebtedness must be expressly
subordinated to the prior payment in full in cash of all Obligations then due with respect to the
Notes and the Note Guarantees;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(19)&nbsp;Indebtedness of Foreign Subsidiaries in an aggregate amount, including all Permitted
Refinancing Indebtedness incurred to renew, refund, refinance, replace, defease or discharge any
Indebtedness incurred pursuant to this clause (19), not to exceed, as of any date of incurrence,
the greater of (a) $150.0&nbsp;million (or the equivalent thereof, measured at the time of each
incurrence, in the applicable foreign currency) or (b)&nbsp;4.0% of Total Assets;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(20)&nbsp;Indebtedness consisting of guarantees of Indebtedness or other obligations of joint
ventures permitted under clause (15)&nbsp;of the definition of &#147;Permitted Investments;&#148; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(21)&nbsp;the incurrence by the Company or any of its Restricted Subsidiaries of additional
Indebtedness in an aggregate principal amount (or accreted value, as applicable), including all
Permitted Refinancing Indebtedness incurred to renew, refund, refinance, replace, defease or
discharge any Indebtedness incurred pursuant to this clause (21), not to exceed, as of any date of
incurrence, the greater of (a) $200.0&nbsp;million or (b)&nbsp;5.0% of Total Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For
purposes of determining compliance with this Section&nbsp;4.04, (i)
in  the event that
an item of Indebtedness meets the criteria of more than one of the categories of Permitted Debt
described in clauses (1)&nbsp;through (21)&nbsp;of Section&nbsp;4.04(b), or is entitled to be incurred pursuant to
Section&nbsp;4.04(a), the Company will be permitted, in its sole discretion, to classify such item of
Indebtedness on the date of its incurrence, or later reclassify all or a portion of such item of
Indebtedness, in any manner that complies with this Section&nbsp;4.04 and will only be required to
include the amount and type of such Indebtedness in
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">one of the
sub-clauses of Section&nbsp;4.04(b) or under Section&nbsp;4.04(a) and
(ii) at the time of incurrence,
the Company will be entitled to divide and classify an item of Indebtedness in more than one of the
types of Indebtedness described in Section&nbsp;4.04(a) or 4.04(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness under Credit Facilities outstanding on the date on which Notes are first issued
and authenticated under the Indenture shall be deemed to have been incurred under Section
4.04(b)(1).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The accrual of interest or preferred stock dividends, the accretion or amortization of
original issue discount, the payment of interest on any Indebtedness in the form of additional
Indebtedness with the same terms, the reclassification of preferred stock as Indebtedness due to a
change in accounting principles, and the payment of dividends on preferred stock or Disqualified
Stock in the form of additional shares of the same class of preferred stock or Disqualified Stock
will not be deemed to be an incurrence of Indebtedness or an issuance of preferred stock or
Disqualified Stock for purposes of this covenant; <I>provided</I>, in each such case, that the amount
thereof is included in Fixed Charges of the Company as accrued.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of determining compliance with any U.S. dollar-denominated restriction on the
incurrence of Indebtedness, the U.S. dollar-equivalent principal amount of Indebtedness denominated
in a foreign currency shall be utilized, calculated based on the relevant currency exchange rate in
effect on the date such Indebtedness was incurred. Notwithstanding any other provision of this
covenant, the maximum amount of Indebtedness that the Company or any Restricted Subsidiary may
incur pursuant to this covenant shall not be deemed to be exceeded solely as a result of
fluctuations in exchange rates or currency values.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.05 <I>Asset Sales.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to,
consummate an Asset Sale unless:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the Company (or the Restricted Subsidiary, as the case may be) receives consideration at
the time of the Asset Sale at least equal to the Fair Market Value (measured as of the date of the
definitive agreement with respect to such Asset Sale) of the assets or Equity Interests issued or
sold or otherwise disposed of; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;at least 75% of the consideration received in the Asset Sale by the Company or such
Restricted Subsidiary is in the form of cash or Cash Equivalents. For purposes of this provision,
each of the following will be deemed to be cash:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) any liabilities, as shown on the Company&#146;s most recent consolidated balance
sheet, of the Company or any Restricted Subsidiary (other than contingent liabilities and
liabilities that are by their terms subordinated to the Notes or any Note Guarantee) that are
assumed by the transferee of any such assets pursuant to a novation, indemnity or similar agreement
that releases the Company or such Restricted Subsidiary from or indemnifies against further
liability;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) any securities, Notes or other obligations received by the Company or any such
Restricted Subsidiary from such transferee that are converted by the Company or such Restricted
Subsidiary into cash within 180&nbsp;days of receipt, to the extent of the cash received in that
conversion;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) any stock or assets of the kind referred to in clauses (2), (4)&nbsp;or (5)&nbsp;of
Section&nbsp;4.05(b); and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) any Designated Non-cash Consideration received by the Company or any of its
Restricted Subsidiaries in such Asset Sale having an aggregate Fair Market Value, taken together
with all other Designated Non-cash Consideration received pursuant to this clause (D)&nbsp;that is at
that time outstanding, not to exceed at the time of the receipt of such Designated Non-cash
Consideration (with the Fair Market Value of each item of Designated Non-cash Consideration being
measured at the time received and without giving effect to subsequent changes in value) the greater
of (i) $50.0&nbsp;million or (ii)&nbsp;1.25% of the  Total Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Within 365&nbsp;days after the receipt of any Net Proceeds from an Asset Sale, the
Company or a Restricted Subsidiary of the Company may apply such Net Proceeds at its option:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;to repay Senior Debt;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;to acquire all or substantially all of the assets of, or any Capital Stock of, another
Permitted Business, if, after giving effect to any such acquisition of Capital Stock, the Permitted
Business is or becomes a Restricted Subsidiary of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;to make a capital expenditure;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;to acquire other assets that are used or useful in a Permitted Business; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;to make an Investment in any one or more businesses that replaces the businesses,
properties and/or assets that are the subject of such Asset Sale; <I>provided </I>that such Investment in
any business is in the form of the acquisition of Capital Stock and, after giving effect to such
Investment, such business is a Restricted Subsidiary of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Pending the final application of any Net Proceeds, the Company or a Restricted
Subsidiary of the Company may temporarily invest the Net Proceeds in any manner that is not
prohibited by the Indenture. Any binding commitment to apply Net Proceeds to invest in accordance
with clauses (2), (3), (4)&nbsp;or (5)&nbsp;of Section&nbsp;4.05(b), as the case may be, shall be treated as a
permitted application of Net Proceeds from the date of such commitment so long as the Company or
such Restricted Subsidiary enters into such commitment with the good faith expectation that such
Net Proceeds will be applied to satisfy such commitment within 180&nbsp;days of such commitment;
<I>provided </I>that if such commitment is later canceled or terminated for any reason such Net Proceeds
shall constitute Excess Proceeds.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Any Net Proceeds from Asset Sales that are not applied or invested as provided
in Section&nbsp;4.05(b) will constitute &#147;<B><I>Excess Proceeds</I></B>.&#148; When the aggregate amount of Excess Proceeds
exceeds $50.0&nbsp;million, within ten Business Days thereof, the Company will make an Asset Sale Offer
as described in Section&nbsp;3.04 to all Holders of Notes and, if required by the terms of any
Indebtedness that is <I>pari passu </I>with the Notes, all holders of other Indebtedness that is <I>pari
passu </I>with the Notes containing provisions similar to those set forth in the Indenture with respect
to offers to purchase, prepay or redeem with the proceeds of sales of assets to purchase, prepay or
redeem the maximum principal amount of Notes and such other <I>pari passu </I>Indebtedness (plus all
accrued interest on the Indebtedness and the amount of all fees and expenses, including premiums,
incurred in connection therewith) that may be purchased, prepaid or redeemed out of the Excess
Proceeds. The offer price in any Asset Sale Offer will be equal to 100% of the principal amount,
plus accrued and unpaid interest, if any, to, but not including, the date of repurchase, subject to
the rights of Holders of Notes on the relevant record date to receive interest due on the relevant
interest payment date, and will be payable in cash. If any Excess Proceeds remain after
consummation of an Asset Sale Offer, the Company may use those Excess Proceeds for any purpose not
otherwise prohibited by the Indenture. If the aggregate principal amount of Notes and other <I>pari
passu </I>Indebtedness tendered in (or required to be prepaid or redeemed in connection with) such
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Asset Sale Offer exceeds the amount of Excess Proceeds, the Trustee will select the Notes and
the Company will select such other <I>pari passu </I>Indebtedness to be purchased on a <I>pro rata </I>basis,
based on the amounts tendered or required to be prepaid or redeemed (with such adjustments as may
be deemed appropriate by the Trustee so that only Notes in denominations of $2,000, or an integral
multiple of $1,000 in excess thereof, will be purchased). Upon completion of each Asset Sale Offer,
the amount of Excess Proceeds will be reset at zero.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company will comply with the requirements of Rule&nbsp;14e-1 under the Exchange
Act and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with each repurchase of Notes pursuant to a Change of
Control Offer or an Asset Sale Offer. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control or Asset Sale provisions of the Indenture, the
Company will comply with the applicable securities laws and regulations and will not be deemed to
have breached its obligations under the Change of Control or Asset Sale provisions of the Indenture
by virtue of such compliance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;4.06 <I>Transactions with Affiliates.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to,
make any payment to or sell, lease, transfer or otherwise dispose of any of its properties or
assets to, or purchase any property or assets from, or enter into or make or amend any transaction,
contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any
Affiliate of the Company (each, an &#147;<B><I>Affiliate Transaction</I></B>&#148;) involving aggregate payments or
consideration in excess of $20.0&nbsp;million, unless:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the Affiliate Transaction is on terms that are not materially less favorable to the
Company or the relevant Restricted Subsidiary than those that would have been obtained in a
comparable transaction by the Company or such Restricted Subsidiary with an unrelated Person; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Company delivers to the Trustee, with respect to any Affiliate Transaction or series
of related Affiliate Transactions involving aggregate consideration in excess of $40.0&nbsp;million, (a)
a resolution of the Board of Directors of the Company set forth in an Officers&#146; Certificate
certifying that such Affiliate Transaction complies with this covenant and that such Affiliate
Transaction has been approved by a majority of the disinterested members of the Board of Directors
of the Company, or (b)&nbsp;an opinion as to the fairness to the
Company or such Restricted Subsidiary of such
Affiliate Transaction from a financial point of view issued by an accounting, appraisal or
investment banking firm of national standing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The following items will not be deemed to be Affiliate Transactions and,
therefore, will not be subject to the provisions of Section&nbsp;4.06(a):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;any employment agreement, change in control/severance agreement, employee benefit plan,
officer or director indemnification agreement or any similar arrangement entered into by the
Company or any of its Restricted Subsidiaries in the ordinary course of business and payments
pursuant thereto;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;transactions between or among the Company and/or its Restricted Subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;transactions with a Person (other than an Unrestricted Subsidiary of the Company) that is
an Affiliate of the Company solely because the Company owns, directly or through a Restricted
Subsidiary, an Equity Interest in, or controls, such Person;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;payment of fees and reimbursements of expenses (pursuant to indemnity arrangements or
otherwise) of officers, directors, employees or consultants of the Company or any of its Restricted
Subsidiaries or parent entities in the ordinary course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;any issuance of Equity Interests (other than Disqualified Stock) of the Company to
Affiliates of the Company and the granting of registration and other customary rights in connection
therewith;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;any Permitted Investments and any Restricted Payments permitted under Section&nbsp;4.02;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;any agreement as in effect as of the date of this Supplemental Indenture, or any amendment
thereto (so long as any such amendment is not materially disadvantageous to the Holders of the
Notes when taken as a whole as compared to the applicable agreement as in effect on the date of
this Supplemental Indenture);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;transactions in which the Company or any of its Restricted Subsidiaries, as the case may
be, delivers to the Trustee a letter from an Independent Financial Advisor stating that such
transaction is fair to the Company or such Restricted Subsidiary from a financial point of view or
stating that the terms are not materially less favorable to the Company or its relevant Restricted
Subsidiary than those that would have been obtained in a comparable transaction by the Company or
such Restricted Subsidiary with an unrelated Person on an arm&#146;s-length basis;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;the Transactions and the payment of all fees and expenses related thereto;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)&nbsp;transactions with customers, clients, suppliers, or purchasers or sellers of goods or
services that are Affiliates, in each case in the ordinary course of business and otherwise in
compliance with the terms of the Indenture which are fair to the Company and its Restricted
Subsidiaries, in the reasonable determination of the Board of Directors of the Company or the
senior management thereof, or are on terms at least as favorable as might reasonably have been
obtained at such time from an unaffiliated party;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11)&nbsp;sales of accounts receivable, or participations therein, or Securitization Assets or
related assets in connection with any Qualified Securitization Facility;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12)&nbsp;transactions between or among the Company and/or its Subsidiaries or transactions between
a Securitization Subsidiary and any Person in which the Securitization Subsidiary has an
Investment;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;any transaction with a Captive Insurance Subsidiary in the ordinary course of operations
of such Captive Insurance Subsidiary; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14)&nbsp;any tax sharing agreement or payment pursuant thereto, between the Company and/or one or
more Subsidiaries on the one hand, and any other Person with which the Company or such Subsidiaries
are required or permitted to file consolidated tax return or with which the Company or such
Subsidiaries are part of a consolidated group for tax purposes on the other hand, which payments by
the Company and the Restricted Subsidiaries are in lieu of and not in excess of the tax liabilities
that would have been payable by them on a stand-alone basis.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.07 <I>Liens.</I>
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will not, and will not permit any of its Restricted Subsidiaries to, create, incur,
assume or otherwise cause or suffer to exist or become effective any Lien of any kind (other than
Permitted Liens) securing Indebtedness upon any of their property or assets, now owned or hereafter
acquired, unless (1)&nbsp;in the case of any Lien securing <I>pari passu </I>Indebtedness, the Notes are
secured by a Lien that is senior in priority to or <I>pari passu </I>with such Lien and (2)&nbsp;in the case of
any Lien securing subordinated Indebtedness, the Notes are secured by a Lien that is senior in
priority to such Lien.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any Lien created for the benefit of the Holders of the Notes pursuant to the preceding
paragraph will provide by its terms that any such Lien shall be automatically and unconditionally
released and discharged upon the release and discharge of the Lien on such other Indebtedness.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;4.08 <I>Offer to Repurchase Upon Change of Control.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If a Change of Control occurs, each Holder of Notes will have the right to
require the Company to repurchase all or any part (equal to $2,000 or an integral multiple of
$1,000 in excess thereof) of that Holder&#146;s Notes pursuant to an offer by the Company (a &#147;<B><I>Change of
Control Offer</I></B>&#148;) on the terms set forth in this Supplemental Indenture. In the Change of Control
Offer, the Company will offer a Change of Control Payment in cash equal to 101% of the aggregate
principal amount of Notes repurchased, plus accrued and unpaid interest, if any, on the Notes
repurchased to, but not including, the date of purchase, subject to the rights of Holders of Notes
on the relevant record date to receive interest due on the relevant interest payment date. Within
ten days following any Change of Control, the Company will mail a notice to each Holder with a copy
to the Trustee describing the transaction or transactions that constitute the Change of Control and
offering to repurchase Notes on the Change of Control Payment Date specified in the notice, which
date will be no earlier than 30&nbsp;days and no later than 60&nbsp;days from the date such notice is mailed,
pursuant to the procedures required by the Indenture and described in such notice. The Company
will comply with the requirements of Rule&nbsp;14e-1 under the Exchange Act and any other securities
laws and regulations thereunder to the extent those laws and regulations are applicable in
connection with the repurchase of the Notes as a result of a Change of Control. To the extent that
the provisions of any securities laws or regulations conflict with the Change of Control provisions
of the Indenture, the Company will comply with the applicable securities laws and regulations and
will not be deemed to have breached its obligations under the Change of Control provisions of the
Indenture by virtue of such compliance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;On the Change of Control Payment Date, the Company will, to the extent lawful:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;accept for payment all Notes or portions of Notes properly tendered pursuant to the Change
of Control Offer;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;deposit with the Paying Agent an amount equal to the Change of Control Payment in respect
of all Notes or portions of Notes properly tendered; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;deliver or cause to be delivered to the Trustee the Notes properly accepted together with
an Officers&#146; Certificate stating the aggregate principal amount of Notes or portions of Notes being
repurchased by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Paying Agent will promptly send to each Holder of Notes properly tendered the Change of
Control Payment for such Notes, and the Trustee will promptly authenticate and mail (or cause to be
transferred by book entry) to each Holder a new Note equal in principal amount to any unpurchased
portion of the Notes surrendered, if any. The Company will publicly announce the results of the
Change of Control Offer on or as soon as practicable after the Change of Control Payment Date.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company will not be required to make a Change of Control Offer upon a Change
of Control if:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;a third party makes the Change of Control Offer in the manner, at the times and otherwise
in compliance with the requirements set forth in the Indenture applicable to a Change of Control
Offer made by the Company and purchases all Notes properly tendered and not withdrawn under the
Change of Control Offer; <I>provided</I>, <I>however</I>, in the event that such third party terminates, or
defaults under, its offer, the Company will be required to make a Change of Control Offer treating
the date of such termination or default as though it were the date of the Change of Control; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;notice of redemption has been given pursuant to the Indenture as described above under
Section&nbsp;3.02, unless and until there is a default in payment of the applicable redemption price.
Notwithstanding anything to the contrary contained herein, a Change of Control Offer may be made in
advance of a Change of Control, conditioned upon the consummation of such Change of Control, if a
definitive agreement is in place for the Change of Control at the time the Change of Control Offer
is made.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.09 <I>No Layering of Debt</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will not incur, create, issue, assume, guarantee or otherwise become liable for
any Indebtedness that is contractually subordinate or junior in right of payment to any Senior Debt
of the Company and senior in right of payment to the Notes. No Guarantor will incur, create,
issue, assume, guarantee or otherwise become liable for any Indebtedness that is contractually
subordinate or junior in right of payment to the Senior Debt of such Guarantor and senior in right
of payment to such Guarantor&#146;s Note Guarantee. No such Indebtedness will be considered to be
contractually subordinated or junior in right of payment to any Senior Debt of the Company or any
Guarantor by virtue of being unsecured or by virtue of being secured on a junior priority basis.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.10 <I>Additional Note Guarantees</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company or any of its Restricted Subsidiaries acquires or creates another Domestic
Subsidiary after the date of this Supplemental Indenture that guarantees or otherwise becomes an
obligor with respect to any Indebtedness of the Company or any of its Restricted Subsidiaries under
a Credit Facility, then that newly acquired or created Domestic Subsidiary will become a Guarantor
and execute a supplemental indenture and deliver an Opinion of
Counsel (as defined in the Original Indenture) to the Trustee within 45
Business Days of the date such Domestic Subsidiary guarantees or otherwise becomes an obligor with
respect to any Indebtedness of the Company or any of its Restricted Subsidiaries under a Credit
Facility; <I>provided </I>that any Domestic Subsidiary that constitutes an Immaterial Subsidiary, a
Captive Insurance Subsidiary or a Securitization Subsidiary, as the case may be, need not become a
Guarantor until such time as it ceases to be an Immaterial Subsidiary, a Captive Insurance
Subsidiary or a Securitization Subsidiary, as the case may be. Each Note Guarantee of a Domestic
Subsidiary will provide by its terms that it will be automatically released under the circumstances
described in Article&nbsp;9.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.11 <I>Payments for Consent</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or
indirectly, pay or cause to be paid any consideration to or for the benefit of any Holder of Notes
for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of
the Indenture or the Notes unless such consideration is offered to be paid and is paid to all
Holders of the Notes that consent, waive or agree to amend in the time frame set forth in the
solicitation documents relating to such consent, waiver or agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.12 <I>Designation of Restricted and Unrestricted Subsidiaries</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of the Company may designate any Restricted Subsidiary to be an
Unrestricted Subsidiary if that designation would not cause a Default. If a Restricted Subsidiary
is designated as an Unrestricted Subsidiary, the aggregate Fair Market Value of all outstanding
Investments owned by the Company and its Restricted Subsidiaries in the Subsidiary designated as
Unrestricted will be deemed to be an Investment made as of the time of the designation in an amount
determined as set forth in the last sentence of the definition of &#147;Investments&#148; and will reduce the
amount available for Restricted Payments under Section&nbsp;4.02 or under one or more clauses of the
definition of Permitted Investments, as determined by the Company. That designation will only be
permitted if the Investment would be permitted at that time and if the Restricted Subsidiary
otherwise meets the definition of an Unrestricted Subsidiary. The Board of Directors of the
Company may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary if that
redesignation would not cause a Default.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any designation of a Subsidiary of the Company as an Unrestricted Subsidiary will be evidenced
to the Trustee by filing with the Trustee a certified copy of a resolution of the Board of
Directors giving effect to such designation and an Officers&#146; Certificate certifying that such
designation complied with the preceding conditions and was permitted by Section&nbsp;4.02. If, at any
time, any Unrestricted Subsidiary would fail to meet the preceding requirements as an Unrestricted
Subsidiary, it will thereafter cease to be an Unrestricted Subsidiary for purposes of the Indenture
and any Indebtedness of such Subsidiary will be deemed to be incurred by a Restricted Subsidiary of
the Company as of such date and, if such Indebtedness is not permitted to be incurred as of such
date under the covenant described under Section&nbsp;4.04, the Company will be in Default of such
covenant. The Board of Directors of the Company may at any time designate any Unrestricted
Subsidiary to be a Restricted Subsidiary of the Company; <I>provided </I>that such designation will be
deemed to be an incurrence of Indebtedness by a Restricted Subsidiary of the Company of any
outstanding Indebtedness of such Unrestricted Subsidiary, and such designation will only be
permitted if (1)(a) such Indebtedness is permitted under Section&nbsp;4.04, or (b)&nbsp;the Fixed Charge
Coverage Ratio would be greater than such ratio immediately prior to such designation, in each
case, calculated on a pro forma basis as if such designation had occurred at the beginning of the
applicable reference period; and (2)&nbsp;no Default or Event of Default would occur and be continuing
following such designation.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;4.13 <I>Changes in Covenants when Notes Are Rated Investment Grade.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If on any date following the date of this Supplemental Indenture:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Notes are rated Investment Grade; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;no Default or Event of Default shall have occurred and be continuing,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then, beginning on that day (the &#147;<B><I>Fall Away Date</I></B>&#148;) and continuing at all times thereafter
regardless of any subsequent changes in the rating of the Notes, the sections specifically listed
below will permanently cease to be in effect with respect to the Notes:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Section&nbsp;4.02 (Restricted Payments);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.03 (Dividend and Other Payment Restrictions Affecting Restricted
Subsidiaries);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Section&nbsp;4.04 (Incurrence of Indebtedness and Issuance of Preferred Stock);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Section&nbsp;4.05 (Asset Sales);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Section&nbsp;4.06 (Transactions with Affiliates);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Section&nbsp;4.09 (No Layering of Debt);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Section&nbsp;4.10 (Additional Note Guarantees);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Section&nbsp;4.11 (Payments for Consent);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Section&nbsp;4.12 (Designation of Restricted and Unrestricted Subsidiaries); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Clause (4)&nbsp;of Section&nbsp;5.01;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the Fall Away Date, the Note Guarantees of each of the Guarantors will be automatically
released. The Company will deliver to the Trustee within five Business Days of the occurrence of
the Fall Away Date an Officers&#146; Certificate specifying the date on which the Fall Away Date has
occurred. The Trustee shall have no independent obligation to determine if the Fall Away Date has
occurred or commenced or to notify Holders regarding the same.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 5.<BR>
SUCCESSORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;5.01 <I>Merger, Consolidation or Sale of Assets</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions in Article&nbsp;V of the Original Indenture shall not apply with respect to the
Notes, and this Article&nbsp;5 supersedes the entirety thereof. <br><br style="font-size: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will not, directly or
indirectly: (1)&nbsp;consolidate or merge with or into another Person (whether or not the Company is the
surviving corporation), or (2)&nbsp;sell, assign, transfer, convey or otherwise dispose of all or
substantially all of the properties or assets of the Company and its Restricted Subsidiaries taken
as a whole, in one or more related transactions, to another Person, unless:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;either:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) the Company is the surviving corporation; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the Person formed by or surviving any such consolidation or merger (if other
than the Company) or to which such sale, assignment, transfer, conveyance or other disposition has
been made is an entity organized or existing under the laws of the United States, any state of the
United States or the District of Columbia; and, if such entity is not a corporation, a co-obligor
of the Notes is a corporation organized or existing under any such laws;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Person formed by or surviving any such consolidation or merger (if other than the
Company) or the Person to which such sale, assignment, transfer, conveyance or other disposition
has been made assumes all the obligations of the Company under the Notes and the Indenture pursuant
to a supplemental indenture substantially in the form attached hereto as Exhibit B or other documents
or instruments;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;immediately after such transaction, no Default or Event of Default exists; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;on the date of such transaction after giving pro forma effect thereto and any related
financing transactions as if the same had occurred at the beginning of the applicable four-quarter
period, either:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) the Company or the Person formed by or surviving any such consolidation or
merger (if other than the Company), or to which such sale, assignment, transfer, conveyance or
other disposition has been made would be permitted to incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section&nbsp;4.04(a) or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the Fixed Charge Coverage Ratio for the Company or the Person formed by or
surviving any such consolidation or merger (if other than the Company), or to which such sale,
assignment, transfer, conveyance or other disposition has been made, would be greater as a result
of such transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company will not, directly or indirectly, lease all or substantially all of
the properties and assets of it and its Restricted Subsidiaries taken as a whole, in one or more
related transactions, to any other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Section&nbsp;5.01 will not apply to any sale, assignment, transfer, conveyance, lease or other
disposition of assets between or among the Company and its Restricted Subsidiaries. Clauses (3)
and (4)&nbsp;of Section&nbsp;5.01 will not apply to (1)&nbsp;any merger or consolidation, or any sale,
assignment, transfer, conveyance, lease or other disposition of assets between or among the Company
with or into one of its Restricted Subsidiaries for any purpose or (2)&nbsp;with or into an Affiliate
solely for the purpose of reincorporating the Company in another jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;5.02 <I>Successor Corporation Substituted.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case of any such consolidation, merger, sale, conveyance, transfer or other disposition set
forth in Section&nbsp;5.01, in which the Company is not the person formed by or surviving such
consolidation or merger or to which such sale, conveyance, transfer or other dispositions (the
&#147;<B><I>Successor Company</I></B>&#148;) and upon the assumption by the Successor Company by supplemental indenture
executed and delivered to the Trustee of the due and punctual payment of the principal of and
interest on all of the Notes, and the due and punctual performance and observance of all of the
covenants and conditions of the Indenture to be
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">performed or satisfied by the Company, such Successor Company shall succeed to, and be
substituted for, and may exercise every right and power of, the Company under the Indenture, with
the same effect as if it had been named herein as the party of this first part, and the Company
shall be discharged from its obligations under the Notes and the Indenture, except in the case of
any such lease. Such Successor Company thereupon may cause to be signed, and may issue either in
its own name or in the name of the Company any or all of the Notes, issuable hereunder that
theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the
order of such Successor Company instead of the Company and subject to all the terms, conditions and
limitations in the Indenture prescribed, the Trustee shall authenticate and shall deliver, or cause
to be authenticated and delivered, any Notes that previously shall have been signed and delivered
by the officers of the Company to the Trustee for authentication, and any Notes that such Successor
Company thereafter shall cause to be signed and delivered to the Trustee for that purpose. All the
Notes so issued shall in all respects have the same legal rank and benefit under the Indenture as
the Notes theretofore or thereafter issued in accordance with the terms of this Supplemental
Indenture as though all of such Notes had been issued at the date of the execution hereof. In the
event of any such consolidation, merger, sale, conveyance, transfer or other disposition upon
compliance with this Article&nbsp;5 the person named as the &#147;Company&#148; in the first paragraph of this
Supplemental Indenture or any successor that shall thereafter have become such in the manner
prescribed in this Article&nbsp;5 may be dissolved, wound up and liquidated at any time thereafter and
such person shall be discharged from its liabilities as obligor and maker of the Notes and from its
obligations under the Indenture with respect to the Notes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;5.03 <I>Opinion of Counsel to Be Given to Trustee</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to execution of any supplemental indenture pursuant to this Article&nbsp;5, the Trustee shall
receive an Officers&#146; Certificate and an Opinion of Counsel in accordance with Section&nbsp;12.4 of the
Original Indenture as conclusive evidence that consolidation, merger, sale, conveyance, transfer,
lease or other disposition set forth in Section&nbsp;5.01 and any such assumption complies with the
provisions of this Article&nbsp;5.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 6.<BR>
DEFAULT AND REMEDIES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.01 <I>Events of Default</I>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sections&nbsp;6.7, 6.9, 6.10 and 6.11 in Article&nbsp;VI of the Original Indenture shall apply with
respect to the Notes, and this Article&nbsp;6 supersedes the remaining sections thereof. <br><br style="font-size: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the
following events shall be an &#147;<B>Event of Default</B>&#148; wherever used herein with respect to the Notes,
and, except to the extent set forth in this Section&nbsp;6.01, the Notes shall not have the benefit of
any &#147;Event of Default&#148; specified in Section&nbsp;6.1 of the Original Indenture:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;default for 30&nbsp;days in the payment when due of interest, if any, on the Notes, whether or
not prohibited by Article&nbsp;12;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;default in the payment when due (at maturity, upon redemption or otherwise) of the
principal of, or premium, if any, on, the Notes, whether or not prohibited by Article&nbsp;12;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;prior to the Fall Away Date, and, to the extent applicable after the Fall Away Date,
failure by the Company or any of its Restricted Subsidiaries to comply with the provisions
described under Article&nbsp;5 for 30&nbsp;days after notice to the Company by the Trustee or the Holders of
at least 25% in aggregate principal amount of the Notes then outstanding;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;prior to the Fall Away Date, failure by the Company or any of its Restricted Subsidiaries
to comply with Section&nbsp;4.02 or Section&nbsp;4.04 for 30&nbsp;days after notice to the Company by the Trustee
or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;failure by the Company or any of its Restricted Subsidiaries for 60&nbsp;days after notice to
the Company by the Trustee or the Holders of at least 25% in aggregate principal amount of the
Notes then outstanding to comply with any of the other agreements in the Indenture;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;default with respect to any mortgage, agreement or other instrument under which there may
be outstanding, or by which may be secured or evidenced any Indebtedness for money borrowed in
excess of $50.0&nbsp;million in the aggregate by the Company or any of its Restricted Subsidiaries,
whether such Indebtedness or Guarantee now exists, or is created after the date of this
Supplemental Indenture, if that default:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) constitutes a failure to pay the principal or interest of any such
Indebtedness or Guarantee when due and payable at its stated maturity, upon required
repurchase, upon declaration or otherwise; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) results in such Indebtedness becoming or being declared due and payable;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;failure by the Company or any of its Restricted Subsidiaries to pay final judgments
entered by a court or courts of competent jurisdiction aggregating in excess of $50.0&nbsp;million,
which judgments are not paid, discharged or stayed, for a period of 60&nbsp;days;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;except as permitted by the Indenture, any Note Guarantee is held in any judicial
proceeding to be unenforceable or invalid or ceases for any reason to be in full force and effect,
or any Guarantor, or any Person acting on behalf of any Guarantor, denies or disaffirms its
obligations under its Note Guarantee;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)&nbsp;the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary or any
group of Restricted Subsidiaries of the Company that, taken together, would constitute a
Significant Subsidiary:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) commences a voluntary case,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) consents to the entry of an order for relief against it in an involuntary
case,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) consents to the appointment of a custodian of it or for all or
substantially all of its property,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) makes a general assignment for the benefit of its creditors, or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) generally is not paying its debts as they become due; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10) a court of competent jurisdiction enters an order or decree under any Bankruptcy
Law that:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) is for relief against the Company or any of its Restricted Subsidiaries
that is a Significant Subsidiary or any group of Restricted Subsidiaries of the Company that,
taken together, would constitute a Significant Subsidiary in an involuntary case;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) appoints a custodian of the Company or any of its Restricted Subsidiaries
that is a Significant Subsidiary or any group of Restricted Subsidiaries of the Company that,
taken together, would constitute a Significant Subsidiary or for all or substantially all of
the property of the Company or any of its Restricted Subsidiaries that is a Significant
Subsidiary or any group of Restricted Subsidiaries of the Company that, taken together, would
constitute a Significant Subsidiary; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) orders the liquidation of the Company or any of its Restricted
Subsidiaries that is a Significant Subsidiary or any group of Restricted Subsidiaries of the
Company that, taken together, would constitute a Significant Subsidiary;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and the order or decree remains unstayed and in effect for 60 consecutive days.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.02 <I>Acceleration.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the case of an Event of Default specified in clause (9)&nbsp;or (10)&nbsp;of Section&nbsp;6.01, with
respect to the Company, any Restricted Subsidiary of the Company that is a Significant Subsidiary
or any group of Restricted Subsidiaries of the Company that, taken together, would constitute a
Significant Subsidiary, all outstanding Notes will become due and payable immediately without
further action or notice. If any other Event of Default occurs and is continuing, the Trustee or
the Holders of at least 25% in aggregate principal amount of the then outstanding Notes may declare
all the Notes to be due and payable immediately. Upon any such declaration, the Notes shall become
due and payable immediately.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Holders of a majority in aggregate principal amount of the then outstanding Notes by
written notice to the Trustee may, on behalf of all of the Holders of all the Notes, rescind an
acceleration and its consequences under the Indenture, if the rescission would not conflict with
any judgment or decree, except a continuing Default or Event of Default in the payment of principal
of, premium on, if any, or interest, if any, on the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.03 <I>Other Remedies.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy
to collect the payment of principal of, premium on, if any, or interest, if any, on, the Notes or
to enforce the performance of any provision of the Notes or the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not
produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Note
in exercising any right or remedy accruing upon an Event of Default shall not impair the right or
remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are
cumulative to the extent permitted by law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.04 <I>Waiver of Past Defaults</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Holders of a majority in aggregate principal amount of the then outstanding Notes by
written notice to the Trustee may, on behalf of the Holders of all of the Notes waive any existing
Default or Event of Default and its consequences hereunder, except a continuing Default or Event of
Default in the payment of principal of, premium on, if any, or interest, if any, on, the Notes
(including in connection
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with an offer to purchase); <I>provided, however</I>, that the Holders of a
majority in aggregate principal amount of the then outstanding Notes may rescind an acceleration
and its consequences, including any related payment default that resulted from such acceleration.
Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom
shall be deemed to have been cured for every purpose of the Indenture with respect to the Notes;
but no such waiver shall extend to any subsequent or other Default or impair any right consequent
thereon.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any Event of Default specified in Section&nbsp;6.01(6), such Event of Default and
all consequences thereof (excluding any resulting payment default, other than as a result of
acceleration of the Notes) shall be annulled, waived and rescinded, automatically and without any
action by the Trustee or the Holders, if within 20&nbsp;days after such Event of Default arose: (1)&nbsp;the
Indebtedness or Note Guarantee that is the basis for such Event of Default has been discharged; or
(2)&nbsp;Holders thereof have rescinded or waived the acceleration, notice or action (as the case may
be) giving rise to such Event of Default; or (3)&nbsp;the default that is the basis for such Event of
Default has been cured.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.05 <I>Control by Majority</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of a majority in principal amount of the then outstanding Notes may direct the time,
method and place of conducting any proceeding for exercising any remedy available to the Trustee or
of exercising any trust or power conferred on it. The Trustee, however, may refuse to follow any
direction that conflicts with law or the Indenture that the Trustee determines is unduly
prejudicial to the rights of any other Holders of a Note or that could result in personal liability
for the Trustee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.06 <I>Limitation on Suits</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case an Event of Default occurs and is continuing, the Trustee will be under no obligation
to exercise any of the rights or powers under the Indenture at the request or direction of any
Holders of Notes unless such Holders have offered to the Trustee indemnity or security satisfactory
to the Trustee against any loss, liability or expense. Except to enforce the right to receive
payment of principal, premium, if any, or interest, if any, when due, no Holder of a Note may
pursue any remedy with respect to the Indenture or the Notes unless:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>such Holder has previously given the Trustee written notice that an Event of Default is
continuing;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Holders of at least 25% in aggregate principal amount of the then outstanding Notes make a
written request to the Trustee to pursue the remedy;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>such Holder or Holders offer and, if requested, provide to the Trustee security or indemnity
reasonably satisfactory to the Trustee against any loss, liability or expense;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" nowrap align="left">(4)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Trustee does not comply with such request within 60&nbsp;days after receipt of the request and
the offer of security or indemnity; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" nowrap align="left">(5)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>during such 60-day period, Holders of a majority in aggregate principal amount of the then
outstanding Notes do not give the Trustee a direction inconsistent with such request.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;6.07 <I>Collection Suit by Trustee.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an Event of Default specified in Section&nbsp;6.01(1) or (2)&nbsp;hereof occurs and is continuing,
the Trustee is authorized to recover judgment in its own name and as trustee of an express trust
against the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->57<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company for the whole amount of principal of, premium on, if any, and interest, if any,
remaining unpaid on, the Notes and interest on overdue principal and, to the extent lawful,
interest and such further amount as shall be sufficient to cover the costs and expenses of
collection, including the reasonable compensation, expenses, disbursements and advances of the
Trustee, its agents and counsel.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 7.<BR>
LEGAL DEFEASANCE AND COVENANT DEFEASANCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.01 <I>Option to Effect Legal Defeasance or Covenant Defeasance.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions in Article&nbsp;VIII of the Original Indenture shall not apply with respect to the
Notes, and this Article&nbsp;7 supersedes the entirety thereof. The Company may at any time, at the
option of its Board of Directors evidenced by a resolution set forth in an Officers&#146; Certificate,
elect to have either Section&nbsp;7.02 or 7.03 hereof be applied to all outstanding Notes upon
compliance with the conditions set forth below in this Article&nbsp;7.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.02 <I>Legal Defeasance and Discharge.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the Company&#146;s exercise under Section&nbsp;7.01 hereof of the option applicable to this Section
7.02, the Company and each of the Guarantors will, subject to the satisfaction of the conditions
set forth in Section&nbsp;7.04 hereof, be deemed to have been discharged from their obligations with
respect to all outstanding Notes (including the Note Guarantees) on the date the conditions set
forth below are satisfied (hereinafter, &#147;<B><I>Legal Defeasance</I></B>&#148;). For this purpose, Legal Defeasance
means that the Company and the Guarantors will be deemed to have paid and discharged the entire
Indebtedness represented by the outstanding Notes (including the Note Guarantees), which will
thereafter be deemed to be &#147;outstanding&#148; only for the purposes of Section&nbsp;7.05 hereof and the other
Sections of this Supplemental Indenture referred to in clauses (1)&nbsp;and (2)&nbsp;below, and to have
satisfied all their other obligations under such Notes, the Note Guarantees and the Indenture (and
the Trustee, on demand of and at the expense of the Company, shall execute proper instruments
acknowledging the same), except for the following provisions which will survive until otherwise
terminated or discharged hereunder:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;the rights of Holders of outstanding Notes to receive payments in respect of the principal
of, premium on, if any, or interest, if any, on, such Notes when such payments are due from the
trust referred to below;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;the Company&#146;s obligations with respect to the Notes concerning issuing temporary Notes,
registration of Notes, mutilated, destroyed, lost or stolen Notes and the maintenance of an office
or agency for payment and money for security payments held in trust;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the rights, powers, trusts, duties and immunities of the Trustee under the Indenture, and
the Company&#146;s and the Guarantors&#146; obligations in connection therewith; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;this Article&nbsp;7.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to compliance with this Article&nbsp;7, the Company may exercise its option under this
Section&nbsp;7.02 notwithstanding the prior exercise of its option under Section&nbsp;7.03 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.03 <I>Covenant Defeasance.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the Company&#146;s exercise under Section&nbsp;7.01 hereof of the option applicable to this Section
7.03, the Company and each of the Guarantors will, subject to the satisfaction of the conditions
set forth
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->58<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in Section&nbsp;7.04 hereof, be released from each of their obligations under the covenants
contained in Sections&nbsp;4.01, 4.02, 4.03, 4.04, 4.05, 4.06, 4.07,
4.08, 4.09, 4.10, 4.11, 4.12 and  4.13
 hereof, clause (4)&nbsp;of Section&nbsp;5.01 hereof and Sections&nbsp;4.3, 4.5, 4.6 and 4.7 of the
Original Indenture, in each case with respect to the outstanding Notes on and after the date the
conditions set forth in Section&nbsp;7.04 hereof are satisfied (hereinafter, &#147;<B><I>Covenant Defeasance</I></B>&#148;), and
the Notes will thereafter be deemed not &#147;outstanding&#148; for the purposes of any direction, waiver,
consent or declaration or act of Holders (and the consequences of any thereof) in connection with
such covenants, but will continue to be deemed &#147;outstanding&#148; for all other purposes hereunder (it
being understood that such Notes will not be deemed outstanding for accounting purposes). For this
purpose, Covenant Defeasance means that, with respect to the outstanding Notes and Note Guarantees,
the Company and the Guarantors may omit to comply with and will have no liability in respect of any
term, condition or limitation set forth in any such covenant, whether directly or indirectly, by
reason of any reference elsewhere herein to any such covenant or by reason of any reference in any
such covenant to any other provision herein or in any other document and such omission to comply
will not constitute a Default or an Event of Default under Section&nbsp;6.01 hereof, but, except as
specified above, the remainder of the Indenture and such Notes and Note Guarantees will be
unaffected thereby. In addition, upon the Company&#146;s exercise under Section&nbsp;7.01 hereof of the
option applicable to this Section&nbsp;7.03, subject to the satisfaction of the conditions set forth in
Section&nbsp;7.04 hereof, Sections&nbsp;6.01 (4), (5), (6), (7)&nbsp;and (8)&nbsp;hereof will not constitute Events of
Default.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.04 <I>Conditions to Legal or Covenant Defeasance.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to exercise either Legal Defeasance or Covenant Defeasance under either Section&nbsp;7.02
or 7.03 hereof:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of
the Holders, cash in U.S. dollars, non-callable Government Securities, or a combination
thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized
investment bank, appraisal firm or firm of independent public accountants, to pay the
principal of, premium on, if any, and interest, if any, on, the outstanding Notes on the
stated date for payment thereof or on the applicable redemption date, as the case may be,
and the Company must specify whether the Notes are being defeased to such stated date for
payment or to a particular redemption date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) in the case of Legal Defeasance, the Company must deliver to the Trustee an Opinion
of Counsel confirming that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) the Company has received from, or there has been published by,
the Internal Revenue Service a ruling; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) since the date of this Supplemental Indenture, there has been a
change in the applicable federal income tax law (or official interpretation
thereof),
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">in either case to the effect that, and based thereon such Opinion of Counsel shall confirm
that, the Holders of the outstanding Notes will not recognize income, gain or loss for
federal income tax purposes as a result of such Legal Defeasance and will be subject to
federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such Legal Defeasance had not occurred;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) in the case of Covenant Defeasance, the Company must deliver to the Trustee an
Opinion of Counsel confirming that the Holders of the outstanding Notes will not recognize
income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance
and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->59<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">will be subject to federal income tax on the same amounts, in the same manner and at the
same times as would have been the case if such Covenant Defeasance had not occurred;
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) no Default or Event of Default shall have occurred and is continuing on the date of
such deposit (other than a Default or Event of Default resulting from the borrowing of funds
to be applied to such deposit (and any similar concurrent deposit relating to other
Indebtedness), and the granting of Liens to secure such borrowings);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) such Legal Defeasance or Covenant Defeasance will not result in a breach or
violation of, or constitute a default under, any material agreement or instrument (other
than the Indenture and the agreements governing any other Indebtedness being defeased,
discharged or replaced) to which the Company or any of the Guarantors is a party or by which
the Company or any of the Guarantors is bound (other than a Default or Event of Default
resulting from the borrowing of funds to be applied to such deposit (and any similar
concurrent deposit relating to other Indebtedness) and the granting of Liens to secure such
borrowings);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) the Company must deliver to the Trustee an Officers&#146; Certificate stating that the
deposit was not made by the Company with the intent of preferring the Holders of Notes over
the other creditors of the Company with the intent of defeating, hindering, delaying or
defrauding any creditors of the Company or others; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) the Company must deliver to the Trustee an Officers&#146; Certificate and an Opinion of
Counsel, each stating that all conditions precedent relating to the Legal Defeasance or the
Covenant Defeasance have been complied with.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.05 <I>Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous
Provisions.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;7.06 hereof, all money and non-callable Government Securities (including
the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for
purposes of this Section&nbsp;7.05, the &#147;<B><I>Trustee</I></B>&#148;) pursuant to Section&nbsp;7.04 hereof in respect of the
outstanding Notes will be held in trust and applied by the Trustee, in accordance with the
provisions of such Notes and the Indenture, to the payment, either directly or through any Paying
Agent (including the Company acting as Paying Agent) as the Trustee may determine, to the Holders
of such Notes of all sums due and to become due thereon in respect of principal, premium, if any,
and interest, if any, but such money need not be segregated from other funds except to the extent
required by law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will pay and indemnify the Trustee against any tax, fee or other charge imposed on
or assessed against the cash or non-callable Government Securities (as defined in the Original
Indenture) deposited pursuant to Section&nbsp;7.04 hereof or the principal and interest received in
respect thereof other than any such tax, fee or other charge which by law is for the account of the
Holders of the outstanding Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Article&nbsp;7 to the contrary, the Trustee will deliver or pay to
the Company from time to time upon the request of the Company any money or non-callable Government
Securities held by it as provided in Section&nbsp;7.04 hereof which, in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof
delivered to the Trustee (which may be the opinion delivered under Section&nbsp;7.04(1) hereof), are in
excess of the amount thereof
that would then be required to be deposited to effect an equivalent Legal Defeasance or
Covenant Defeasance.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->60<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.06 <I>Repayment to Company.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the requirements of applicable law, any monies deposited with or paid to the
Trustee for payment of the principal of or interest, if any, on the Notes and not applied but
remaining unclaimed by the Holders of the Notes for two years after the date upon which the
principal of or interest, if any, on such Notes, as the case may be, shall have become due and
payable, shall be repaid to the Company by the Trustee on demand, and all liability of the Trustee
shall thereupon cease with respect to such monies; and the Holder of any of the Notes shall
thereafter look only to the Company for any payment or delivery that such Holder of the Notes may
be entitled to collect unless an applicable abandoned property law designates another person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;7.07 <I>Reinstatement.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Trustee or Paying Agent is unable to apply any U.S. dollars or non-callable Government
Securities in accordance with Section&nbsp;7.02 or 7.03 hereof, as the case may be, by reason of any
order or judgment of any court or governmental authority enjoining, restraining or otherwise
prohibiting such application, then the Company&#146;s and the Guarantors&#146; obligations under the
Indenture and the Notes and the Note Guarantees will be revived and reinstated as though no deposit
had occurred pursuant to Section&nbsp;7.02 or 7.03 hereof until such time as the Trustee or Paying Agent
is permitted to apply all such money in accordance with Section&nbsp;7.02 or 7.03 hereof, as the case
may be; <I>provided, however</I>, that, if the Company makes any payment of principal of, premium on, if
any, or interest, if any, on, any Note following the reinstatement of its obligations, the Company
will be subrogated to the rights of the Holders of such Notes to receive such payment from the
money held by the Trustee or Paying Agent.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 8.<BR>
SATISFACTION AND DISCHARGE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.01 <I>Satisfaction and Discharge of the Supplemental Indenture</I>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Articles VIII and XI of the Original Indenture shall not apply to the Notes. Instead, the
satisfaction and discharge provisions set forth in this Article&nbsp;8 shall, with respect to the Notes,
supersede in their entirety Articles VIII and XI of the Original Indenture, and all references in
the Original Indenture to Articles VIII and XI thereof and satisfaction and discharge provisions
therein, as the case may be, shall, with respect to the Notes, be deemed to be references to this
Article&nbsp;9 and the satisfaction and discharge provisions set forth in this Article&nbsp;8, respectively.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indenture will be discharged with respect to the Notes and will cease to be of further
effect as to all Notes issued hereunder, when:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;either:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all Notes that have been authenticated, except lost, stolen or destroyed
Notes that have been replaced or paid and Notes for whose payment money has been deposited in
trust and thereafter repaid to the Company, have been delivered to the Trustee for
cancellation; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) all Notes that have not been delivered to the Trustee for cancellation
have become due and payable by reason of the mailing of a notice of redemption or otherwise
or will become due and payable within one year or are to be called for redemption within one
year and the Company or any Guarantor has irrevocably deposited or caused to be deposited
with the Trustee as trust funds in trust solely for the benefit of the Holders, cash in U.S.
dollars,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->61<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">non-callable Government Securities, or a combination thereof, in amounts as will be
sufficient, without consideration of any reinvestment of interest, to pay and discharge the
entire Indebtedness on the Notes not delivered to the Trustee for cancellation for principal
of, premium on, if any, and interest, if any, on, the Notes to the date of maturity or
redemption;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;in respect of clause 1(b), no Default or Event of Default has occurred and is continuing
on the date of the deposit (other than a Default or Event of Default resulting from the borrowing
of funds to be applied to such deposit and any similar deposit relating to other Indebtedness and,
in each case, the granting of Liens to secure such borrowings) and the deposit will not result in a
breach or violation of, or constitute a default under, any other material instrument to which the
Company or any Guarantor is a party or by which the Company or any Guarantor is bound (other than
with respect to the borrowing of funds to be applied concurrently to make the deposit required to
effect such satisfaction and discharge and any similar concurrent deposit relating to other
Indebtedness, and in each case the granting of Liens to secure such borrowings);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;the Company or any Guarantor has paid or caused to be paid all sums payable by it under
the Indenture with respect to the Notes; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;the Company has delivered irrevocable instructions to the Trustee under the Indenture to
apply the deposited money toward the payment of the Notes at maturity or on the redemption date, as
the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company must deliver an Officers&#146; Certificate and an Opinion of Counsel to
the Trustee stating that all conditions precedent to satisfaction and discharge have been
satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the satisfaction and discharge of the Indenture, if money has been deposited
with the Trustee pursuant to subclause (b)&nbsp;of clause (1)&nbsp;of this Section&nbsp;8.01, the provisions of
Sections&nbsp;8.02 and 7.06 hereof will survive. In addition, nothing in this Section&nbsp;8.01 will be
deemed to discharge those provisions of Section&nbsp;7.7 of the Original Indenture, that, by their
terms, survive the satisfaction and discharge of the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;8.02 <I>Application of Trust Money.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section&nbsp;7.06 hereof, all money deposited with the Trustee
pursuant to Section&nbsp;8.01 hereof shall be held in trust and applied by it, in accordance with the
provisions of the Notes and the Indenture, to the payment, either directly or through any Paying
Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the
Persons entitled thereto, of the principal, premium, if any, and interest, if any, for whose
payment such money has been deposited with the Trustee; but such money need not be segregated from
other funds except to the extent required by law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Trustee or Paying Agent is unable to apply any money or Government Securities in
accordance with Section&nbsp;8.01 hereof by reason of any legal proceeding or by reason of any order or
judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting
such application, the Company&#146;s and any Guarantor&#146;s obligations under the Indenture and the Notes
shall be revived and reinstated as though no deposit had occurred pursuant to Section&nbsp;8.01 hereof;
<I>provided </I>that if the Company has made any payment of principal of, premium on, if any, or interest,
if any, on, any Notes
because of the reinstatement of its obligations, the Company shall be subrogated to the rights
of the Holders of such Notes to receive such payment from the money or Government Securities held
by the Trustee or Paying Agent.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->62<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 9.<BR>
NOTE GUARANTEES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.01 <I>Guarantee.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to this Article&nbsp;9, each of the Guarantors hereby, jointly and severally,
unconditionally guarantees to each Holder of a Note authenticated and delivered by the Trustee and
to the Trustee and its successors and assigns, irrespective of the validity and enforceability of
the Indenture, the Notes or the obligations of the Company hereunder or thereunder, that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) the principal of, premium on, if any, and interest, if any, on, the Notes will be
promptly paid in full when due, whether at maturity, by acceleration, redemption or
otherwise, and interest on the overdue principal of, premium on, if any, and interest, if
any, on, the Notes, if lawful, and all other obligations of the Company to the Holders or
the Trustee hereunder or thereunder will be promptly paid in full or performed, all in
accordance with the terms hereof and thereof; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) in case of any extension of time of payment or renewal of any Notes or any of such
other obligations, that same will be promptly paid in full when due or performed in
accordance with the terms of the extension or renewal, whether at stated maturity, by
acceleration or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Failing payment when due of any amount so guaranteed or any performance so guaranteed for
whatever reason, the Guarantors will be jointly and severally obligated to pay the same
immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of
collection.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Guarantors hereby agree that their obligations hereunder are unconditional,
irrespective of the validity, regularity or enforceability of the Notes or the Indenture, the
absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with
respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any
action to enforce the same or any other circumstance which might otherwise constitute a legal or
equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence,
presentment, demand of payment, filing of claims with a court in the event of insolvency or
bankruptcy of the Company, any right to require a proceeding first against the Company, protest,
notice and all demands whatsoever and covenant that this Note Guarantee will not be discharged
except by complete performance of the obligations contained in the Notes and the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If any Holder or the Trustee is required by any court or otherwise to return to
the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting
in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or
such Holder, this Note Guarantee, to the extent theretofore discharged, will be reinstated in full
force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each Guarantor agrees that it will not be entitled to any right of subrogation
in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of
all obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors,
on the one hand, and the Holders and the Trustee, on the other hand, (1)&nbsp;the maturity of the
obligations guaranteed hereby may be accelerated as provided in Article&nbsp;6 hereof for the purposes
of such Guarantor&#146;s Note Guarantee,
notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the obligations guaranteed hereby, and (2)&nbsp;in the event of any declaration of
acceleration of such obligations as provided in Article&nbsp;6 hereof, such obligations (whether or not
due and payable) will forthwith become due and payable by the Guarantors for the purpose of such
Guarantor&#146;s Note Guarantee. The Guarantors
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->63<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">will have the right to seek contribution from any
non-paying Guarantor so long as the exercise of such right does not impair the rights of the
Holders under the Note Guarantee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;9.02 <I>Subordination of Note Guarantee.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Obligations of each Guarantor under its Note Guarantee pursuant to this Article&nbsp;9 will be
junior and subordinated to the Senior Debt of such Guarantor on the same basis as the Notes are
junior and subordinated to Senior Debt of the Company. For the purposes of the foregoing sentence,
the Trustee and the Holders will have the right to receive and/or retain payments by any of the
Guarantors only at such times as they may receive and/or retain payments in respect of the Notes
pursuant to the Indenture, including Article&nbsp;12 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;9.03 <I>Limitation on Guarantor Liability.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the
intention of all such parties that the Note Guarantee of such Guarantor not constitute a fraudulent
transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the
Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any
Note Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors
hereby irrevocably agree that the obligations of such Guarantor will be limited to the maximum
amount that will, after giving effect to such maximum amount and all other contingent and fixed
liabilities of such Guarantor that are relevant under such laws, and after giving effect to any
collections from, rights to receive contribution from or payments made by or on behalf of any other
Guarantor in respect of the obligations of such other Guarantor under this Article&nbsp;9, result in the
obligations of such Guarantor under its Note Guarantee not constituting a fraudulent transfer or
conveyance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;9.04 <I>Execution and Delivery.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To evidence its Note Guarantee set forth in Section&nbsp;9.01 hereof, each Guarantor hereby agrees
that this Supplemental Indenture will be executed on behalf of such Guarantor by one of its
Officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Guarantor hereby agrees that its Note Guarantee set forth in Section&nbsp;9.01 hereof will
remain in full force and effect notwithstanding the absence of the endorsement of any notation of
such Guarantee on the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an Officer whose signature is on this Supplemental Indenture no longer holds that office at
the time the Trustee authenticates the Notes, the Note Guarantee will be valid nevertheless.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The delivery of any Note by the Trustee, after the authentication thereof hereunder, will
constitute due delivery of the Note Guarantee set forth in this Supplemental Indenture on behalf of
the Guarantors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Company or any of its Restricted Subsidiaries creates or acquires any
Domestic Subsidiary after the date of this Supplemental Indenture, if required by Section&nbsp;4.10
hereof, the Company will cause such Domestic Subsidiary to comply with the provisions of Section
4.10 hereof and this Article&nbsp;9, to the extent applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;9.05 <I>Guarantors May Consolidate, etc., on Certain Terms.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Guarantor may sell or otherwise dispose of all or substantially all of its assets to, or
consolidate with or merge with or into (whether or not such Guarantor is the surviving Person)
another Person, other than the Company or another Guarantor, unless:
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->64<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) immediately after giving effect to such transaction, no Default or Event of
Default exists; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) either:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Person acquiring the property in any such sale or disposition or the
Person formed by or surviving any such consolidation or merger unconditionally assumes all
the obligations of that Guarantor under its Note Guarantee and the Indenture pursuant to a
supplemental indenture substantially in the form attached hereto as Exhibit&nbsp;B ; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Net Proceeds of such sale or other disposition are applied in
accordance with Section&nbsp;4.05 hereof, to the extent applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In case of any such consolidation, merger, sale or conveyance and upon the assumption by the
successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory
in form to the Trustee, of the due and punctual performance of all of the covenants and conditions
of the Indenture to be performed by the Guarantor, such successor Person will succeed to and be
substituted for the Guarantor with the same effect as if it had been named herein as a Guarantor.
All the Note Guarantees so issued will in all respects have the same legal rank and benefit under
the Indenture as the Note Guarantees theretofore and thereafter issued in accordance with the terms
of the Indenture as though all of such Note Guarantees had been issued at the date of the execution
hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in Articles 4 and 5 hereof, and notwithstanding clauses 2(a) and (b)
above, nothing contained in the Indenture or in any of the Notes will prevent any consolidation or
merger of a Guarantor with or into the Company or another Guarantor, or will prevent any sale or
conveyance of the property of a Guarantor as an entirety or substantially as an entirety to the
Company or another Guarantor.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;9.06 <I>Releases.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Note Guarantee of a Guarantor will be automatically released:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;in connection with any sale or other disposition of all or substantially all of the assets
of that Guarantor, by way of merger, consolidation or otherwise, to a Person that is not (either
before or after giving effect to such transaction) the Company or a Restricted Subsidiary of the
Company, if the sale or other disposition does not violate
Section&nbsp;4.05;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;in connection with any sale or other disposition of Capital Stock of that Guarantor to a
Person that is not (either before or after giving effect to such transaction) the Company or a
Restricted Subsidiary of the Company, if the sale or other disposition does not violate Section
4.05 and the Guarantor ceases to be a Restricted Subsidiary of the Company as a result of the sale
or other disposition;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;if the Company designates any Restricted Subsidiary that is a Guarantor to be an
Unrestricted Subsidiary in accordance with the provisions of the Indenture described under Section
4.12;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;with respect to any Guarantor that, as of the date of this Supplemental Indenture, is a
guarantor or other obligor with respect to any Indebtedness under any Credit Facility, if that
Guarantor ceases to be a guarantor or other obligor with respect to any such Indebtedness;
<I>provided</I>, <I>however</I>, that if, at any time following such release, that Guarantor subsequently
guarantees or otherwise becomes an obligor with respect to any Indebtedness under a Credit
Facility, then that Guarantor will be required to provide a Note Guarantee at such time;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->65<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;with respect to any Guarantor that, as of the date of this Supplemental Indenture, is not
a guarantor or other obligor with respect to any Indebtedness under any Credit Facility, in
connection with any sale or other disposition of all or substantially all of the assets of that
Guarantor, by way of merger, consolidation or otherwise, to any Restricted Subsidiary that is not a
Guarantor;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;upon legal defeasance, covenant defeasance or satisfaction and discharge of the Indenture
as provided in Article&nbsp;7 and Article&nbsp;8; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;on the Fall Away Date.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 10.<BR>
SUPPLEMENTAL INDENTURES</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section 10.01 <I>Supplemental Indentures Without Consent of Holders</I>. In lieu of Section&nbsp;9.1 of the Original
Indenture, the Company, the Guarantors and the Trustee may amend or supplement the Indenture, the
Notes or the Note Guarantees without notice to or the consent of any Holder of the Notes to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;to cure any ambiguity, defect or inconsistency;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;to provide for uncertificated Notes in addition to or in place of Physical
Notes;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;to provide for the assumption of the Company&#146;s or a Guarantor&#146;s obligations to
Holders of Notes and Note Guarantees in the case of a merger or consolidation or sale of all or
substantially all of the Company&#146;s or such Guarantor&#146;s assets, as applicable;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;to make any change that would provide any additional rights or benefits to the
Holders of Notes or that does not adversely affect the legal rights under the Indenture of any
Holder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;to comply with requirements of the SEC in order to effect or maintain the
qualification of the Indenture under the Trust Indenture Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;to conform this Supplemental Indenture, the Notes and the Note Guarantees and
the form or terms of the Notes to the &#147;Description of Notes&#148; section as set forth in the final
prospectus supplement related to the offering and sale of the Notes dated June&nbsp;8, 2011 to the
extent that such description was intended to be a verbatim recitation of a provision in the
Indenture, the Notes or the Note Guarantees, which intent will be evidenced by an Officers&#146;
Certificate to that effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;to provide for the issuance of Additional Notes in accordance with the
limitations set forth in the Indenture as of the date of this Supplemental Indenture;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;to allow any Guarantor to execute a Supplemental Indenture and/or a Note
Guarantee with respect to the Notes; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;to release a Guarantor from its Note Guarantee pursuant to the terms of the
Indenture when permitted or required pursuant to the terms of the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;10.02 <I>Supplemental Indentures With Consent of Holders</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to certain exceptions, the Indenture, the Notes or the Note Guarantees may be amended
or supplemented with the consent of the Holders of at least a majority in aggregate principal
amount of the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->66<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then outstanding Notes (including, without limitation, Additional Notes, if any)
voting as a single class
(including, without limitation, consents obtained in connection with a tender offer or
exchange offer for, or purchase of, the Notes), and any existing Default or Event of Default (other
than a Default or Event of Default in the payment of the principal of, premium on, if any, or
interest, if any, on, the Notes, except a payment default resulting from an acceleration that has
been rescinded) or compliance with any provision of the Indenture or the Notes or the Note
Guarantees may be waived with the consent of the Holders of a majority in aggregate principal
amount of the then outstanding Notes (including, without limitation, Additional Notes, if any)
voting as a single class (including, without limitation, consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes). In lieu of Section&nbsp;9.2 of the Original
Indenture, which shall not apply with respect to the Notes, without the consent of each Holder
affected thereby, no amendment, supplement or waiver, including a waiver in relation to a past
Event of Default, may:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;reduce the principal amount of Notes whose Holders must consent to an amendment,
supplement or waiver;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;reduce the principal of or change the fixed maturity of any Note or alter or
waive any of the provisions with respect to the redemption of the Notes (for the avoidance of
doubt, the provisions with respect to the redemption of the Notes referred to in this clause (b)&nbsp;do
not include the offers to purchase Notes described in
Sections&nbsp;4.05 and 4.08);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;reduce the rate of or change the time for payment of interest, including default
interest, on any Note;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;waive a Default or Event of Default in the payment of principal of, premium on,
if any, or interest, if any, on, the Notes (except a rescission of acceleration of the Notes by the
Holders of at least a majority in aggregate principal amount of the then outstanding Notes and a
waiver of the payment default that resulted from such acceleration);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;make any Note payable in money other than that stated in the Notes;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;make any change in the provisions of the Indenture relating to waivers of past
Defaults or the rights of Holders of Notes to receive payments of principal of, premium on, if any,
or interest, if any, on, the Notes;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;waive a redemption payment with respect to any Note (other than a payment
required by Sections&nbsp;4.05 or 4.08);<SUP style="FONT-size: 85%; vertical-align: text-top"> </SUP>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;release any Guarantor from any of its obligations under its Note Guarantee or
the Indenture, except in accordance with the terms of the Indenture; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;make any change in the preceding amendment and waiver provisions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, any amendment to, or waiver of, Article&nbsp;12 that adversely affects the rights of
the Holders of the Notes will require the consent of the Holders of at least 75% in aggregate
principal amount of Notes then outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consent of the Holders is not necessary under the Indenture to approve the particular form
of any proposed amendment. It is sufficient if such consent approves the substance of the proposed
amendment.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->67<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;10.03 <I>Notice of Amendment or Supplement</I>. After an amendment or supplement under this Article&nbsp;10 or
Article&nbsp;IX of the Original Indenture becomes effective, the Company shall mail to the Holders a
notice briefly describing such amendment or supplement. However, the failure to give such notice
to all the Holders, or any defect in the notice, shall not impair or affect the validity of the
amendment or supplement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 11.<BR>
MISCELLANEOUS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.01 <I>Governing Law</I>. THIS SUPPLEMENTAL INDENTURE, EACH OF THE NOTES, EACH OF THE NOTE GUARANTEES
AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, EACH
OF THE NOTES AND EACH OF THE NOTE GUARANTEES, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.02 <I>No Security Interest Created</I>. Nothing in this Supplemental Indenture, in the Notes or in the
Note Guarantees expressed or implied, shall be construed to constitute a security interest under
the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect, in
any jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.03 <I>Trust Indenture Act</I>. This Supplemental Indenture will be subject to, and governed by, the
provisions of the Trust Indenture Act that are required to be part of this Supplemental Indenture
and shall, to the extent applicable, be governed by such provisions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.04 <I>Benefits of Supplemental Indenture</I>. Nothing in this Supplemental Indenture, in the Notes or
the Note Guarantees, express or implied, shall give to any person (including any Registrar, any
Paying Agent and their successors hereunder), other than the parties hereto, any benefit or any
legal or equitable right, remedy or claim under this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.05 <I>Calculations</I>. Except as otherwise provided in this Supplemental Indenture, the Company shall
be responsible for making all calculations called for under the Notes. These calculations include,
but are not limited to, determinations of accrued interest payable on the Notes. The Company shall
make all these calculations in good faith and, absent manifest error, the Company&#146;s calculations
shall be final and binding on Holders of Notes. The Company shall provide a schedule of its
calculations to the Trustee and the Trustee is entitled to rely conclusively upon the accuracy of
the Company&#146;s calculations without independent verification. The Trustee will forward the
Company&#146;s calculations to any Holder of Notes upon the request of that Holder at the sole cost and
expense of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.06 <I>Effect of Headings and Table of Contents</I>. The Article and Section headings herein and the
Table of Contents are for convenience only and shall not affect the construction hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.07 <I>Execution in Counterparts</I>. This Supplemental Indenture may be executed in any number of
counterparts, each of which shall be an original, but such counterparts shall together constitute
but one and the same instrument.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.08 <I>Separability Clause</I>. In case any provision in this Supplemental Indenture, in any Note or
coupon or in any Note Guarantee shall be invalid, illegal or unenforceable, the validity, legality
and enforceability of the remaining provisions shall not in any way be affected or impaired
thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.09 <I>Ratification of Original Indenture</I>. The Original Indenture, as supplemented by this
Supplemental Indenture, is in all respects ratified and confirmed, and this Supplemental Indenture
shall be
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->68<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed part of the Original Indenture in the manner and to the extent herein and therein
provided. For the avoidance of doubt, each of the Company, each of the Guarantors and each Holder
of the Notes, by its acceptance of
such Notes, acknowledges and agrees that all of the rights, privileges, protections,
immunities, indemnities and benefits afforded to the Trustee under the Original Indenture are
deemed to be incorporated herein, and shall be enforceable by the Trustee hereunder, in each of its
capacities hereunder as if set forth herein in full.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;11.10 <I>The Trustee</I>. The recitals in this Supplemental Indenture are made by the Company and the
Guarantors only and not the Trustee, and all of the provisions contained in the Original Indenture
in respect of the rights, privileges, immunities, powers and duties of the Trustee shall be
applicable in respect of the Notes, the Note Guarantees and of this Supplemental Indenture as fully
and with like effect as set forth in full herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;11.11 <I>No Recourse Against Others</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No director, officer, employee, incorporator or stockholder of the Company or any Guarantor,
as such, shall have any liability for any obligations of the Company or the Guarantors under the
Notes, the Indenture, the Note Guarantees or any claim based on, in respect of, or by reason of,
such obligations or their creation. Each Holder of Notes by accepting a Note waives and releases
all such liability. The waiver and release are part of the consideration for issuance of the Notes.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 12.<BR>
SUBORDINATION</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.01 <I>Agreement to Subordinate</I>. The Company agrees, and each Holder by accepting a Note agrees,
that the Indebtedness evidenced by the Notes is subordinated in right of payment, to the extent and
in the manner provided in this Article&nbsp;12, to the prior payment in full of all Senior Debt (whether
outstanding on the date hereof or hereafter created, incurred, assumed or guaranteed), and that the
subordination is for the benefit of the holders of Senior Debt.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.02 <I>Liquidation; Dissolution; Bankruptcy</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Upon any distribution to creditors of the Company in a liquidation or
dissolution of the Company or in a bankruptcy, reorganization, insolvency, receivership or similar
proceeding relating to the Company or its property, in an assignment for the benefit of creditors
or any marshaling of the Company&#146;s assets and liabilities:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;holders of Senior Debt will be entitled to receive payment in full of all Obligations due
in respect of such Senior Debt (including interest after the commencement of any bankruptcy
proceeding at the rate specified in the applicable Senior Debt) before the Holders of Notes will be
entitled to receive any payment with respect to the Notes (except that Holders of Notes may receive
and retain Permitted Junior Securities and payments made from either of the trusts created pursuant
to Sections&nbsp;7.05 and 8.02 hereof); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;until all Obligations with respect to Senior Debt (as provided in clause (1)&nbsp;above) are
paid in full, any distribution to which Holders would be entitled but for this Article&nbsp;12 will be
made to holders of Senior Debt, (except that Holders of Notes may receive and retain Permitted
Junior Securities and payments made from either of the trusts created pursuant to Sections&nbsp;7.05 and
8.02 hereof), as their interests may appear.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->69<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the extent any payment of Senior Debt is declared to be fraudulent or
preferential, set aside or required to be paid to any receiver, trustee in bankruptcy, liquidating
trustee, agent or other similar person under any bankruptcy, reorganization, insolvency,
receivership or similar
proceeding, the Senior Debt or part thereof originally intended to be satisfied shall be
deemed to be reinstated and outstanding as if such payment had not occurred and the provisions of
this Article&nbsp;12 will be applied accordingly.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Section&nbsp;12.03 <I>Default on Designated Senior Debt</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company may not make, directly or indirectly through any Subsidiary or other
person, any payment or distribution to the Trustee or any Holder in respect of Obligations with
respect to the Notes and may not acquire from the Trustee or any Holder any Notes for cash or
property (except that Holders of Notes may receive and retain Permitted Junior Securities and
payments made from either of the trusts created pursuant to Sections&nbsp;7.05 and 8.02 hereof) until
all principal and other Obligations with respect to the Senior Debt have been paid in full if:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;a default in the payment of principal, premium, if any, interest or any other Obligation
due on any Designated Senior Debt (a &#147;<B><I>Payment Default</I></B>&#148;) occurs and is continuing (including,
without limitation, a payment that has become due as a result of the acceleration of any Designated
Senior Debt); or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;any other default (a &#147;<B><I>Nonpayment Default</I></B>&#148;) occurs and is continuing on any series of
Designated Senior Debt that permits holders of that series of Designated Senior Debt to accelerate
its maturity and the Trustee receives a notice of such default (a &#147;<B><I>Payment Blockage Notice</I></B>&#148;) from
the Company or any administrative agent or other agent or trustee for any Designated Senior Debt.
The Trustee shall promptly deliver a copy of any Payment Blockage Notice received by it to the
Company and the Company shall promptly deliver such copy to all holders of Designated Senior Debt.
If the holders of a majority in principal amount of all Designated Senior Debt outstanding at the
time such Payment Blockage Notice is delivered to the Company shall, within 10&nbsp;days of their
receipt thereof, deliver to the Company and the Trustee a notice rescinding such Payment Blockage
Notice, such Payment Blockage Notice shall be deemed not to have been delivered for all purposes of
the Indenture. If the Trustee receives any such Payment Blockage Notice, no subsequent Payment
Blockage Notice will be effective for purposes of this Section&nbsp;12.03 unless and until at least 360
days have elapsed since the delivery of the immediately prior Payment Blockage Notice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Nonpayment Default that existed or was continuing on the date of delivery of any Payment
Blockage Notice to the Trustee may be, or may be made, the basis for a subsequent Payment Blockage
Notice unless such default has been cured or waived for a period of not less than 90&nbsp;days.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company may and will resume payments on and distributions in respect of the
Notes and may acquire them upon the earlier of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;in the case of a Payment Default, upon the date upon which such default is cured or
waived, and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;in the case of a Nonpayment Default, upon the earlier of the date on which such Nonpayment
Default is cured or waived or 179&nbsp;days after the date on which the applicable Payment Blockage
Notice is received, unless the maturity of any Designated Senior Debt has been accelerated (in
which event the foregoing subclause (1)&nbsp;shall apply),
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->70<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">if this Article&nbsp;12 otherwise permits such payment, distribution or acquisition at the time of such
payment, distribution or acquisition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.04 <I>Acceleration of Notes</I>. If payment of the Notes is accelerated because of an Event of Default,
the Company may not make, directly or indirectly through any Subsidiary or other person, any
payment or distribution to the Trustee or any Holder in respect of Obligations with respect to the
Notes and may not acquire from the Trustee or any Holder any Notes for cash or property until all
principal and other Obligations with respect to the Senior Debt have been paid in full or such
acceleration is rescinded in accordance with the terms of this Supplemental Indenture. The Company
will promptly notify holders of Senior Debt of any such acceleration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.05 <I>When Distribution Must Be Paid Over</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Trustee or any Holder of the Notes receives any payment of any
Obligations with respect to the Notes at a time when the payment is prohibited by Section&nbsp;12.03 or
Section&nbsp;12.04, such payment will be held by the Trustee or such Holder, in trust for the benefit
of, and will be paid forthwith over and delivered, upon written request, to, the holders of Senior
Debt as their interests may appear or their Representative, if any, under the agreement, Indenture
or other document (if any) pursuant to which Senior Debt may have been issued, as their respective
interests may appear, for application to the payment of all Obligations with respect to Senior Debt
remaining unpaid to the extent necessary to pay such Obligations in full in accordance with their
terms, after giving effect to any concurrent payment or distribution to or for the holders of
Senior Debt.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to the holders of Senior Debt, the Trustee undertakes to perform only those
obligations on the part of the Trustee as are specifically set forth in this Article&nbsp;12, and no
implied covenants or obligations with respect to the holders of Senior Debt will be read into this
Supplemental Indenture against the Trustee. The Trustee will not be deemed to owe any fiduciary
duty to the holders of Senior Debt, and will not be liable to any such holders if the Trustee pays
over or distributes to or on behalf of Holders or the Company or any other person money or assets
to which any holders of Senior Debt are then entitled by virtue of this Article&nbsp;12, except if such
payment is made as a result of the willful misconduct or gross negligence of the Trustee.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.06 <I>Notice by Company</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will promptly notify the Trustee and the Paying Agent of any facts known to the
Company that would cause a payment of any Obligations with respect to the Notes to violate this
Article&nbsp;12, but failure to give such notice will not affect the subordination of the Notes to the
Senior Debt as provided in this Article&nbsp;12.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.07 <I>Subrogation</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After all Senior Debt is paid in full and until the Notes are paid in full, Holders of Notes
will be subrogated (equally and ratably with all other Indebtedness <I>pari passu </I>with the Notes) to
the rights of holders of Senior Debt to receive distributions applicable to Senior Debt to the
extent that distributions otherwise payable to the Holders of Notes have been applied to the
payment of Senior Debt. A distribution made under this Article&nbsp;12 to holders of Senior Debt that
otherwise would have been made to Holders of Notes is not, as between the Company and Holders, a
payment by the Company on the Notes.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.08 <I>Relative Rights</I>.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->71<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Article&nbsp;12 defines the relative rights of Holders of Notes and holders of Senior Debt.
Nothing in this Supplemental Indenture will:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;impair, as between the Company and Holders of Notes, the obligation of the Company, which
is absolute and unconditional, to pay principal of, and interest, if any, on the Notes in
accordance with their terms;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;affect the relative rights of Holders of Notes and creditors of the Company other than
their rights in relation to holders of Senior Debt; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;prevent the Trustee or any Holder of Notes from exercising its available remedies upon a
Default or Event of Default, subject to the rights of holders and owners of Senior Debt to receive
distributions and payments otherwise payable to Holders of Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company fails because of this Article&nbsp;12 to pay principal of, or interest, if any, on
the Notes in accordance with their terms, the failure is still a Default or Event of Default.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.09 <I>Subordination May Not Be Impaired by Company</I>. No right of any holder of Senior Debt to
enforce the subordination of the Indebtedness evidenced by the Notes may be impaired by any act or
failure to act by the Company or any Holder or by the failure of the Company or any Holder to
comply with this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.10 <I>Distribution or Notice to Representative or Holders of Senior Debt</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever a distribution is to be made or a notice given to holders of any series of Senior
Debt, the distribution may be made and the notice given to their Representative, if they have
appointed one, and if no Representative has been appointed by the holders of any series of Senior
Debt, such distribution or notice shall be made or given directly to such holders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon any payment or distribution of assets of the Company referred to in this Article&nbsp;12, the
Trustee and the Holders of Notes will be entitled to rely upon any order or decree made by any
court of competent jurisdiction or upon any certificate of such Representative or of the
liquidating trustee or agent or other person making any distribution to the Trustee or to the
Holders of Notes for the purpose of ascertaining the persons entitled to participate in such
distribution, the holders of the Senior Debt and other Indebtedness of the Company, the amount
thereof or payable thereon, the amount or amounts paid or distributed thereon and all other facts
pertinent thereto or to this Article&nbsp;12.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.11 <I>Rights of Trustee and Paying Agent</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the provisions of this Article&nbsp;12 or any other provision of the Indenture, the
Trustee will not be charged with knowledge of the existence of any facts that would prohibit the
making of any payment or distribution by the Trustee, and the Trustee and the Paying Agent may
continue to make payments on the Notes, unless the Trustee has received at its Corporate Trust
Office at least three Business Days prior to the date of such payment written notice of facts that
would cause the payment of any Obligations with respect to the Notes to violate this Article&nbsp;12,
except for any acceleration of the Notes prior to making any such payment or distribution which is
known by any officer of the Trustee prior to making any such payment or distribution. The notice
may only be given by the Company or a Representative. For the avoidance of doubt, no such notice
shall constitute a Payment Blockage Notice unless delivered in accordance with Section&nbsp;12.03(a)(2).
Nothing in this Article&nbsp;12 will impair the claims of, or payments to, the Trustee under or
pursuant to Section&nbsp;7.7 of the Original Indenture.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->72<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Trustee in its individual or any other capacity may hold Senior Debt with the same rights
it would have if it were not Trustee. Any Registrar, any Paying Agent and their successors
hereunder may do the same with like rights.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.12 <I>Authorization to Effect Subordination; Filing Proof of Claim</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Holder of Notes, by the Holder&#146;s acceptance thereof, authorizes and directs the Trustee
on such Holder&#146;s behalf to take such action as may be necessary or appropriate to effectuate the
subordination as provided in this Article&nbsp;12, and appoints the Trustee to act as such Holder&#146;s
attorney-in-fact for any and all such purposes. If the Trustee does not file a proper proof of
claim or proof of debt in the form required in any proceeding referred to in Section&nbsp;6.9 of the
Original Indenture at least 30&nbsp;days before the expiration of the time to file such claim or any
Representative, are hereby authorized to file an appropriate claim for and on behalf of the Holders
of the Notes.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.13 <I>Reliance and Amendments</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each Holder of Notes by its acceptance thereof acknowledges and agrees that the
subordination provisions set forth in this Article&nbsp;12 are, and are intended to be, an inducement
and a consideration for each holder of any Senior Debt, whether such Senior Debt was created or
acquired before or after the issuance of the Notes, to acquire and continue to hold, or to continue
to hold, such Senior Debt, and such holder of Senior Debt shall be deemed conclusively to have
relied on such subordination provisions in acquiring and continuing to hold or in continuing to
hold such Senior Debt.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The provisions of this Article&nbsp;12 may not be amended or modified without the
written consent of the holders of all Senior Debt. In addition, any amendment to, or waiver of,
the provisions of this Article&nbsp;12 that adversely affects the rights of the Holders of the Notes
will require the consent of the Holders of a majority in aggregate principal amount of Notes then
Outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;12.14 <I>No Waiver of Subordination Provisions</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without in any way limiting the generality of Section&nbsp;12.09, the holders of Senior Debt may,
at any time and from time to time, without the consent of or notice to the Trustee or the Holders,
without incurring responsibility to the Holders and without impairing or releasing the
subordination provided in this Article&nbsp;12 or the obligations hereunder of the Holders to the
holders of Senior Debt, do any one or more of the following: (a)&nbsp;change the manner, place or terms
of payment or extend the time of payment of, or renew or alter, Senior Debt, or otherwise amend or
supplement in any manner Senior Debt or any instrument evidencing the same or any agreement under
which Senior Debt is outstanding; (b)&nbsp;sell, exchange, release or otherwise deal with any property
pledged, mortgaged or otherwise securing Senior Debt; (c)&nbsp;release any person liable in any manner
for the collection of Senior Debt; and (d)&nbsp;exercise or refrain from exercising any rights against
the Company and any other person.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><I>&#091;Remainder of the page intentionally left blank&#093;</I>
</DIV>








<P align="center" style="font-size: 10pt"><!-- Folio -->73<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TELEFLEX INCORPORATED<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Richard A. Meier
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Richard A. Meier&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->74<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="54%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AIRFOIL TECHNOLOGIES INTERNATIONAL-CALIFORNIA, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AIRFOIL TECHNOLOGIES INTERNATIONAL-OHIO, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ARROW INTERNATIONAL INVESTMENT CORP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ARROW INTERVENTIONAL, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SPECIALIZED MEDICAL DEVICES, LLC</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TECHNOLOGY HOLDING COMPANY</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TECHNOLOGY HOLDING COMPANY II</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TECHNOLOGY HOLDING COMPANY III</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TELEFLEX HOLDING COMPANY II</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TFX EQUITIES INCORPORATED</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TFX GROUP LLC</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TFX INTERNATIONAL CORPORATION</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TFX MEDICAL WIRE PRODUCTS, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TFX NORTH AMERICA INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">VASONOVA, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THE STEPIC MEDICAL DISTRIBUTION CORPORATION</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TELEFLEX MEDICAL INCORPORATED</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ARROW INTERNATIONAL, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ARROW MEDICAL PRODUCTS, LTD.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">                                      /s/ C. Jeffrey Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left" NOWRAP>(1) Vice President and Treasurer (other than as<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noted below)<br>
(2)  President and
Treasurer (in the case of <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TFX North America Inc.)<br>
(3)  Vice President
(in the case of TFX Equities<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated)<br>
(4)  President (in the
case of Technology <BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holding Company, Technology Holdings<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company II, Technology Holding Company<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;III and TFX International Corporation)<br>
(5)  Vice President
and Secretary (in the case <BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of Teleflex Holding Company II and TFX<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Group LLC)&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">WELLS FARGO BANK, N.A., as Trustee<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD align="left">By:&nbsp;</TD>

    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Richard Prokosch
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="2" align="left">Name:&nbsp;&nbsp;Richard Prokosch&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="2" align="left">Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>SCHEDULE A</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Guarantors</B></FONT>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="90%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Jurisdiction of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Entity</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Formation</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-California, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-Ohio, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International Investment Corp.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Interventional, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specialized Medical Devices LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TeleFlex Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Equities Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Group LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX International Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Medical Wire Products, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX North America Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">VasoNova, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">The Stepic Medical Distribution Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">NY</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TeleFlex Medical Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Medical Products Ltd.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT A</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;Face of Note&#093;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#091;THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS
REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITORY. THIS NOTE IS EXCHANGEABLE FOR
NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE
LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS NOTE (OTHER THAN A
TRANSFER OF THIS NOTE AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A NOMINEE
OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY) MAY BE REGISTERED EXCEPT
IN LIMITED CIRCUMSTANCES.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A
NEW YORK CORPORATION (&#147;DTC&#148;), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR
PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE &#038; CO. OR IN SUCH OTHER NAME AS IS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE &#038; CO. OR
TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE &#038; CO., HAS AN INTEREST HEREIN. &#093;*
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>This legend should be included only if the Note is issued as a Global Note.</TD>
</TR>

</TABLE>




<P align="center" style="font-size: 10pt"><!-- Folio -->A-1<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">CUSIP/CINS 879369AB2
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">6.875% Senior Subordinated Notes due 2019
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%"></TD>
    <TD width="3%"></TD>
    <TD width="48%"></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">No. &#95;&#95;&#95;
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">$&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;<SUP style="FONT-size: 85%; vertical-align: text-top">*</SUP></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TELEFLEX INCORPORATED</B>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">promises to pay to &#95;&#95;&#95;&#95;&#95;&#95;&#95; or registered assigns,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the principal sum of &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95; DOLLARS &#091;(or such lesser principal amount as
shall be reflected in the books and records of the Trustee and Depository)&#093; on June&nbsp;1, 2019.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Interest Payment Dates: June 1 and December 1
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Regular Record Dates: May&nbsp;15 and November&nbsp;15
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dated: &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;, 20&#091; &#093;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IN WITNESS WHEREOF, TELEFLEX INCORPORATED has caused this instrument to be signed manually or by
facsimile by two of its duly authorized Officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Date: June &#95;&#95;&#95;, 2011
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">TELEFLEX INCORPORATED<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Richard A. Meier&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and Chief
Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">C. Jeffrey Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This is one of the Notes referred to<BR>
in the within-mentioned Indenture:

</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">WELLS FARGO BANK, N.A.,<BR>
as Trustee<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center">Authorized Signatory&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 0pt; width: 28%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->A-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;Back of Note&#093;<BR>
6.875% Senior Subordinated Notes due 2019</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized terms used herein have the meanings assigned to them in the Indenture referred to
below unless otherwise indicated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) <FONT style="FONT-variant: SMALL-CAPS"><I>Interest</I></FONT>. Teleflex Incorporated, a Delaware corporation (the &#147;<I>Company</I>&#148;),
promises to pay or cause to be paid interest on the principal amount of this Note at 6.875%
per annum from &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;, &#95;&#95;&#95; until maturity. The Company will pay, if any,
semi-annually in arrears on June 1 and December 1 of each year, or if any such day is not a
Business Day, on the next succeeding Business Day (each, an &#147;<I>Interest Payment Date</I>&#148;).
Interest on the Notes will accrue from the most recent date to which interest has been paid
or, if no interest has been paid, from the date of issuance; <I>provided </I>that, if this Note is
authenticated between a record date referred to on the face hereof and the next succeeding
Interest Payment Date, interest shall accrue from such next succeeding Interest Payment
Date; <I>provided further </I>that the first Interest Payment Date shall be &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;, &#95;&#95;&#95;&#95;.
The Company will pay interest (including post-petition interest in any proceeding under any
Bankruptcy Law) on overdue principal at the otherwise applicable interest rate on the Notes
to the extent lawful; it will pay interest (including post-petition interest in any
proceeding under any Bankruptcy Law) on overdue installments of interest, if any (without
regard to any applicable grace period), at the same rate to the extent lawful.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest will be computed on the basis of a 360-day year comprised of twelve 30-day
months.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) <FONT style="FONT-variant: SMALL-CAPS"><I>Method of Payment</I></FONT>. The Company will pay interest on the Notes (except
defaulted interest, if any) to the Persons who are registered Holders
of Notes at 5:00 p.m., New York City time, on the May&nbsp;15 or November&nbsp;15 next preceding the Interest Payment Date, even if
such Notes are canceled after such record date and on or before such Interest Payment Date,
except as provided in Section&nbsp;2.12 of the Original Indenture with respect to defaulted
interest. The Company shall pay the principal of and interest on any Global Note in
immediately available funds to the Depository or its nominee, as the case may be, as the
registered Holder of such Global Note. The Company, through the Paying Agent, shall make
all payments of principal, premium, if any, and interest, if any, with respect to Physical
Notes by wire transfer of immediately available funds to the accounts specified by the
Holders of the Physical Notes or, if no such account is specified, by mailing a check to
each such Holder&#146;s registered address. Such payment will be in such coin or currency of the
United States of America as at the time of payment is legal tender for payment of public and
private debts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) <FONT style="FONT-variant: SMALL-CAPS"><I>Paying Agent and Registrar</I></FONT>. Initially, Wells Fargo Bank, N.A., the
Trustee under the Indenture, will act as Paying Agent and Registrar. The Company may change
the Paying Agent or Registrar without prior notice to the Holders of the Notes. The Company
or any of its Subsidiaries may act as Paying Agent or Registrar.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) <FONT style="FONT-variant: SMALL-CAPS"><I>Indenture</I></FONT>. The Company issued the Notes under a base indenture dated
August&nbsp;2, 2010, between the Company and the Trustee (the &#147;<I>Original Indenture</I>&#148;), as
supplemented by the Second Supplemental Indenture dated as of June&nbsp;13, 2011 (the &#147;<I>Second
Supplemental Indenture</I>&#148; and the Original Indenture as supplemented by the Second
Supplemental Indenture, the &#147;<I>Indenture</I>&#148;) among the Company, the Guarantors and the Trustee.
The terms of the Notes include those stated in the Indenture and those made part of the
Indenture by reference to the TIA.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->A-3<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Notes are subject to all such terms, and Holders are referred to the Indenture
and such Act for a statement of such terms. To the extent any provision of this Note
conflicts with the express provisions of the Indenture, the provisions of the Indenture
shall govern and be controlling. The Notes are unsecured obligations of the Company. The
Indenture does not limit the aggregate principal amount of Notes that may be issued
thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;<FONT style="FONT-variant: SMALL-CAPS"><I>Optional Redemption</I></FONT><I>.</I>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;At any time prior to June&nbsp;1, 2014, the Company may on any one or more
occasions redeem up to 35% of the aggregate principal amount of Notes issued under the
Supplemental Indenture (including any Additional Notes), upon not less than 30 nor more than
60&nbsp;days&#146; notice, at a redemption price equal to 106.875% of the principal amount of the
Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of
redemption (subject to the rights of Holders of Notes on the relevant record date to receive
interest on the relevant interest payment date), with the net cash proceeds of an Equity
Offering by the Company; <I>provided </I>that:</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) at least 65% of the aggregate principal amount of Notes
originally issued under the Supplemental Indenture (excluding Notes held by the
Company and its Subsidiaries) remains outstanding immediately after the occurrence
of such redemption; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the redemption occurs within 120&nbsp;days of the date of the closing
of such Equity Offering.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;At any time prior to June&nbsp;1, 2015, the Company may on any one or more
occasions redeem all or a part of the Notes, upon not less than 30 nor more than 60&nbsp;days&#146;
notice, at a redemption price equal to 100% of the principal amount of the Notes redeemed,
plus the Applicable Premium as of, and accrued and unpaid interest, if any, to, but not
including, the date of redemption, subject to the rights of Holders of Notes on the relevant
record date to receive interest due on the relevant interest payment date.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except pursuant to the preceding paragraphs, the Notes will not be
redeemable at the Company&#146;s option prior to June&nbsp;1, 2015.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;On or after June&nbsp;1, 2015, the Company may on any one or more occasions
redeem all or a part of the Notes, upon not less than 30 nor more than 60&nbsp;days&#146; notice, at
the redemption prices (expressed as percentages of principal amount) set forth below, plus
accrued and unpaid interest, if any, on the Notes redeemed, to, but not including, the
applicable date of redemption, if redeemed during the twelve-month period beginning on June
1 of the years indicated below, subject to the rights of Holders of Notes on the relevant
record date to receive interest on the relevant interest payment date:</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Year</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Percentage</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2015</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">103.438</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2016</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">101.719</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2017 and thereafter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">100.000</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Unless the Company defaults in the payment of the redemption price, interest will cease to
accrue on the Notes or portions thereof called for redemption on the applicable redemption
date.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->A-4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(6)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Mandatory Redemption</I></FONT><I>. </I>The Company is not required to make
mandatory redemption or sinking fund payments with respect to the Notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(7)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Repurchase at the Option of Holder</I></FONT><I>.</I>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If a Change of Control occurs, each Holder of Notes will have the right
to require the Company to repurchase all or any part (equal to $2,000 or an integral
multiple of $1,000 in excess thereof) of that Holder&#146;s Notes pursuant to an offer by the
Company (a &#147;<B><I>Change of Control Offer</I></B>&#148;) on the terms set forth in the Indenture. In the
Change of Control Offer, the Company will offer a Change of Control Payment in cash equal to
101% of the aggregate principal amount of Notes repurchased, plus accrued and unpaid
interest, if any, on the Notes repurchased to, but not including, the date of purchase,
subject to the rights of Holders of Notes on the relevant record date to receive interest
due on the relevant interest payment date. Within ten days following any Change of Control,
the Company will mail a notice to each Holder with a copy to the Trustee describing the
transaction or transactions that constitute the Change of Control and offering to repurchase
Notes on the Change of Control Payment Date specified in the notice, which date will be no
earlier than 30&nbsp;days and no later than 60&nbsp;days from the date such notice is mailed, pursuant
to the procedures required by the Indenture and described in such notice. The Company will
comply with the requirements of Rule&nbsp;14e-1 under the Exchange Act and any other securities
laws and regulations thereunder to the extent those laws and regulations are applicable in
connection with the repurchase of the Notes as a result of a Change of Control. To the
extent that the provisions of any securities laws or regulations conflict with the Change of
Control provisions of the Indenture, the Company will comply with the applicable securities
laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Indenture by virtue of such compliance.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;If the Company or a Restricted Subsidiary of the Company consummates any
Asset Sales, within ten Business Days of each date on which the aggregate amount of Excess
Proceeds exceeds $50.0&nbsp;million, the Company will make an offer (an &#147;<B><I>Asset Sale Offer</I></B>&#148;) to
all Holders of Notes and, if required by the terms of any Indebtedness that is <I>pari passu</I>
with the Notes, all holders of other Indebtedness that is <I>pari passu </I>with the Notes
containing provisions similar to those set forth in the Indenture with respect to offers to
purchase, prepay or redeem with the proceeds of sales of assets to purchase, prepay or
redeem the maximum principal amount of Notes and such other <I>pari passu </I>Indebtedness (plus
all accrued interest on the Indebtedness and the amount of all fees and expenses, including
premiums, incurred in connection therewith) that may be purchased, prepaid or redeemed out
of the Excess Proceeds. The offer price in any Asset Sale Offer will be equal to 100% of
the principal amount, plus accrued and unpaid interest, if any, to, but not including, the
date of repurchase, subject to the rights of Holders of Notes on the relevant record date to
receive interest due on the relevant interest payment date, and will be payable in cash. If
any Excess Proceeds remain after consummation of an Asset Sale Offer, the Company may use
those Excess Proceeds for any purpose not otherwise prohibited by the Indenture. If the
aggregate principal amount of Notes and other <I>pari passu </I>Indebtedness tendered in (or
required to be prepaid or redeemed in connection with) such Asset Sale Offer exceeds the
amount of Excess Proceeds, the Trustee will select the Notes and the Company will select
such other <I>pari passu </I>Indebtedness to be purchased on a <I>pro rata </I>basis, based on the amounts
tendered or required to be prepaid or redeemed (with such adjustments as may be deemed
appropriate by the Trustee so that only Notes in denominations of $2,000, or an integral
multiple of $1,000 in excess thereof, will be purchased). Upon completion of each Asset Sale
Offer, the amount of Excess Proceeds will be reset at zero. Holders of Notes that are
subject of an offer purchase will receive an Asset Sale Offer from the Company prior to any
related purchase date and may elect to</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->A-5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">have such Notes purchased by completing the form entitled &#147;<I>Option of Holder to Elect
Purchase</I>&#148; attached to the Notes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(8)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Notice of Redemption</I></FONT>. At least 30&nbsp;days but not more than 60&nbsp;days
before a redemption date, the Company will mail or cause to be mailed, by first class mail,
a notice of redemption to each Holder whose Notes are to be redeemed at its registered
address, except that redemption notices may be mailed more than 60&nbsp;days prior to a
redemption date if the notice is issued in connection with a defeasance of the Notes or a
satisfaction and discharge of the Indenture pursuant to Articles 7 or 8 of the Second
Supplemental Indenture. Notes and portions of Notes selected will be in amounts of $2,000
or whole multiples of $1,000 in excess thereof; except that if all of the Notes of a Holder
are to be redeemed or purchased, the entire outstanding amount of Notes held by such Holder
shall be redeemed or purchased.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(9)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Denominations, Transfer, Exchange</I></FONT>. The Notes are in registered
form in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The
transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture.
The Registrar and the Trustee may require a Holder, among other things, to furnish
appropriate endorsements and transfer documents and the Company may require a Holder to pay
any taxes and fees required by law or permitted by the Indenture. The Company need not
exchange or register the transfer of any Note or portion of a Note selected for redemption,
except for the unredeemed portion of any Note being redeemed in part. Also, the Company
need not exchange or register the transfer of any Notes for a period of 15&nbsp;days before a
selection of Notes to be redeemed or during the period between a record date and the next
succeeding Interest Payment Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(10)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Persons Deemed Owners</I></FONT>. The registered Holder of a Note may be
treated as the owner of it for all purposes. Only registered Holders have rights under the
Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(11)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Amendment, Supplement and Waiver</I></FONT>. The provisions governing
amendment, supplement and waiver of any provision of the Indenture, the Notes or the Note
Guarantees are set forth in Article&nbsp;10 of the Second Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(12)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Defaults and Remedies</I></FONT>. The Defaults and Event of Default
relating to the Notes are set forth in Section&nbsp;6.01 of the Second Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13)&nbsp;<I>S</I><FONT style="FONT-variant: SMALL-CAPS"><I>ubordination</I></FONT><I>. </I>Payment of principal of, premium on, if any, and
interest, if any, on, the Notes is subordinated to the prior payment of Senior Debt on the
terms provided in the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(14)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Trustee Dealings with Company</I></FONT>. The Trustee, in its individual
or any other capacity, may make loans to, accept deposits from, and perform services for the
Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if
it were not the Trustee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(15)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>No Recourse Against Others</I></FONT>. No director, officer, employee,
incorporator or stockholder of the Company or any Guarantor, as such, will have any
liability for any obligations of the Company or the Guarantors under the Notes, the
Indenture, the Note Guarantees or for any claim based on, in respect of, or by reason of,
such obligations or their creation. Each Holder of Notes by accepting a Note waives and
releases all such liability. The waiver and release are part of the consideration for
issuance of the Notes.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->A-6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(16)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Authentication</I></FONT>. This Note will not be valid until authenticated
by the manual signature of the Trustee or an authenticating agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(17)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>Abbreviations</I></FONT>. Customary abbreviations may be used in the name
of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by
the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in
common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(18)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>CUSIP Numbers</I></FONT>. Pursuant to a recommendation promulgated by the
Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of
redemption as a convenience to Holders. No representation is made as to the accuracy of
such numbers either as printed on the Notes or as contained in any notice of redemption, and
reliance may be placed only on the other identification numbers placed thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">(19)</FONT> <FONT style="FONT-variant: SMALL-CAPS"><I>GOVERNING LAW. </I></FONT>THE INDENTURE, EACH OF THE NOTES, EACH OF THE
NOTE GUARANTEES AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THE
INDENTURE, EACH OF THE NOTES AND EACH OF THE NOTE GUARANTEES SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->A-7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Assignment Form</B></FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To assign this Note, fill in the form below:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(I)&nbsp;or
(we)&nbsp;assign and transfer this Note to
:&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 0pt; margin-left=50%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Insert assignee&#146;s legal name)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="width: 100%; border-bottom: 1px solid #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>
<DIV align="center" style="font-size: 10pt">(Insert assignee&#146;s soc. sec. or tax I.D. no.)</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="width: 100%; border-bottom: 1px solid #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="width: 100%; border-bottom: 1px solid #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="width: 100%; border-bottom: 1px solid #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<DIV style="width: 100%; border-bottom: 1px solid #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>
<DIV align="center" style="font-size: 10pt">(Print or type assignee&#146;s name, address and zip code)</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and irrevocably appoint <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
to transfer this Note on the books of the Company. The agent may substitute another to act for
him.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Date: &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top" nowrap> Your Signature:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">(Sign exactly as your name appears on the face of this Note)&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="2" align="left" nowrap>Signature Guarantee*:
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="0" align="left" style="border-top= 1px solid black">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>


<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 6pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor
acceptable to the Trustee).</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->A-8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Option of Holder to Elect Purchase</B></FONT>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you want to elect to have this Note purchased by the Company pursuant to Section&nbsp;4.05 or
4.08 of the Second Supplemental Indenture, check the appropriate box below:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-family: Wingdings">&#111;</FONT> Section&nbsp;4.05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT style="font-family: Wingdings">&#111;</FONT> Section&nbsp;4.08
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you want to elect to have only part of the Note purchased by the Company pursuant to
Section&nbsp;4.05 or Section&nbsp;4.08 of the Indenture, state the amount you elect to have purchased:
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">$&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Date: &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top" nowrap> Your Signature:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">(Sign exactly as your name appears on the face of this Note)&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top" nowrap>Tax Identification No.:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="2" align="left" nowrap>Signature Guarantee*:
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="0" align="left" style="border-top= 1px solid black">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>


<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 6pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor
acceptable to the Trustee).</TD>
</TR>

</TABLE>




<P align="center" style="font-size: 10pt"><!-- Folio -->A-9<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT B</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;FORM OF SUPPLEMENTAL INDENTURE<BR>
TO BE DELIVERED BY SUBSEQUENT GUARANTORS&#093;</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="FONT-variant: SMALL-CAPS">Supplemental Indenture</FONT> (this &#147;<I>Supplemental Indenture</I>&#148;), dated as of &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;,
among &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95; (the &#147;<I>Guaranteeing Subsidiary</I>&#148;), a subsidiary of Teleflex Incorporated (or
its permitted successor), a Delaware corporation (the &#147;<I>Company</I>&#148;), the Company, the other Guarantors
(as defined in the Indenture referred to herein) and Wells Fargo Bank, N.A., as trustee under the
Indenture referred to below (the &#147;<I>Trustee</I>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>WITNESSETH</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture (the
"<I>Original Indenture</I>&#148;), dated as of August&nbsp;2, 2010 and a second supplemental indenture, dated as of
June&nbsp;13, 2011 (the &#147;<I>Second Supplemental Indenture</I>&#148; and, together with the Original Indenture, the
"<I>Indenture</I>&#148;) providing for the issuance of 6.875% Senior Subordinated Notes due 2019 (the &#147;<I>Notes</I>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary
shall execute and deliver to the Trustee a supplemental indenture pursuant to which the
Guaranteeing Subsidiary shall unconditionally guarantee all of the Company&#146;s Obligations under the
Notes and the Indenture on the terms and conditions set forth herein (the &#147;<I>Note Guarantee</I>&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to Section&nbsp;10.01 of the Second Supplemental Indenture, the Trustee is
authorized to execute and deliver this Supplemental Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the
Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes
as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">Capitalized Terms</FONT>. Capitalized terms used herein without definition shall have
the meanings assigned to them in the Indenture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">Agreement to Guarantee</FONT>. The Guaranteeing Subsidiary hereby agrees to provide an
unconditional Guarantee on the terms and subject to the conditions set forth in the Second
Supplemental Indenture including but not limited to Article&nbsp;9 thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">No Recourse Against Others</FONT>. No director, officer, employee, incorporator or
stockholder of the Company or any Guarantor, as such, will have any liability for any obligations
of the Company or the Guarantors under the Notes, the Indenture, the Note Guarantees or for any
claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of
Notes by accepting a Note waives and releases all such liability. The waiver and release are part
of the consideration for issuance of the Notes.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;NEW YORK LAW TO GOVERN. THIS SUPPLEMENTAL INDENTURE AND ANY CLAIM, CONTROVERSY OR DISPUTE
ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">Counterparts</FONT>. The parties may sign any number of copies of this Supplemental
Indenture. Each signed copy shall be an original, but all of them together represent the same
agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->B-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">Effect of Headings</FONT>. The Section headings herein are for convenience only and
shall not affect the construction hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<FONT style="FONT-variant: SMALL-CAPS">The Trustee</FONT>. The Trustee shall not be responsible in any manner whatsoever for or
in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of
the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary
and the Company.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->B-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and attested, all as of the date first above written.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dated: &#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;&#95;,
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&#091;<FONT style="FONT-variant: SMALL-CAPS">Guaranteeing Subsidiary</FONT>&#093;<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><FONT style="FONT-variant: SMALL-CAPS">Teleflex Incorporated</FONT><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&#091;<FONT style="FONT-variant: SMALL-CAPS">Existing Guarantors</FONT>&#093;<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">WELLS FARGO BANK, N.A.,<BR>
as Trustee<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Authorized Signatory&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->B-3<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>y91654exv5w1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv5w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><b>Exhibit&nbsp;5.1</b>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;June&nbsp;13, 2011
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Incorporated<BR>
155 South Limerick Road<br>
Limerick, Pennsylvania 19468
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have acted as counsel to Teleflex Incorporated, a Delaware corporation (the &#147;Company&#148;) and
the Guarantors listed on Schedule&nbsp;I hereto (the &#147;Guarantors&#148;) in connection with the Registration
Statement on Form S-3 filed by the Company with the Securities and Exchange Commission (the
&#147;Commission&#148;) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), on August&nbsp;2,
2010, as amended by Post-Effective Amendment No.&nbsp;1 thereto filed with the Commission by the Company
and the Guarantors on June&nbsp;1, 2011 (the &#147;Registration Statement&#148;), relating to the issuance by the
Company of $250,000,000 aggregate principal amount of 6.875% Senior Subordinated Notes due 2019
(the &#147;Securities&#148;) and the issuance by the Guarantors of guarantees (the &#147;Guarantees&#148;) with respect
to the Securities pursuant to the Underwriting Agreement, dated June&nbsp;8, 2011 (the &#147;Underwriting
Agreement&#148;), among the Company, the Guarantors, Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated,
Goldman, Sachs &#038; Co. and J.P. Morgan Securities LLC. The Securities and the Guarantees will be
issued under the Indenture dated as of August&nbsp;2, 2010 (the &#147;Base Indenture&#148;) between the Company
and Wells Fargo Bank, N.A., as trustee (the &#147;Trustee&#148;), as supplemented by the Second Supplemental
Indenture relating to the Securities and the Guarantees dated as of June&nbsp;13,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">2011 (the &#147;Second Supplemental Indenture&#148; and, together with the Base Indenture, the
&#147;Indenture&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have examined the Registration Statement, Post-Effective Amendment No.&nbsp;1, the Base
Indenture, which has been filed with the Commission as an exhibit to the Registration Statement,
and the Second Supplemental Indenture, which is being filed with the Commission on the date hereof.
We also have examined the originals, or duplicates or certified or conformed copies, of such
records, agreements, documents and other instruments and have made such other investigations as we
have deemed relevant and necessary in connection with the opinions hereinafter set forth. As to
questions of fact material to this opinion, we have relied upon certificates or comparable
documents of public officials and of officers and representatives of the Company and the
Guarantors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In rendering the opinions set forth below, we have assumed the genuineness of all signatures,
the legal capacity of natural persons, the authenticity of all documents submitted to us as
originals, the conformity to original documents of all documents submitted to us as duplicates or
certified or conformed copies and the authenticity of the originals of such latter documents. We
also have assumed that the Indenture is the valid and legally binding obligation of the Trustee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have assumed further that (1)&nbsp;each of the Guarantors listed on Schedule&nbsp;II hereto (the
&#147;Pennsylvania Guarantors&#148;) is validly existing and in good standing under the law of the
Commonwealth of Pennsylvania, (2)&nbsp;each of the Pennsylvania Guarantors has duly authorized, executed
and delivered the Second Supplemental Indenture in accordance with the law of the Commonwealth of
Pennsylvania and (3)&nbsp;the execution, delivery and performance by each of the Pennsylvania Guarantors
of the Second Supplemental Indenture (including the Guarantees set
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">forth therein) (A)&nbsp;do not and will not violate the law of the Commonwealth of Pennsylvania or
any other applicable laws (excepting the law of the State of New York and the federal laws of the
United States) and (B)&nbsp;do not and will not constitute a violation of its charter, by-laws or
similar organizational documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based upon the foregoing, and subject to the qualifications, assumptions and limitations
stated herein, we are of the opinion that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Upon the due authentication, issuance and delivery of the Securities and payment
therefor in accordance with the Underwriting Agreement, the Securities will constitute valid
and legally binding obligations of the Company enforceable against the Company in accordance
with their terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Upon the issuance and delivery of the Guarantees and the due authentication,
issuance and delivery of the Securities and payment therefor in accordance with the
Underwriting Agreement, the Guarantees set forth in the Second Supplemental Indenture will
constitute valid and legally binding obligations of the Guarantors enforceable against the
Guarantors in accordance with their terms.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our opinions set forth above are subject to (i)&nbsp;the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting
creditors&#146; rights generally, (ii)&nbsp;general equitable principles (whether considered in a proceeding
in equity or at law) and (iii)&nbsp;an implied covenant of good faith and fair dealing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not express any opinion herein concerning any law other than the law of the State of New
York, the federal law of the United States, the Delaware General Corporation Law (including the
statutory provisions, all applicable provisions of the Delaware Constitution and reported judicial
decisions interpreting the foregoing), the Delaware Limited Liability Company Act (including the
statutory provisions, all applicable provisions of the Delaware Constitution and reported judicial
decisions interpreting the foregoing) and the law of the State of California (only with respect to
the matters described in the opinion in paragraph 2 above).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We hereby consent to the filing of this opinion letter as Exhibit&nbsp;5.1 to the Company&#146;s Current
Report on Form 8-K filed on June&nbsp;13, 2011 and to the use of our name under the caption &#147;Validity of
the Securities&#148; in the Prospectus included in the Registration Statement, as supplemented by the
prospectus supplement dated June&nbsp;8, 2011.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ SIMPSON THACHER &#038; BARTLETT LLP
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SIMPSON THACHER &#038; BARTLETT LLP&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Schedule&nbsp;I</B></FONT>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Guarantors</B></FONT>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="79%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Jurisdiction of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Entity</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Formation</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-California, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-Ohio, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International Investment Corp.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Interventional Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specialized Medical Devices LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Teleflex Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Equities Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Group LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX International Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Medical Wire Products, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX North America Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">VasoNova, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">The Stepic Medical Distribution Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">NY</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Teleflex Medical Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Medical Products Ltd
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Schedule&nbsp;II</B></FONT>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Pennsylvania Guarantors</B></FONT>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="79%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Jurisdiction of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Entity</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Formation</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Medical Products Ltd
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>y91654exv5w2.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv5w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;5.2</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">June&nbsp;13, 2011

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Teleflex Incorporated<BR>
155 South Limerick Road<BR>
Limerick, Pennsylvania 19468

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I am Executive Vice President, General Counsel, Chief Administrative Officer and Secretary of
Teleflex Incorporated, a Delaware corporation (the &#147;Company&#148;) and have acted as counsel to the
Company and the Guarantors listed on Schedule&nbsp;I hereto (the &#147;Guarantors&#148;) in connection with the
Registration Statement on Form S-3 filed by the Company with the Securities and Exchange Commission
(the &#147;Commission&#148;) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), on August
2, 2010, as amended by Post-Effective Amendment No.&nbsp;1 thereto filed with the Commission by the
Company and the Guarantors on June&nbsp;1, 2011 (the &#147;Registration Statement&#148;), relating to the issuance
by the Company of $250,000,000 aggregate principal amount of 6.875% Senior Subordinated Notes due
2019 (the &#147;Securities&#148;) and the issuance by the Guarantors of guarantees (the &#147;Guarantees&#148;) with
respect to the Securities pursuant to the Underwriting Agreement, dated June&nbsp;8, 2011 (the
&#147;Underwriting Agreement&#148;), among the Company, the Guarantors, Merrill Lynch, Pierce, Fenner &#038; Smith
Incorporated, Goldman, Sachs &#038; Co. and J.P. Morgan Securities LLC. The Securities and the
Guarantees will be issued under the Indenture dated as of August&nbsp;2, 2010 (the &#147;Base Indenture&#148;)
between the Company and Wells Fargo Bank, N.A., as trustee (the &#147;Trustee&#148;), as supplemented by the
Second Supplemental Indenture relating to the Securities and the Guarantees dated as of
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">June&nbsp;13, 2011 (the &#147;Second Supplemental Indenture&#148; and, together with the Base Indenture, the
&#147;Indenture&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I, and lawyers under my supervision, have examined the Registration Statemen<B>t, </B>the Indenture
and the originals, or duplicates or certified or conformed copies, of such corporate and other
records, agreements, documents and other instruments and have made such other investigations as I
have deemed relevant and necessary in connection with the opinion hereinafter set forth. As to
questions of fact material to this opinion, I, and lawyers under my supervision, have relied upon
certificates or comparable documents of public officials and of officers and representatives of the
Company and the Guarantors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I have assumed that the Indenture is the valid and legally binding obligation of the Trustee.
I have assumed further that the Indenture has been duly authorized, executed and delivered by the
Company and the Guarantors other than the Guarantors listed on Schedule&nbsp;II hereto (the
&#147;Pennsylvania Guarantors&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based upon the foregoing and subject to the qualifications, assumptions and limitations stated
herein, I am of the opinion that upon the issuance and delivery of the Guarantees issued by the
Pennsylvania Guarantors and the due authentication, issuance and delivery of the Securities and
payment therefore in accordance with the Underwriting Agreement, the Guarantees set forth in the
Second Supplemental Indenture issued by the Pennsylvania Guarantors will constitute valid and
legally binding obligations of the Pennsylvania Guarantors enforceable against the Pennsylvania
Guarantors in accordance with their terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The opinion set forth in the paragraph above is subject to the effects of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(i)&nbsp;bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar
laws relating to or affecting creditors&#146; rights generally, (ii)&nbsp;general equitable principles
(whether considered in a proceeding in equity or at law) and (iii)&nbsp;an implied covenant of good
faith and fair dealing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I do not express any opinion herein concerning any law other than the law of the Commonwealth
of Pennsylvania and the federal law of the United States.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I hereby consent to the filing of this opinion letter as Exhibit&nbsp;5.2 to the Company&#146;s Current
Report on Form 8-K filed on June&nbsp;13, 2011 and to the reference to me under the caption &#147;Validity of
the Securities&#148; in the Prospectus included in the Registration Statement, as supplemented by the
prospectus supplement dated June&nbsp;8, 2011.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Laurence G. Miller
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Laurence G. Miller,&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Executive Vice President,<BR>
General Counsel, Chief<BR> Administrative
Officer and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Schedule&nbsp;I</B></FONT>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Guarantors</B></FONT>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Jurisdiction of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Entity</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Formation</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-California, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Airfoil Technologies International-Ohio, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International Investment Corp.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Interventional, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specialized Medical Devices, LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology Holding Company III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Teleflex Holding Company II
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Equities Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Group LLC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX International Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX Medical Wire Products, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TFX North America Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">VasoNova, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">DE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">The Stepic Medical Distribution Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">NY</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Teleflex Medical Incorporated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Medical Products, Ltd.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Schedule&nbsp;II</B></FONT>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><FONT style="FONT-variant: SMALL-CAPS"><B>Pennsylvania Guarantors</B></FONT>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Jurisdiction of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Entity</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Formation</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow International, Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arrow Medical Products, Ltd.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">PA</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
